
<html lang="en"     class="pb-page"  data-request-id="3a1fa450-53fe-443a-8ce5-d3b0183f316a"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;article:article:10.1021/acs.jmedchem.7b01716;issue:issue:10.1021/jmcmar.2018.61.issue-8;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Toward β-Secretase-1 Inhibitors with Improved Isoform Selectivity" /></meta><meta name="dc.Creator" content="Patrik  Johansson" /></meta><meta name="dc.Creator" content="Karin  Kaspersson" /></meta><meta name="dc.Creator" content="Ian K.  Gurrell" /></meta><meta name="dc.Creator" content="Elisabeth  Bäck" /></meta><meta name="dc.Creator" content="Susanna  Eketjäll" /></meta><meta name="dc.Creator" content="Clay W.  Scott" /></meta><meta name="dc.Creator" content="Gvido  Cebers" /></meta><meta name="dc.Creator" content="Philip  Thorne" /></meta><meta name="dc.Creator" content="Michael J.  McKenzie" /></meta><meta name="dc.Creator" content="Haydn  Beaton" /></meta><meta name="dc.Creator" content="Paul  Davey" /></meta><meta name="dc.Creator" content="Karin  Kolmodin" /></meta><meta name="dc.Creator" content="Jörg  Holenz" /></meta><meta name="dc.Creator" content="Mark E.  Duggan" /></meta><meta name="dc.Creator" content="Samantha  Budd Haeberlein" /></meta><meta name="dc.Creator" content="Roland W.  Bürli" /></meta><meta name="dc.Description" content="BACE1 is responsible for the first step in APP proteolysis, leading to toxic Aβ production, and has been indicated to play a key role in the pathogenesis of Alzheimer’s disease. The related isoform..." /></meta><meta name="Description" content="BACE1 is responsible for the first step in APP proteolysis, leading to toxic Aβ production, and has been indicated to play a key role in the pathogenesis of Alzheimer’s disease. The related isoform..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 4, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b01716" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01716" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b01716" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01716" /></link>
        
    
    

<title>Toward β-Secretase-1 Inhibitors with Improved Isoform Selectivity | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b01716" /></meta><meta property="og:title" content="Toward β-Secretase-1 Inhibitors with Improved Isoform Selectivity" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/large/jm-2017-01716g_0012.jpeg" /></meta><meta property="og:description" content="BACE1 is responsible for the first step in APP proteolysis, leading to toxic Aβ production, and has been indicated to play a key role in the pathogenesis of Alzheimer’s disease. The related isoform BACE2 is thought to be involved in processing of the pigment cell-specific melanocyte protein. To avoid potential effects on pigmentation, we investigated the feasibility for developing isoform-selective BACE1 inhibitors. Cocrystal structures of 47 compounds were analyzed and clustered according to their selectivity profiles. Selective BACE1 inhibitors were found to exhibit two distinct conformational features proximal to the flap and the S3 subpocket. Several new molecules were designed and tested to make use of this observation. The combination of a pyrimidinyl C-ring and a methylcyclohexyl element resulted in lead molecule 28, which exhibited ∼50-fold selectivity. Compared to a nonselective BACE1/2 inhibitor, 28 showed significantly less inhibition of PMEL processing in human melanocytes, indicating good functional selectivity of this inhibitor class." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b01716"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b01716">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b01716&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b01716&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b01716&amp;href=/doi/10.1021/acs.jmedchem.7b01716" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 8</span><span class="cit-fg-pageRange">, 3491-3502</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/8" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b01694" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b01775" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Toward β-Secretase-1 Inhibitors with Improved Isoform Selectivity</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Patrik Johansson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Patrik Johansson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Sciences, IMED Biotech Unit, AstraZeneca, S-43183 Mölndal, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Patrik++Johansson">Patrik Johansson</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Karin Kaspersson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Karin Kaspersson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Sciences, IMED Biotech Unit, AstraZeneca, S-43183 Mölndal, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Karin++Kaspersson">Karin Kaspersson</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ian K. Gurrell</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ian K. Gurrell</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Neuroscience, IMED Biotech Unit, AstraZeneca, Cambridge CB21 6GH, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ian+K.++Gurrell">Ian K. Gurrell</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Elisabeth Bäck</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Elisabeth Bäck</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Sciences, IMED Biotech Unit, AstraZeneca, S-43183 Mölndal, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Elisabeth++B%C3%A4ck">Elisabeth Bäck</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Susanna Eketjäll</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Susanna Eketjäll</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Cardiovascular and Metabolic Diseases, IMED Biotech Unit, AstraZeneca, 141 57 Huddinge, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Susanna++Eketj%C3%A4ll">Susanna Eketjäll</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Clay W. Scott</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Clay W. Scott</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Safety, Drug Safety and Metabolism, IMED Biotech Unit, AstraZeneca, Waltham, Massachusetts 02451, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Clay+W.++Scott">Clay W. Scott</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Gvido Cebers</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gvido Cebers</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Neuroscience, IMED Biotech Unit, AstraZeneca, Cambridge CB21 6GH, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gvido++Cebers">Gvido Cebers</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Philip Thorne</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Philip Thorne</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Charnwood Molecular, Loughborough LE11 5DA, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Philip++Thorne">Philip Thorne</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Michael J. McKenzie</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michael J. McKenzie</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Charnwood Molecular, Loughborough LE11 5DA, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michael+J.++McKenzie">Michael J. McKenzie</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Haydn Beaton</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Haydn Beaton</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Charnwood Molecular, Loughborough LE11 5DA, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Haydn++Beaton">Haydn Beaton</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Paul Davey</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Paul Davey</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Oncology Chemistry, IMED Biotech Unit, AstraZeneca, Cambridge CB4 0WG, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Paul++Davey">Paul Davey</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Karin Kolmodin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Karin Kolmodin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Sprint Bioscience, 141 57 Huddinge, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Karin++Kolmodin">Karin Kolmodin</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jörg Holenz</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jörg Holenz</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Neuroscience, IMED Biotech Unit, AstraZeneca, Cambridge CB21 6GH, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=J%C3%B6rg++Holenz">Jörg Holenz</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mark E. Duggan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mark E. Duggan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Neuroscience, IMED Biotech Unit, AstraZeneca, Cambridge CB21 6GH, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mark+E.++Duggan">Mark E. Duggan</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Samantha Budd Haeberlein</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Samantha Budd Haeberlein</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Neuroscience, IMED Biotech Unit, AstraZeneca, Cambridge CB21 6GH, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Samantha++Budd+Haeberlein">Samantha Budd Haeberlein</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Roland W. Bürli</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Roland W. Bürli</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Neuroscience, IMED Biotech Unit, AstraZeneca, Cambridge CB21 6GH, U.K.</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: +44 1223 898071. E-mail: <a href="/cdn-cgi/l/email-protection#35475a59545b511b574047595c75544f5b5040475a1b565a58"><span class="__cf_email__" data-cfemail="6f1d00030e010b410d1a1d03062f0e15010a1a1d00410c0002">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Roland+W.++B%C3%BCrli">Roland W. Bürli</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7377-7628" title="Orcid link">http://orcid.org/0000-0001-7377-7628</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01716&amp;href=/doi/10.1021%2Facs.jmedchem.7b01716" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 8</span><span class="cit-pageRange">, 3491–3502</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 4, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>21 November 2017</li><li><span class="item_label"><b>Published</b> online</span>4 April 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 April 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b01716" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01716</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3491%26pageCount%3D12%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DPatrik%2BJohansson%252C%2BKarin%2BKaspersson%252C%2BIan%2BK.%2BGurrell%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D8%26contentID%3Dacs.jmedchem.7b01716%26title%3DToward%2B%25CE%25B2-Secretase-1%2BInhibitors%2Bwith%2BImproved%2BIsoform%2BSelectivity%26numPages%3D12%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3502%26publicationDate%3DApril%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b01716"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1578</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">16</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b01716" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Toward β-Secretase-1 Inhibitors with Improved Isoform Selectivity&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Patrik&quot;,&quot;last_name&quot;:&quot;Johansson&quot;},{&quot;first_name&quot;:&quot;Karin&quot;,&quot;last_name&quot;:&quot;Kaspersson&quot;},{&quot;first_name&quot;:&quot;Ian&quot;,&quot;last_name&quot;:&quot;K. Gurrell&quot;},{&quot;first_name&quot;:&quot;Elisabeth&quot;,&quot;last_name&quot;:&quot;Bäck&quot;},{&quot;first_name&quot;:&quot;Susanna&quot;,&quot;last_name&quot;:&quot;Eketjäll&quot;},{&quot;first_name&quot;:&quot;Clay&quot;,&quot;last_name&quot;:&quot;W. Scott&quot;},{&quot;first_name&quot;:&quot;Gvido&quot;,&quot;last_name&quot;:&quot;Cebers&quot;},{&quot;first_name&quot;:&quot;Philip&quot;,&quot;last_name&quot;:&quot;Thorne&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;J. McKenzie&quot;},{&quot;first_name&quot;:&quot;Haydn&quot;,&quot;last_name&quot;:&quot;Beaton&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;Davey&quot;},{&quot;first_name&quot;:&quot;Karin&quot;,&quot;last_name&quot;:&quot;Kolmodin&quot;},{&quot;first_name&quot;:&quot;Jörg&quot;,&quot;last_name&quot;:&quot;Holenz&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;E. Duggan&quot;},{&quot;first_name&quot;:&quot;Samantha&quot;,&quot;last_name&quot;:&quot;Budd Haeberlein&quot;},{&quot;first_name&quot;:&quot;Roland&quot;,&quot;last_name&quot;:&quot;W. Bürli&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;04&quot;,&quot;issue&quot;:&quot;8&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;3491-3502&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b01716&quot;},&quot;abstract&quot;:&quot;BACE1 is responsible for the first step in APP proteolysis, leading to toxic Aβ production, and has been indicated to play a key role in the pathogenesis of Alzheimer’s disease. The related isoform BACE2 is thought to be involved in processing of the pigment cell-specific melanocyte protein. To avoid potential effects on pigmentation, we investigated the feasibility for developing isoform-selective BACE1 inhibitors. Cocrystal structures of 47 compounds were analyzed and clustered according to their selectivity profiles. Selective BACE1 inhibitors were found to exhibit two distinct conformational features proximal to the flap and the S3 subpocket. Several new molecules were designed and tested to make use of this observation. The combination of a pyrimidinyl C-ring and a methylcyclohexyl element resulted in lead molecule 28, which exhibited ∼50-fold selectivity. Compared to a nonselective BACE1/2 inhibitor, 28 showed significantly less inhibition of PMEL processing in human melanocytes, indicating good functio&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01716&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01716" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01716&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01716" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01716&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01716" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01716&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01716&amp;href=/doi/10.1021/acs.jmedchem.7b01716" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b01716" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b01716" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b01716%26sid%3Dliteratum%253Aachs%26pmid%3D29617572%26genre%3Darticle%26aulast%3DJohansson%26date%3D2018%26atitle%3DToward%2B%25CE%25B2-Secretase-1%2BInhibitors%2Bwith%2BImproved%2BIsoform%2BSelectivity%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D8%26spage%3D3491%26epage%3D3502%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/8" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/jmcmar.2018.61.issue-8/20180426/jmcmar.2018.61.issue-8.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/medium/jm-2017-01716g_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/large/jm-2017-01716g_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01716&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">BACE1 is responsible for the first step in APP proteolysis, leading to toxic Aβ production, and has been indicated to play a key role in the pathogenesis of Alzheimer’s disease. The related isoform BACE2 is thought to be involved in processing of the pigment cell-specific melanocyte protein. To avoid potential effects on pigmentation, we investigated the feasibility for developing isoform-selective BACE1 inhibitors. Cocrystal structures of 47 compounds were analyzed and clustered according to their selectivity profiles. Selective BACE1 inhibitors were found to exhibit two distinct conformational features proximal to the flap and the S3 subpocket. Several new molecules were designed and tested to make use of this observation. The combination of a pyrimidinyl C-ring and a methylcyclohexyl element resulted in lead molecule <b>28</b>, which exhibited ∼50-fold selectivity. Compared to a nonselective BACE1/2 inhibitor, <b>28</b> showed significantly less inhibition of PMEL processing in human melanocytes, indicating good functional selectivity of this inhibitor class.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77041" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77041" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Cerebral formation of amyloid β peptides (Aβ) of 38–43 amino acid length and subsequent aggregation/plaque formation have long been established as a hallmark of Alzheimer’s disease (AD).<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> These toxic Aβ peptides result from processing the amyloid precursor protein (APP) by proteases; specifically, cleavage of the APP protein by the β-site APP cleaving enzyme 1, commonly known as β-secretase 1 or BACE1, constitutes the first step in APP degradation leading to the membrane-bound intermediate called C99 and a soluble fragment (sAPPβ).<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Further fragmentation of C99 by γ-secretase then liberates the toxic Aβ peptides.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4,5)</a> This cascade of events leading to Aβ fragments, combined with incomplete Aβ removal, eventually leads to plaque deposits and ultimately degeneration of neuronal structure and function. Notably, other forms of secretases have been implicated in APP processing and the spatial and temporal interplay of activities of these individual proteases in different brain tissues at various time points is clearly complex and not fully understood.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6,7)</a> Supporting target validation for BACE1 is the fact that familial Alzheimer’s disease mutations like the Swedish mutations K670N, M671L, and A673 V, respectively, which are located proximal to the BACE1 cleavage site of APP, increase processing, thus leading to elevated Aβ production.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8,9)</a> In contrast, the A673T mutation impairs BACE1-mediated APP cleavage and appears to have a protective effect.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Taken together, these genetic and mechanistic data form a strong hypothesis for BACE1 inhibition as a disease-modifying therapy for patients who are at risk of developing AD. Thus, extensive research has been conducted since the unraveling of the role of the BACE1 protease in APP processing which has led to inhibitors with remarkable potency and brain permeability, several of which are subject to ongoing clinical efficacy studies.<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11,12)</a></div><div class="NLM_p">While the role of BACE1 has been extensively investigated and a number of substrates with biologically relevant functions at various developmental stages have been reported, less is known about the second isoform, β-secretase 2 (BACE2).<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> However, there are several studies indicating that BACE2 adopts an important role in melanogenesis. In mice, it has been demonstrated that BACE2-mediated cleavage of the pigment cell-specific melanocyte protein (PMEL) is required to form functional (nonpathogenic) amyloid fibrils during melanogenesis.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Consistent with this finding, BACE2 is highly expressed in pigment cells and genetic ablation of this enzyme leads to coat color defects in BACE2<sup>–/–</sup>, which has not been observed in BACE1<sup>–/–</sup> mice. It has recently been confirmed that wild type as well as BACE2<sup>+/–</sup> and BACE2<sup>–/–</sup> mice upon treatment with a nonselective BACE1/2 inhibitor display a reversible, dose-dependent appearance of depigmented hair which may indicate that in the absence of BACE2, BACE1 can partially compensate for its function in melanogenesis.<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15,16)</a> Consistent with these data, a distinct phenotype has been documented for migration of zebra fish melanocytes carrying mutations in BACE2 but not in BACE1.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Notably, other substrates for BACE2 have been discovered that may be affected by a nonselective BACE inhibitor.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div><div class="NLM_p">The majority of BACE inhibitors documented to date do not address subtype selectivity.<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11,12)</a> While it is currently not fully understood if or to which extent the observations in BACE2-impaired mice and zebra fish might translate to humans who are treated with a nonselective β-secretase inhibitor, it is encouraging that no changes in melanisation levels were observed in skin biopsies of human subjects following 12 days of daily lanabecestat (AZD3293, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) treatment at doses of up to 150 mg per day.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/medium/jm-2017-01716g_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/large/jm-2017-01716g_0001.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures and biochemical activities for AZ3839 and lanabecestat (AZD3293).<a onclick="showRef(event, 'ref12 ref19'); return false;" href="javascript:void(0);" class="ref ref12 ref19">(12,19)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/large/jm-2017-01716g_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01716&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">We set out to investigate the feasibility of developing a BACE2-sparing inhibitor as it has yet to be shown in patients that BACE2 inhibition over a prolonged period will not result in a peripheral effect. As part of this strategy, selective inhibition of BACE1 needs to be combined with other properties such as good cell-based potency, blood–brain barrier (BBB) permeability, low metabolic clearance and minimal risk for off target activities.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35753" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35753" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">To gain insights on which structural elements of non-peptido-mimetic BACE inhibitors may influence isoform selectivity, we analyzed biochemical inhibitory data of a total of 257 compounds for which we had activities for both human BACE isoforms. These inhibitors represent a diverse range of structures analogous to AZD3839 (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>)<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> with substitution patterns leading to variable selectivity characteristics. The data used for this comparison were based on testing the inhibitory effect of compounds on the human BACE1 or BACE2 forms. The same fluorescently labeled peptide substrate designed to span across the BACE cleavage site of APP was used in both protease assays. A large number of compounds displayed minimal desired selectivity or even a slight preference for BACE2, while about 55 inhibitors showed a greater than 10-fold preference for inhibiting the BACE1 isoform.</div><div class="NLM_p">Encouraged by this finding, we analyzed the structure–selectivity relationship and the active site pockets of the two proteases. BACE1 features a wide binding site crevice containing two catalytic residues D32 and D228. The pocket is lined by a long flexible β hairpin flap that shields the active side chains. Residue Y71 of the flap has been shown to play a critical role in the conformation of the hairpin for both substrate and inhibitor binding. In the BACE1 apo structure (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1W50">1W50</a>)<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> as well as in many structures containing ligands, the hydroxy group of Y71 interacts with the indole nitrogen of W76, closing the flap and acting as a gate to the S2′ pocket.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> However, most larger ligands expand into the S2′ pocket, rotating the tyrosine side chain toward the tip of the hairpin.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> A second loop located on the other side of the wide substrate binding cleft, near S10, forms a deep water-filled crevice termed the S3 subpocket. The S10 loop has been shown to exhibit two discrete ligand-induced conformations connected to the complicated water network of the pocket. Compounds that do not disturb this hydrogen bond network retain the S3 subpocket in its open conformation (see <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>), while even a minimal displacement of the top S3 water molecule causes the pocket to collapse. This conformational change is typically associated with a substantial potency gain, possibly due to the release of four well-coordinated H<sub>2</sub>O molecules into bulk solvent.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Proximal to the two catalytic aspartate residues, the active sites of the BACE1 and BACE2 isoforms are structurally highly homologous. However, several differences exist within the second layer and toward the edge of the relatively large pockets. The two β-secretases exhibit four substitutions between G66 and W76 of the flap hairpin of BACE1 (between D82 and W92 in BACE2), whereby the residues P70 and K75 located above the catalytic dyad are particularly important. Just beneath the flap, R128 is replaced by K144 in BACE2, decorating one of the sides of the S2′ pocket.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> The neighboring loop connecting β6 and β7 contains several substitutions including K107/N123, I110/L126, N111/P127, and S113/I129, shaping the rim above the S1 pocket differently in BACE1 compared to BACE2. However, despite of amino acid changes like Q12/R28, L152/M168, and L154/M170 proximal to the S10 loop, the BACE2 S3 subpocket features a complex water network that is very similar to that of BACE1.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/medium/jm-2017-01716g_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/large/jm-2017-01716g_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Crystal structures of BACE inhibitors with variable BACE1 selectivity bound to BACE1: red (<3-fold), yellow (3- to 10-fold), green (>10-fold). The most selective compounds were found to induce a conformational change of the BACE1 flap and/or to interact with a well-conserved H<sub>2</sub>O keeping the BACE1 S3 subpocket in an open conformation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/large/jm-2017-01716g_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01716&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Of the above tested 257 inhibitors, we had crystal structures of 47 inhibitors bound to BACE1 available to probe for differences that could be correlated with the observed selectivity. To analyze these inhibitors, we categorized them into three groups according to their selectivity profile: red (<3-fold); yellow (3- to 10-fold); green (>10-fold). This comparison highlighted two distinct structural features influencing selectivity (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>): compounds bearing a substituent that reaches into the S3 subpocket tend to display no or little selectivity, whereas molecules that present an H-bond acceptor interacting with the top S3 water molecule show a trend for improved BACE1 selectivity. This observation might be attributed to the difference in property of the top S3 water molecules when bound to the two isoforms, combined with the large gain in desolvation energy when the C-ring substituent enters the S3 subpocket, releasing the signature H<sub>2</sub>O molecules.</div><div class="NLM_p">We also noted that many inhibitors with preference for inhibiting BACE1 tend to induce a conformational change to the flap loop and push it outward. In many of the co-structures of nonselective inhibitors bound to BACE1, Y71 is within hydrogen bonding distance of the backbone carbonyl of K107 in the loop between β6 and β7. Strikingly, the most selective compounds push the flap element outward by more than 2 Å, shifting the Y71 side chain toward the backbone carbonyl of D106. In BACE2, D106 is replaced by E122 and K107 by N123, respectively. This change, combined with the G66/D82, Y68/T84, P70/K86, K75/S91 differences in the BACE1/2 hairpin, might lead to less flexibility in the BACE2 flap, thus rendering BACE2 less tolerant toward inhibitors that occupy the space close to Y71 and induce a conformational change. Notably, a recently published molecular dynamics study also arrived at the conclusion that the BACE1 active site cavity is more spacious in the flap region as compared to that of BACE2.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><div class="NLM_p">Although this structure-selectivity relationship around the flap and the S3 subpocket did show promise, the most selective chemotypes in this analysis had functionalities that would likely hamper their further development due to lack of BBB permeability and/or other undesired properties. Our next goal was to incorporate the above-described principles in the design of compounds with balanced properties and improved selectivity for BACE1 inhibition. The di-spiro core motif of lanabecestat, our potent pan BACE1/2 inhibitor that is currently studied in advanced clinical trials, served as an excellent starting point for this study. In the design of new inhibitors, we aimed to probe the effect of intruding the S3 subpocket and increasing the steric demand of the cyclohexyl unit adjacent to the flap loop. Further, in line with the properties of lanabecestat as well as literature data, we intended to keep compounds weakly basic with a p<i>K</i><sub>a</sub> value for the conjugate protonated form between 6 and 8 and their lipophilicity as well as polar surface areas within acceptable range.<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26,27)</a> We decided to restrict the number of H-bond donors to two for the NH<sub>2</sub> group in order to minimize the challenges with brain permeability. In this context, aminooxazoline xanthenes have previously been reported to exhibit a low propensity for Pgp-mediated efflux.<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28,29)</a> Thus, to optimize isoform selectivity and brain exposure, we elected to combine the Asp-interacting aminooxazoline group with our previously reported di-spiro core motif of lanabecestat.<a onclick="showRef(event, 'ref12 ref30'); return false;" href="javascript:void(0);" class="ref ref12 ref30">(12,30)</a></div><div class="NLM_p">Our initial compounds, the phenyl nitriles <b>18</b> and <b>20</b>, displayed promising cell-based potency but no preference for inhibiting BACE1 over BACE2 (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). As anticipated by modeling, the chlorophenyl nitrile <b>18</b> is ∼100-fold more potent than its enantiomer <b>17</b>. We synthesized the corresponding dideuterio analogs <b>19</b> and <b>21</b> in anticipation that deuteration of the methylene group at the partially saturated oxazole unit may slow down metabolism.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> While with these match pairs no significant difference in the metabolic turnover was found, in some instances, we observed a trend toward reduced efflux ratio in MDCK cells overexpressing P-glycoprotein 1 (also known as multidrug resistance gene 1, MDR1). For instance, the dihydrooxazole <b>20</b> showed a higher efflux ratio than the dideutero analog <b>21</b> (3.1 vs. 1.8, respectively). An in vivo pharmacokinetic study further indicated that relative to their nondeuterated match pairs (<b>18</b> and <b>20</b>), the deuterated analogs <b>19</b> and <b>21</b> displayed improved Kp<sub>u,u</sub> values, i.e., ratios of unbound brain to plasma concentrations (Kp<sub>u,u</sub> of 0.21 for <b>18</b>, 0.68 for <b>19</b>, 0.07 for <b>20</b>, and 0.27 for <b>21</b>, respectively; for details, see <a href="/doi/suppl/10.1021/acs.jmedchem.7b01716/suppl_file/jm7b01716_si_001.pdf" class="ext-link">Supporting Information</a>). Encouraged by these preliminary data, we decided to keep the CD<sub>2</sub> group intact for the subsequent structure–activity relationship studies. Following the design guidelines described above, the next step was to investigate compounds without a C-ring substituent to avoid occupancy of the S3 subpocket. For this, we introduced known heterocyclic C-rings such as pyridines and pyrimidines,<a onclick="showRef(event, 'ref19 ref28'); return false;" href="javascript:void(0);" class="ref ref19 ref28">(19,28)</a> which may present an H-bond acceptor functionality pointing toward the S3 subpocket. Indeed, the unsubstituted pyridine <b>22</b> and pyrimidine <b>24</b> displayed moderate preferences for inhibiting BACE1, whereas methylating the pyridine ring resulted in significant loss of biochemical activity (see <b>23</b>), presumably due to an unproductive conformational change.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/medium/jm-2017-01716g_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/large/jm-2017-01716g_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Left: Structure of less active enantiomer <b>17</b>. Right: Generic structure for compounds <b>18</b>–<b>24</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/large/jm-2017-01716g_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01716&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. In Vitro Biological and DMPK Data for Compounds <b>17</b>−<b>24</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/medium/jm-2017-01716g_0011.gif" alt="" id="fx1" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup><sup>a</sup></sup><p class="last">Cell-based potency as determined by sAPPβ release in SH-SY5Y cells (standard deviation, number of repeats),</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">biochemical inhibitory activity for BACE1 and BACE2 (standard deviation, number of repeats),</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">efflux ratios (ER) as measured in MDR1 overexpressing MDCK cells,</p></div><div class="footnote" id="t1fn4"><sup><sup>d</sup></sup><p class="last">metabolic stability in the presence of human liver microsomes (HLM, μg/ min/mg) and</p></div><div class="footnote" id="t1fn5"><sup><sup>e</sup></sup><p class="last">rat hepatocytes (rHeps, μg/ min/10<sup>6</sup> cells),</p></div><div class="footnote" id="t1fn6"><sup><sup>f</sup></sup><p class="last">n.d.: not determined.</p></div></div><div></div></div><div class="NLM_p">The compounds described in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> were synthesized according to <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Tebbe methylenation of the commercially available indanone <b>1</b> resulted in alkene <b>2</b>.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> The corresponding dideuterated alkene <b>3</b> was synthesized by a Wittig-type olefination using triphenyl(trideuteriomethyl)phosphonium iodide. The aminooxazolines <b>4</b> and <b>5</b> were constructed in two steps by treating the corresponding olefins (<b>2</b>, <b>3</b>) with in situ formed iodoisocyanate followed by NH<sub>4</sub>OH. Enantiomers were separated by supercritical fluid chromatography on a chiral stationary phase (→<b>6</b>–<b>9</b>) and the resulting bromides converted to the final compounds <b>17</b>–<b>24</b> under standard Pd-mediated coupling conditions.</div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/medium/jm-2017-01716g_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/large/jm-2017-01716g_0009.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>17</b>–<b>24</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/large/jm-2017-01716g_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01716&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents: (a) Tebbe’s reagent, THF, 0 °C, 95%; (b) Ph<sub>3</sub>CD<sub>3</sub>PI, <i>n</i>-BuLi, −30 °C, 85%; (c) AgNCO, I<sub>2</sub>, THF, CH<sub>3</sub>CN, 22 °C, then THF, NH<sub>4</sub>OH, 84% (<b>4</b>), or 82% (<b>5</b>); (d) chiral SFC; (e) arylbromide, 1,1-bis(di-<i>tert</i>-butylphosphino)ferrocene palladium dichloride, K<sub>2</sub>CO<sub>3</sub>, H<sub>2</sub>O, 1,4-dioxane, 100 °C.</p></p></figure><div class="NLM_p">A crystal structure of compound <b>23</b> bound to BACE1 led to an unambiguous assignment of the absolute configuration of <b>23</b>, as well as the precursor <b>9</b> from which it derived (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> The absolute configuration of the other molecules was determined based on this assignment.</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/medium/jm-2017-01716g_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/large/jm-2017-01716g_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Cocrystal structure of compound <b>23</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EJ3">6EJ3</a>) bound to BACE1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/large/jm-2017-01716g_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01716&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Notably, compared to the biochemical activity, most compounds displayed improved cellular potency as determined by analysis of sAPPβ release in SH-SY5Y cells. This observed “drop-on effect” may be caused by several factors; on the one hand, the fluorescently labeled peptide used in the biochemical assay may be processed less efficiently by the protease than membrane-bound, full-length APP. On the other hand, the pH within the subcellular microenvironment where BACE1 processes APP may slightly differ from the biochemical assay, thus resulting in increased proteolytic activity of BACE.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> We reasoned that low nanomolar cellular potency will be the critical factor for a successful BACE1 inhibitor and used the biochemical activities to understand isoform selectivity.</div><div class="NLM_p">On the basis of our initial structure–selectivity relationship analysis, we hypothesized that substitution at the cyclohexyl moiety of the di-spiro unit may influence the conformation of the proteases in the flap region. As described above, such an induced fit might be more readily achieved in BACE1 than in BACE2, thus contributing to subtype selectivity. We therefore initiated a small but systematic study to explore the effect of one or two alkyl groups at the cyclohexane ring with the above-described pyrimidyl unit as the preferred C-ring (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>).</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/medium/jm-2017-01716g_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/large/jm-2017-01716g_0005.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Structures <b>25</b>–<b>29</b> for <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/large/jm-2017-01716g_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01716&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. In Vitro Biological and DMPK Data for Compounds <b>25</b>−<b>29</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">cell (IC<sub>50</sub>, nM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">BACE1 (<i>K</i><sub>i</sub>, nM)<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">BACE2 (<i>K</i><sub>i</sub>, nM)<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i(BACE2)</sub>/<i>K</i><sub>i(BACE1)</sub></th><th class="colsep0 rowsep0" align="center">MDR1-MDCK (ER)<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">HLM (CL<sub>int</sub>)<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center">rHeps (CL<sub>int</sub>)<a class="ref internalNav" href="#t2fn5" aria-label="e">e</a></th><th class="colsep0 rowsep0" align="center">hERG<a class="ref internalNav" href="#t2fn6" aria-label="f">f</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">1.5 (0.04, <i>n</i> = 2)</td><td class="colsep0 rowsep0" align="left">45 (26, <i>n</i> = 7)</td><td class="colsep0 rowsep0" align="left">1011 (85, <i>n</i> = 7)</td><td class="colsep0 rowsep0" align="left">23</td><td class="colsep0 rowsep0" align="left">4.3</td><td class="colsep0 rowsep0" align="left">187</td><td class="colsep0 rowsep0" align="left">137</td><td class="colsep0 rowsep0" align="left">n.d.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">0.9 (0.33, <i>n</i> = 2)</td><td class="colsep0 rowsep0" align="left">118 (73, <i>n</i> = 4)</td><td class="colsep0 rowsep0" align="left">1299 (387, <i>n</i> = 4)</td><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left">4.5</td><td class="colsep0 rowsep0" align="left">52.4</td><td class="colsep0 rowsep0" align="left">82</td><td class="colsep0 rowsep0" align="left">>33 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">0.91 (0.56, <i>n</i> = 3)</td><td class="colsep0 rowsep0" align="left">25 (11, <i>n</i> = 3)</td><td class="colsep0 rowsep0" align="left">443 (25, <i>n</i> = 3)</td><td class="colsep0 rowsep0" align="left">18</td><td class="colsep0 rowsep0" align="left">5.0</td><td class="colsep0 rowsep0" align="left">149</td><td class="colsep0 rowsep0" align="left">138</td><td class="colsep0 rowsep0" align="left">15%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">1.1 (0.51, <i>n</i> = 10)</td><td class="colsep0 rowsep0" align="left">16 (7.6, <i>n</i> = 11)</td><td class="colsep0 rowsep0" align="left">817 (213, <i>n</i> = 11)</td><td class="colsep0 rowsep0" align="left">52</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">47</td><td class="colsep0 rowsep0" align="left">66</td><td class="colsep0 rowsep0" align="left">>33 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">2.0 (0.09, <i>n</i> = 3)</td><td class="colsep0 rowsep0" align="left">45 (18, <i>n</i> = 3)</td><td class="colsep0 rowsep0" align="left">2022 (55, <i>n</i> = 3)</td><td class="colsep0 rowsep0" align="left">45</td><td class="colsep0 rowsep0" align="left">3.6</td><td class="colsep0 rowsep0" align="left">153</td><td class="colsep0 rowsep0" align="left">158</td><td class="colsep0 rowsep0" align="left">29%</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Cell-based potency as determined by sAPPβ release in SH-SY5Y cells (standard deviation, number of repeats),</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">biochemical inhibitory activity for BACE1 and BACE2 (standard deviation, number of repeats),</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">efflux ratios (ER) as measured in MDR1 overexpressing MDCK cells,</p></div><div class="footnote" id="t2fn4"><sup><sup>d</sup></sup><p class="last">metabolic stability in the presence of human liver microsomes (HLM, μg/ min/mg) and</p></div><div class="footnote" id="t2fn5"><sup><sup>e</sup></sup><p class="last">rat hepatocytes (rHeps, μg/ min/10<sup>6</sup> cells),</p></div><div class="footnote" id="t2fn6"><sup><sup>f</sup></sup><p class="last">hERG activity:<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> either percentage activity at 11.1 μM or IC<sub>50</sub> value (μM).</p></div></div></div><div class="NLM_p">The dimethylcyclohexane <b>25</b> (rac) showed low nanomolar cell-based activity and a promising 23-fold selectivity for BACE1. Unfortunately, this compound was very unstable in the presence of microsomes or hepatocytes, likely due to the added lipophilicity. The ethyl analogs <b>27</b> and <b>29</b> were also highly metabolized, whereas the slightly less lipophilic methyl isomers <b>26</b> and <b>28</b> displayed improved resistance to metabolism. In accordance to our design hypothesis, all five compounds preferentially inhibited BACE1 over the other isoform. The methyl and ethyl substituted compounds <b>28</b> and <b>29</b>, which place the alkyl group toward the R128 side chain near the flap loop, exhibited the most promising selectivity patterns with a 52- and 45-fold preference for BACE1.</div><div class="NLM_p">Compounds bearing alkyl substituents at the cyclohexyl moiety were synthesized as illustrated in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. A double 1,4-addition to the indanone <b>10</b> followed by a Dieckmann cyclization, methylation, and decarboxylation resulted in racemic α-methyl ketone <b>11</b>. Regio- and stereoselective reduction of this diketone (<b>11</b>) using NaBH<sub>4</sub>/CeCl<sub>3</sub> provided alcohol <b>12</b> (rac) which was methylated to yield the corresponding ether <b>13</b> (rac). Dideuteriomethylenation under Wittig-type conditions as described above gave the olefin <b>14</b> (rac) which was further converted to the corresponding dideuteriooxazole-2-amine, and enantioseparation of the resulting products by supercritical fluid chromatography provided the key intermediates <b>15</b> and <b>16</b>. The intermediates for the synthesis of compounds <b>25</b>, <b>27</b>, and <b>29</b>, respectively, were synthesized in an analogous fashion as described above (documented in the <a href="/doi/suppl/10.1021/acs.jmedchem.7b01716/suppl_file/jm7b01716_si_001.pdf" class="ext-link">Supporting Information</a>). In the ultimate step, Pd-mediated coupling of pyrimidin-5-ylboronic acid to the corresponding bromo-intermediates provided final compounds <b>25</b>–<b>29</b>, respectively. All final compounds were purified by HPLC and analyzed by <sup>1</sup>H NMR spectroscopy, high-resolution mass spectroscopy, and analytical HPLC and displayed purities in excess of 95%.</div><figure id="sch2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/medium/jm-2017-01716g_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/large/jm-2017-01716g_0010.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds Shown in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/large/jm-2017-01716g_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01716&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents: (a) methyl acrylate, CH<sub>3</sub>I, KO<sup><i>t</i></sup>Bu, THF, then LiOH·H<sub>2</sub>O, THF, H<sub>2</sub>O, 44% (2 steps); (b) CeCl<sub>3</sub>·7H<sub>2</sub>O, NaBH<sub>4</sub>, THF, −70 °C, 56%; (c) CH<sub>3</sub>I, NaH, DMF, 0 °C, 67%; (d) Ph<sub>3</sub>CD<sub>3</sub>PI, <i>n</i>-BuLi, THF, −30 °C, 76%; (e) AgNCO, I<sub>2</sub>, THF, CH<sub>3</sub>CN, 22 °C, then THF, NH<sub>4</sub>OH, 84%; (f) aryl bromide, 1,1-bis(di-<i>tert</i>-butylphosphino)ferrocene palladium dichloride, K<sub>2</sub>CO<sub>3</sub>, H<sub>2</sub>O, 1,4-dioxane, 100 °C.</p></p></figure><div class="NLM_p">A crystal structure of pyrimidine <b>28</b> bound to the active site of BACE1 allowed the assignment of the relative and absolute configuration of this compound as well as its precursor <b>15</b> (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>).<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> The configurations of the remaining final compounds derived from <b>15</b> were unambiguously assigned based on this information. As anticipated, the CH<sub>3</sub>-substituted cyclohexane of <b>28</b> was found to open the flap conformation, with the methyl group pointing outward from the induced S2′ pocket. This places the CH<sub>3</sub> group between the Cβ of Y71 and the side chain of R128, which is replaced by K144 in BACE2. The structure also demonstrates how the pyrimidine ring offers a ring nitrogen as an H-bond acceptor to the water molecule in the S3 subpocket.</div><figure id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/medium/jm-2017-01716g_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/large/jm-2017-01716g_0006.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Cocrystal structure of compound <b>28</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EJ2">6EJ2</a>) bound to the active site of BACE1. Top: Inhibitor <b>28</b> bound to the active site. Middle: Methylcyclohexyl inducing an open flap conformation. Bottom: Pyrimidyl nitrogen engaging in the H-bond network within the S3 subpocket.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/large/jm-2017-01716g_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01716&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The calculated physicochemical properties of pyrimidine <b>28</b> are similar to those of lanabecestat: formal removal of the propynyl unit and introduction of a second nitrogen to the C-ring led to a lower molecular weight (378.5 vs. 412.5) and a higher polar surface area (75.6 vs. 66.2 Å<sup>2</sup>), while the predicted basicity of both inhibitors is very similar (p<i>K</i><sub>a</sub> of 6.7 vs 6.9). As compound <b>28</b> displayed the best overall profile, we studied it in more detail in vitro and in vivo. Encouragingly, lead molecule <b>28</b> did not show propensity to interact with the human ether-a-go-go-related gene channel (hERG) up to 33 μM concentrations, a characteristic that has plagued previously reported BACE inhibitors.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Further, compound <b>28</b> did not show any inhibitory activity for cathepsin D, cathepsin S, renin, and pepsin at concentrations up to 100 μM, indicating that it is a very selective protease inhibitor. We also set up an assay in human melanocytes to compare its BACE2-mediated activity with lanabecestat.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Following a protocol by Rochin et al.,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Mβ levels were quantified by Western blotting to assess functional BACE2 activity.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> It has previously been demonstrated that Mβ, a cleavage product of PMEL, is further processed by BACE2; hence, its inhibition should result in Mβ accumulation. The Western blot shown in <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a> indeed confirmed that lanabecestat gave rise to significant Mβ accumulation whereas treatment of the melanocytes with compound <b>28</b> led to a slight increase of Mβ only at much higher concentrations (∼10 μM), which is consistent with its selectivity pattern.</div><figure id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/medium/jm-2017-01716g_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/large/jm-2017-01716g_0007.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Comparison of compound <b>28</b> with lanabecestat (AZD3293, IC<sub>50(BACE1)</sub> = 0.6 nM; IC<sub>50(BACE2)</sub> = 0.9 nM) on PMEL processing. Human melanocyte (MNT1) cells were incubated with different concentrations of BACE inhibitors or vehicle (0.1% DMSO) and processed to identify parent PMEL (P1) and proteolytically cleaved Mβ fragment. Mβ fragment accumulates when BACE2 is inhibited.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/large/jm-2017-01716g_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01716&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A pharmacokinetic study in rat indicated that the pyrimidine <b>28</b> distributed well into brain tissue with a Kp<sub>u,u</sub> of 0.37; however, it also exhibited high systemic clearance. The brain distribution of <b>28</b> was commensurate with its physicochemical properties and moderate efflux observed in the MDR1-MDCK assay. We subsequently performed an in vivo PK/PD study in C57BL/6 mice with the objective to investigate whether compound <b>28</b> has the potential for reducing Aβ levels in peripheral (blood) and central (brain) compartments.</div><div class="NLM_p">Following oral administration to C57BL/6 mice, <b>28</b> exhibited a robust, exposure-driven reduction in Aβ<sub>40</sub> plasma concentrations (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>). In brain tissue, we observed a less pronounced trend toward reduced Aβ<sub>40</sub> and Aβ<sub>42</sub> concentrations, when compared to vehicle control. This result is consistent with the finding that <b>28</b> is still a mild substrate for the P-glycoprotein efflux transporter (Pgp) and free brain concentrations are lower than free plasma exposure. At the 3 h time point, compound <b>28</b> induced a ∼30% reduction of Aβ<sub>42</sub> with a free brain concentration of ∼50 nM (<b>28</b>). This magnitude of Aβ<sub>42</sub> reduction is in the range of that observed for AZD3839 (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), AstraZeneca’s initial clinical candidate.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div><figure id="fig8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/medium/jm-2017-01716g_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/large/jm-2017-01716g_0008.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. PK/PD study in mice following 50 mg/kg oral administration (po). Top: Free brain and plasma exposure of compound <b>28</b> over time. Bottom: Aβ<sub>40</sub> and Aβ<sub>42</sub> levels in brain and peripheral Aβ<sub>40</sub> levels over time.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/large/jm-2017-01716g_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01716&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62068" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62068" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">An analysis of biochemical activity and structural data of BACE inhibitors with variable isoform selectivity revealed new design guidelines pointing to elements that can be modified to improve selectivity for BACE1 inhibition. We found that a hydrogen bond acceptor in proximity of the S3 subpocket in combination with a small substituent at the cyclohexyl A-ring occupying the volume neighboring the flap region led to optimal BACE1 selectivity. It is conceivable that these “selectivity hotspots” can be exploited in a similar manner using known BACE inhibitors such as aminohydantoins or other scaffolds as structural starting points.<a onclick="showRef(event, 'ref11 ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref11 ref36 ref37">(11,36,37)</a> A number of new inhibitors were investigated starting from a central di-spiro scaffold and an aminooxazoline headgroup. We replaced the CH<sub>2</sub> element of this head group by CD<sub>2</sub>, initially with the aim to reduce metabolic vulnerability. While there was no marked change in metabolism between deuterated and nondeuterated analogs, a trend toward reduced Pgp-mediated efflux has been observed. The deuteriomethylene group was therefore kept intact for this study. Pyrimidine <b>28</b> displayed a 52-fold selectivity for BACE1 inhibition, low nanomolar cellular activity (1.1 nM), and a good overall profile (including no hERG interaction and cathepsin D, renin, or pepsin inhibition). To demonstrate that a BACE1 selective inhibitor exhibits reduced potential for altering pigmentation, we set up a melanocyte assay. Compound <b>28</b> showed Mβ accumulation only at very high concentrations (∼10 μM) while lanabecestat, a nonselective BACE1/2 inhibitor, displayed a significant effect at ∼10 nM. In vivo, pyrimidine <b>28</b> is relatively highly cleared in rodents but showed an exposure-dependent trend toward Aβ<sub>40</sub> and Aβ<sub>42</sub> reduction in brain tissue. Further studies with <b>28</b> and analogs in mice and other species will be required to evaluate the potential of this chemotype for further development.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28630" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28630" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Commercially available anhydrous solvents were routinely used for reactions. Room temperature (rt) refers to 20–25 °C. Nuclear magnetic resonance (NMR) spectra were recorded on a 400 MHz Jeol JNM-LA400 spectrometer fitted with a probe of suitable configuration. Spectra were recorded at rt unless otherwise stated. Chemical shifts are given in parts per million (ppm) with resonance multiplicities denoted as s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), br (broad), and app (apparent), respectively. The high-resolution mass spectroscopy (HRMS) analysis was carried using a Quattro Xevo Qtof in full scan ESI positive ion mode with leucine enkephalin as the lock mass. Mass spectrometry (MS) analysis was performed in positive or negative ion mode using electrospray ionization (ESI<sup>±</sup>) or atmospheric pressure chemical ionization (APCI<sup>±</sup>). High pressure liquid chromatography (HPLC) analysis was performed using a Waters system with Agilent Poroshell 120 SB-C18 column (2.7 mm, 4.6 mm i.d. × 30 mm). Mobile phases consisted of CH<sub>3</sub>CN and H<sub>2</sub>O, both containing 0.1% v/v formic acid. Diode array data were captured from 210 to 400 nm. Final compounds displayed purities of ≥95%. The optical rotations were determined on an Autopol III automatic polarimeter using a 100 mm cell at 26.0 °C (average of 5 × 5 scans).</div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> General Procedure 1</h3><div class="NLM_p last">Under N<sub>2</sub> at rt, a mixture of aryl bromide (1 equiv), boronic acid (2 equiv), 1,1-bis(di<i>tert</i>-butylphosphino)ferrocene palladium dichloride (0.1 equiv) in 1,4-dioxane (3 mL) was treated with a solution of K<sub>2</sub>CO<sub>3</sub> (3 equiv) in H<sub>2</sub>O (1 mL) and heated at 100 °C for 2–4 h. The mixture was cooled to rt, treated with Deloxan (Pd scavenger resin), stirred for 15 min, and concentrated in vacuo. The residue was suspended in CH<sub>2</sub>Cl<sub>2</sub>, filtered, concentrated, and purified by HPLC (Gilson, 0.2% NH<sub>3</sub> or 0.1% HCOOH or 0.1% TFA in H<sub>2</sub>O/CH<sub>3</sub>CN). Evaporation and freeze-drying afforded the title compound.</div></div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> (1<i>r</i>,4<i>r</i>)-6′-Bromo-4-methoxy-1′-methylene-1′,3′-dihydrospiro[cyclohexane-1,2′-indene] (<b>2</b>)</h3><div class="NLM_p last">To a stirred solution of 6′-bromo-4-methoxy-spiro[cyclohexane-1,2′-indane]-1′-one <b>1</b> (6.18 g, 20.0 mmol) in THF (200 mL) at 0 °C under N<sub>2</sub> was added a 1 M solution of Tebbe’s reagent (44 mL, 22 mmol) in toluene over 5 min. The mixture was warmed to rt, stirred for 64 h, and diluted with Et<sub>2</sub>O (100 mL) and 0.1 M aq NaOH solution (10 mL). The layers were separated and the organic phase dried (MgSO<sub>4</sub>), filtered (Celite), and evaporated. Flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>) gave the title compound as a solid (5.86 g, 95%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 1.34–1.44 (m, 2H), 1.48–1.66 (m, 4H), 2.00–2.08 (m, 2H), 2.84 (s, 2H), 3.18–3.28 (m, 1H), 3.38 (s, 3H), 4.95 (s, 1H), 5.46 (s, 1H), 7.09 (d, <i>J</i> = 8.0, 1H), 7.31 (dd, <i>J</i> = 8.0, 1.8, 1H), 7.58 (d, <i>J</i> = 1.8, 1H).</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> (1<i>r</i>,4<i>r</i>)-6′-Bromo-1′-(dideuteriomethylene)-4-methoxy-spiro[cyclohexane-1,2′-indane] (<b>3</b>)</h3><div class="NLM_p last">At −30 °C under N<sub>2</sub>, a mixture of triphenyl(trideuteriomethyl)phosphonium iodide (19.8 g, 48.5 mmol) in THF (1 l) was treated with a solution of <i>n</i>-BuLi (2.5 M in hexane, 19.4 mL, 48.5 mmol) and stirred for 45 min at −30 °C. A solution of indanone <b>1</b> (10.0 g, 32.3 mmol) in THF (150 mL) was dropwise added, and the mixture was allowed to warm to rt and stirred for 12 h. The mixture was concentrated in vacuo, and the crude oil was vigerously stirred in Et<sub>2</sub>O (1 l). The resulting suspension was filtered and washed with Et<sub>2</sub>O. The filtrate was concentrated and purified by flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>) to afford the desired product <b>3</b> as a white solid (8.51 g, 85%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 1.25–1.39 (m, 2H), 1.42–1.62 (m, 4H), 1.95–2.03 (m, 2H), 2.76 (s, 2H), 3.12–3.21 (m, 1H), 3.31 (s, 3H), 7.03 (d, <i>J</i> = 8.0, 1H), 7.24 (dd, <i>J</i> = 8.0, 1.8, 1H), 7.51 (d, <i>J</i> = 1.8, 1H).</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> (1<i>r</i>,4<i>r</i>)-6′-Bromo-4-methoxy-3′<i>H</i>,5″<i>H</i>-dispiro[cyclohexane-1,2′-indene-1′,4″-oxazol]-2″-amine (<b>4</b>)</h3><div class="NLM_p last">A solution of olefin <b>2</b> (5.86 g, 19.0 mmol) in THF (60 mL) and CH<sub>3</sub>CN (60 mL) at 22 °C was treated with isocyanatosilver (8.58 g, 57.2 mmol) followed by iodine (7.26 g, 28.6 mmol), stirred at rt for 4 h, filtered through Celite, and evaporated. The resulting yellow solids were dissolved in THF (90 mL), treated with NH<sub>4</sub>OH (10 mL), and stirred at rt for 18 h. The mixture was concentrated in vacuo and the residue partitioned between CH<sub>2</sub>Cl<sub>2</sub> (200 mL) and H<sub>2</sub>O (200 mL). The aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> (2 × 40 mL), and the combined organic extracts were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and evaporated. The residue was suspended in MeOH (200 mL), filtered (Celite), and evaporated. The resulting solids were triturated with Et<sub>2</sub>O (140 mL), collected by filtration, and dried to afford <b>4</b> as a pale yellow solid (6.37 g, 91%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 1.22–1.36 (m, 3H), 1.44–1.59 (m, 3H), 1.96–2.04 (m, 2H), 2.85 (q, <i>J</i> = 15.7, 2H), 3.15–3.19 (m, 1H), 3.35 (s, 3H), 4.21 (d, <i>J</i> = 9.3, 1H), 4.64 (d, <i>J</i> = 9.3, 1H), 7.14 (d, <i>J</i> = 7.9, 1H), 7.35 (dd, <i>J</i> = 8.0, 1.8, 1H), 7.37 (d, <i>J</i> = 1.8, 1H). LCMS: <i>t</i><sub>R</sub> = 2.36 min, <i>m</i>/<i>z</i> = 365/367 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> (1<i>r</i>,4<i>r</i>)-6′-Bromo-4-methoxy-3′<i>H</i>,5″<i>H</i>-dispiro[cyclohexane-1,2′-indene-1′,4″-oxazol]-5″,5″-d2-2″-amine (<b>5</b>)</h3><div class="NLM_p last">A solution of indane <b>3</b> (8.50 g, 27.0 mmol) in THF (80 mL) and CH<sub>3</sub>CN (80 mL) at rt was treated with isocyanatosilver (12.3 g, 81.9 mmol) followed by a portionwise addition of I<sub>2</sub> (10.4 g, 40.9 mmol). The gray mixture was stirred for 4 h and the resulting suspension filtered through Celite and concentrated in vacuo. The resulting solids were dissolved in THF (200 mL), treated with NH<sub>4</sub>OH (40 mL), and stirred at rt for 48 h. The mixture was concentrated in vacuo and diluted with EtOAc (500 mL) and H<sub>2</sub>O (500 mL). The layers were separated, and the aqueous phase was extracted with EtOAc (250 mL). The combined organic extracts were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and evaporated to leave a pale-yellow solid which was triturated with Et<sub>2</sub>O (250 mL), filtered, and dried to afford compound <b>5</b> as a pale yellow solid (8.30 g, 82%) which was directly subjected to chiral SFC.</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> (1<i>r</i>,1′<i>R</i>,4<i>R</i>)-6′-Bromo-4-methoxy-3′<i>H</i>,5″<i>H</i>-dispiro[cyclohexane-1,2′-indene-1′,4″-oxazol]-2″-amine (<b>6</b>) and (1<i>r</i>,1′<i>S</i>,4<i>S</i>)-6′-bromo-4-methoxy-3′<i>H</i>,5″<i>H</i>-dispiro[cyclohexane-1,2′-indene-1′,4″-oxazol]-2″-amine (<b>7</b>)</h3><div class="NLM_p last">Supercritical fluid chromatography (25 cm × 20 mm ChromegaChiral CC4 column from ES Industries, West Berlin, NJ) of racemate <b>4</b> (5.50 g, dissolved in MeOH, CH<sub>2</sub>Cl<sub>2</sub> 9:1) applying an isocratic method (CH<sub>3</sub>CN/MeOH 3:1 plus 1% <sup><i>i</i></sup>PropNH<sub>2</sub> and CO<sub>2</sub> as cosolvent (80/min, 100 bar, 25 °C) yielded isomer <b>6</b> (second eluting isomer, 2.2 g, analyt. SFC purity = 98%, ee = 100%) and isomer <b>7</b> (first eluting isomer, 2.3 g, analyt. SFC: purity = 92%, ee = 98.8%).</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> (1<i>r</i>,1′<i>S</i>,4<i>S</i>)-6′-Bromo-4-methoxy-3′<i>H</i>,5″<i>H</i>-dispiro[cyclohexane-1,2′-indene-1′,4″-oxazol]-5″,5″-d2-2″-amine (<b>8</b>) and (1<i>r</i>,1′<i>R</i>,4<i>R</i>)-6′-Bromo-4-methoxy-3′<i>H</i>,5″<i>H</i>-dispiro[cyclohexane-1,2′-indene-1′,4″-oxazol]-5″,5″-d2-2″-amine (<b>9</b>)</h3><div class="NLM_p last">Supercritical fluid chromatography (Chiralpak AD 20 mm × 250 mm, 5 μm) of racemate <b>5</b> (5.0 g, dissolved in MeOH) applying an isocratic method (MeOH plus 0.2% DIEA) yielded isomer <b>8</b> (first eluting isomer, 2.21 g), <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 1.15–1.60 (m, 6H), 1.94–2.03 (m, 2H), 2.67 (d, <i>J</i> = 15.7, 1H), 2.84 (d, <i>J</i> = 15.7, 1H), 3.04–3.14 (m, 1H), 3.33 (s, 3H), 4.35 (br. s, 2H), 7.03 (d, <i>J</i> = 8.0, 1H), 7.28 (dd, <i>J</i> = 7.9, 1.8, 1H), 7.33 (d, <i>J</i> = 1.8, 1H). LCMS: <i>t</i><sub>R</sub> = 2.72 min, <i>m</i>/<i>z</i> = 367/369 [M + H]<sup>+</sup>, purity = 99% (ee = 98%); and isomer <b>9</b> (2.08 g), <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 1.15–1.59 (m, 6H), 1.92–2.03 (m, 2H), 2.66 (d, <i>J</i> = 15.7, 1H), 2.84 (d, <i>J</i> = 15.7, 1H), 3.03–3.13 (m, 1H), 3.33 (s, 3H), 4.35 (br. s, 2H), 7.02 (d, <i>J</i> = 7.9, 1H), 7.28 (dd, <i>J</i> = 7.9, 1.8, 1H), 7.32 (d, <i>J</i> = 1.7, 1H). LCMS: <i>t</i><sub>R</sub> = 2.72 min, <i>m</i>/<i>z</i> = 367/369 [M + H]<sup>+</sup>, purity = 100% (ee = 100%).</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> (1<i>S</i>,3<i>S</i>)-6′-Bromo-3-methyl-spiro[cyclohexane-1,2′-indene]-1′,4(3′<i>H</i>)-dione (<b>11</b>, rac)</h3><div class="NLM_p last">At 0 °C under N<sub>2</sub>, a mixture of indanone <b>10</b> (15.0 g, 71.1 mmol) and methyl acrylate (13.4 mL, 149 mmol) in THF (150 mL) was treated with KO<sup><i>t</i></sup>Bu (9.47 g, 85 mmol) in small portions over a period of 30 min. The mixture was stirred for 3 h at rt, treated with DMF (40 mL) followed by CH<sub>3</sub>I (8.85 mL, 142 mmol), and stirred for 16 h. The resulting suspension was treated with 10% aq citric acid (100 mL) and concentrated in vacuo to afford an orange oil which was washed with H<sub>2</sub>O/MeOH (9:1). The resulting semisolid material was treated with toluene and evaporated (4 × 500 mL) and the crude product used for the next step without further purification. A solution of this crude material in THF (450 mL) and H<sub>2</sub>O (450 mL) was treated with LiOH·H<sub>2</sub>O (11.9 g, 284 mmol), stirred at rt for 55 h, heated at 70 °C for 14 h, and concentrated in vacuo. The resulting suspension was collected by filtration and the cake washed with H<sub>2</sub>O (400 mL) and MeOH resulting in a white solid (8.42 g). The filtrate was concentrated in vacuo and the resulting residue was stirred in Et<sub>2</sub>O (50 mL) to give second batch of the desired product (1.25 g), yielding racemate <b>11</b> (9.67 g, 44%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 1.05 (d, <i>J</i> = 6.5, 3H), 1.72–1.82 (m, 2H), 1.93 (t, <i>J</i> = 13.4, 1H), 2.12–2.24 (m, 1H), 2.46–2.64 (m, 3H), 3.27 (s, 2H), 7.38 (d, <i>J</i> = 8.1, 1H), 7.72 (dd, <i>J</i> = 8.1, 1.9, 1H), 7.88 (d, <i>J</i> = 1.9, 1H). LCMS: <i>t</i><sub>R</sub> = 3.26 min, <i>m</i>/<i>z</i> = 307/309 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> (1<i>S</i>,3<i>S</i>,4<i>S</i>)-6′-Bromo-4-hydroxy-3-methyl-spiro[cyclohexane-1,2′-inden]-1′(3′<i>H</i>)-one (<b>12</b>, rac)</h3><div class="NLM_p last">A solution of cerium(III) chloride heptahydrate (1.17 g, 3.15 mmol) in MeOH (140 mL) under N<sub>2</sub> at rt was treated with a mixture of racemic diketone <b>11</b> (9.67 g, 31.4 mmol) in THF (240 mL), cooled to −70 °C, stirred for 30 min, and treated with NaBH<sub>4</sub> (0.48 g, 12.6 mmol) in small portions. The mixture was stirred at −70 °C for 2 h and carefully treated with a sat. aq NH<sub>4</sub>Cl (100 mL) and H<sub>2</sub>O (200 mL) while maintaining the internal temperature below −65 °C. The mixture was allowed to warm to rt and extracted with EtOAc (3 × 250 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated and the residue purified by flash chromatography (10–50% EtOAc in toluene) to afford racemic alcohol <b>12</b> as a white foam (5.50 g, 56%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 1.03 (d, <i>J</i> = 5.9, 3H), 1.32–1.58 (m, 4H), 1.71 (d, <i>J</i> = 4.5, 1H), 1.74–1.86 (m, 1H), 1.98–2.08 (m, 1H), 2.99 (s, 2H), 3.23–3.36 (m, 1H), 7.32 (d, <i>J</i> = 8.1, 1H), 7.67 (dd, <i>J</i> = 8.2, 1.9, 1H), 7.85 (d, <i>J</i> = 1.9, 1H). LCMS <i>t</i><sub>R</sub> = 3.10 min; <i>m</i>/<i>z</i> = 309/311 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> (1<i>S</i>,3<i>S</i>,4<i>S</i>)-6′-Bromo-4-methoxy-3-methyl-spiro[cyclohexane-1,2′-indane]-1′-one (<b>13</b>, rac)</h3><div class="NLM_p last">At 0 °C under N<sub>2</sub>, a solution alcohol <b>12</b> (2.50 g, 8.09 mmol) in DMF (30 mL) was treated portionwise with NaH (60% dispersion in mineral oil, 0.39 g, 16.2 mmol), stirred for 2 h, treated with CH<sub>3</sub>I (1.41 mL, 22.6 mmol), allowed to warm to rt, and stirred for 15 h. The mixture was treated with H<sub>2</sub>O (100 mL) and EtOAc (250 mL). The organic phase was separated, washed with H<sub>2</sub>O (2 × 150 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), and evaporated to afford yellow solid. Purification of the crude material by flash chromatography (10–40% EtOAc in toluene) gave racemic methyl ether <b>13</b> as a white solid (1.76 g, 67%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 1.00 (d, <i>J</i> = 6.1, 3H), 1.20–1.79 (m, 6H), 2.14–2.24 (m, 1H), 2.75–2.84 (m, 1H), 2.97 (s, 2H), 3.38 (s, 3H), 7.31 (d, <i>J</i> = 8.1, 1H), 7.67 (dd, <i>J</i> = 8.1, 1.9, 1H), 7.85 (d, <i>J</i> = 1.9, 1H). LCMS <i>t</i><sub>R</sub> = 3.53 min <i>m</i>/<i>z</i> 324 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> (1<i>S</i>,3<i>S</i>,4<i>S</i>)-6′-Bromo-1′-(dideuteriomethylene)-4-methoxy-3-methyl-spiro[cyclohexane-1,2′-indane] (<b>14</b>, rac)</h3><div class="NLM_p last">At–30 °C under N<sub>2</sub>, a mixture of <i>n</i>-BuLi (2.5 M in hexane, 3.14 mL, 7.84 mmol) and THF (50 mL) was treated with a solution of triphenyl(trideuteriomethyl)phosphonium iodide (3.19 g, 7.84 mmol) in THF (∼20 mL), stirred for 45 min, and treated dropwise with a solution of ketone <b>13</b> (1.69 g, 5.23 mmol) in THF (20 mL). The mixture was allowed to warm to rt, stirred for 12 h, and concentrated in vacuo. The residue was purified by flash chromatography (60–80% CH<sub>2</sub>Cl<sub>2</sub> in hexane) to give the desired olefin <b>14</b> as a clear oil (1.28 g, 76%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 0.92 (d, <i>J</i> = 6.3, 3H), 1.16–1.35 (m, 2H), 1.40–1.65 (m, 4H), 1.98–2.10 (m, 1H), 2.71 (br. td, <i>J</i> = 10.6, 4.2, 1H), 2.77 (s, 2H), 3.33 (s, 3H), 7.01 (d, <i>J</i> = 8.0, 1H), 7.24 (dd, <i>J</i> = 8.0 1.8, 1H), 7.51 (d, <i>J</i> = 1.8, 1H).</div></div><div id="sec4_1_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> (1<i>S</i>,1′<i>R</i>,3<i>S</i>,4<i>S</i>)-6′-Bromo-4-methoxy-3-methyl-3′<i>H</i>,5″<i>H</i>-dispiro[cyclohexane-1,2′-indene-1′,4″-oxazol]-5″,5″-d2-2″-amine (<b>15</b>) and (1<i>R</i>,1′<i>R</i>,3<i>R</i>,4<i>R</i>)-6′-Bromo-4-methoxy-3-methyl-3′<i>H</i>,5″<i>H</i>-dispiro[cyclohexane-1,2′-indene-1′,4″-oxazol]-5″,5″-d2-2″-amine (<b>16</b>)</h3><div class="NLM_p last">At rt, a stirred solution of olefin <b>14</b> (1.60 g, 4.95 mmol) in THF (20 mL) and CH<sub>3</sub>CN (20 mL) was treated with isocyanatosilver (2.23 g, 14.8 mmol) followed by portionwise addition of I<sub>2</sub> (1.88 g, 7.42 mmol). The mixture was stirred 4 h, filtered through Celite, washed with THF (50 mL), and evaporated. The residue was dissolved in THF (30 mL), treated with NH<sub>4</sub>OH (5 mL), stirred at rt for 18 h, and concentrated. The residue was partitioned between EtOAc (250 mL) and sat. aq NaHCO<sub>3</sub> (250 mL). The aqueous layer was extracted with EtOAc (200 mL) and the combined organic extracts were dried (Na<sub>2</sub>SO<sub>4</sub>) and evaporated to leave a beige solid (2.4 g). Chiral SFC (Lux C4 column, 250 mm × 20 mm, 5 μm) applying an isocratic method (MeOH/CO<sub>2</sub> 40%) of the crude product (dissolved in MeOH) yielded isomer <b>15</b> (second eluting isomer, solids, 419 mg), <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 0.80–0.92 (m, 4H), 1.05–1.58 (m, 6H), 1.93–2.03 (m, 1H), 2.56–2.67 (m, 1H), 2.71 (s, 2H), 5.91 (br. s, 2H), 7.14 (d, <i>J</i> = 7.9, 1H), 7.19 (s, 1H), 7.28 (d, <i>J</i> = 7.8, 1H). LCMS: <i>t</i><sub>R</sub> = 3.33 min, <i>m</i>/<i>z</i> = 381/383 [M + H]<sup>+</sup>, purity = 100% (ee = 97%); and isomer <b>16</b> (first eluting isomer, solids, 410 mg), <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 0.96 (d, <i>J</i> = 6.2, 3H), 1.14–1.36 (m, 3H), 1.43–1.62 (m, 3H), 2.02–2.11 (m, 1H), 2.60–2.73 (m, 2H), 2.88 (d, <i>J</i> = 15.6, 1H), 3.36 (s, 3H), 7.05 (d, <i>J</i> = 8.0, 1H), 7.31 (dd, <i>J</i> = 7.9, 1.9, 1H), 7.34 (d, <i>J</i> = 1.8, 1H). LCMS: <i>t</i><sub>R</sub> = 3.33 min, <i>m</i>/<i>z</i> = 381/383 [M + H]<sup>+</sup>, purity = 99% (ee = 100%).</div></div><div id="sec4_1_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> {3-((1<i>r</i>,1′<i>S</i>,4<i>S</i>)-2″-Amino-4-methoxy-3′<i>H</i>,5″<i>H</i>-dispiro[cyclohexane-1,2′-indene-1′,4″-oxazol]-6′-yl)-5-chlorobenzonitrile} (<b>17</b>)</h3><div class="NLM_p last">The title compound (50 mg, beige solid, 35%) was prepared according to general procedure 1 using bromoindane <b>6</b> (121 mg, 0.33 mmol) and 3-chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile (105 mg, 0.40 mmol). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 1.30–1.48 (m, 3H), 1.50–1.66 (m, 3H), 2.02–2.12 (m, 2H), 3.02 (q, <i>J</i> = 16.3, 2H), 3.16–3.27 (m, 1H), 3.37 (s, 3H), 4.65 (d, <i>J</i> = 9.5, 1H), 5.02 (d, <i>J</i> = 9.6, 1H), 7.42 (d, <i>J</i> = 7.8, 1H), 7.63 (dd, <i>J</i> = 7.8, 1.8, 1H), 7.68 (d, <i>J</i> = 1.4, 1H), 7.78 (t, <i>J</i> = 1.5, 1H), 7.97–8.01 (m, 2H), 2H not observed. HRMS (ESI) <i>m</i>/<i>z</i> 422.1633 (calcd 422.1635 for C<sub>24</sub>H<sub>24</sub>ClN<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>). Analyt. HPLC: <i>t</i><sub>R</sub> = 2.90 min (>99%).</div></div><div id="sec4_1_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> {3-((1<i>r</i>,1′<i>R</i>,4<i>R</i>)-2″-Amino-4-methoxy-3′<i>H</i>,5″<i>H</i>-dispiro[cyclohexane-1,2′-indene-1′,4″-oxazol]-6′-yl)-5-chlorobenzonitrile} (<b>18</b>)</h3><div class="NLM_p last">The title compound (46 mg, beige solid, 33%) was prepared according to general procedure 1 using bromoindane <b>7</b> (121 mg, 0.33 mmol) and 3-chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile (105 mg, 0.40 mmol). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 1.29–1.50 (m, 3H), 1.50–1.68 (m, 3H), 2.02–2.13 (m, 2H), 3.03 (q, <i>J</i> = 16.2, 2H), 3.16–3.27 (m, 1H), 3.37 (s, 3H), 4.69 (d, <i>J</i> = 9.6, 1H), 5.06 (d, <i>J</i> = 9.6, 1H), 7.43 (d, <i>J</i> = 7.9, 1H), 7.66 (dd, <i>J</i> = 7.8, 1.8, 1H), 7.70 (d, <i>J</i> = 1.4, 1H), 7.78 (d, <i>J</i> = 1.5, 1H), 7.97–8.01 (m, 2H), 2H not observed. HRMS (ESI) <i>m</i>/<i>z</i> 422.1633 (calcd 422.1635 for C<sub>24</sub>H<sub>24</sub>ClN<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>). Analyt. HPLC: <i>t</i><sub>R</sub> = 2.98 min (>99%).</div></div><div id="sec4_1_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> {3-((1<i>r</i>,1′<i>R</i>,4<i>R</i>)-2″-Amino-4-methoxy-3′<i>H</i>,5″<i>H</i>-dispiro[cyclohexane-1,2′-indene-1′,4″-oxazol]-6′-yl-5″,5″-d<sub>2</sub>)-5-chlorobenzonitrile} (<b>19</b>)</h3><div class="NLM_p last">The title compound (65 mg, white solids, 22%) was prepared according to general procedure 1 using bromoindane <b>9</b> (250 mg, 0.68 mmol) and 3-chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile (360 mg, 1.37 mmol). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 1.28–1.47 (m, 3H), 1.50–1.68 (m, 3H), 2.02–2.13 (m, 2H), 3.04 (q, <i>J</i> = 16.3, 2H), 3.18–3.26 (m, 1H), 3.37 (s, 3H), 7.45 (d, <i>J</i> = 8.0, 1H), 7.68 (dd, <i>J</i> = 7.9, 1.8, 1H), 7.74 (d, <i>J</i> = 1.6, 1H), 7.79 (t, <i>J</i> = 1.5, 1H), 7.99–8.01 (m, 2H), 2H not observed. HRMS (ESI) <i>m</i>/<i>z</i> 424.1761 (calcd 424.1765 for C<sub>24</sub>H<sub>22</sub>D<sub>2</sub>ClN<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>). Analyt. HPLC: <i>t</i><sub>R</sub> = 2.88 min (>99%).</div></div><div id="sec4_1_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> {3-((1<i>r</i>,1′<i>R</i>,4<i>R</i>)-2″-Amino-4-methoxy-3′<i>H</i>,5″<i>H</i>-dispiro[cyclohexane-1,2′-indene-1′,4″-oxazol]-6′-yl)-5-methoxybenzonitrile} (<b>20</b>)</h3><div class="NLM_p last">The title compound (112 mg, white solids, 79%) was prepared according to general procedure 1 using bromoindane <b>7</b> (121 mg, 0.33 mmol) and 3-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile (103 mg, 0.40 mmol). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 1.29–1.45 (m, 3H), 1.50–1.68 (m, 3H), 2.02–2.12 (m, 2H), 3.01 (q, <i>J</i> = 16.2, 2H), 3.16–3.24 (m, 1H), 3.37 (s, 3H), 3.90 (s, 3H), 4.61 (d, <i>J</i> = 9.5, 1H), 4.99 (d, <i>J</i> = 9.5, 1H), 7.26 (dd, <i>J</i> = 2.3, 1.2, 1H), 7.39 (d, <i>J</i> = 7.8, 1H), 7.45 (t, <i>J</i> = 1.6, 1H), 7.56 (t, <i>J</i> = 1.3, 1H), 7.59 (dd, <i>J</i> = 7.8, 1.6, 1H), 7.63 (s, 1H), 2H not observed. HRMS (ESI) <i>m</i>/<i>z</i> 418.2140 (calcd 418.2140 for C<sub>25</sub>H<sub>27</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>). Analyt. HPLC: <i>t</i><sub>R</sub> = 2.84 min (95.1%).</div></div><div id="sec4_1_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> {3-((1<i>r</i>,1′<i>R</i>,4<i>R</i>)-2″-Amino-4-methoxy-3′<i>H</i>,5″<i>H</i>-dispiro[cyclohexane-1,2′-indene-1′,4″-oxazol]-6′-yl-5″,5″-d<sub>2</sub>)-5-methoxybenzonitrile} (<b>21</b>)</h3><div class="NLM_p last">The title compound (84 mg, white solids, 80%) was prepared according to general procedure 1 using bromoindane  <b>9</b> (92 mg, 0.25 mmol) and 3-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile (64 mg, 0.25 mmol). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 1.31–1.47 (m, 3H), 1.50–1.70 (m, 3H), 2.04–2.14 (m, 2H), 3.03 (q, <i>J</i> = 16.3, 2H), 3.18–3.26 (m, 1H), 3.37 (s, 3H), 3.88 (s, 3H), 7.28 (dd, <i>J</i> = 2.4, 1.2, 1H), 7.42 (d, <i>J</i> = 7.8, 1H), 7.47 (dd, <i>J</i> = 2.4, 1.7, 1H), 7.59 (t, <i>J</i> = 1.4, 1H), 7.65 (dd, <i>J</i> = 7.8, 1.8, 1H), 7.70 (d, J = 1.5, 1H), 2H not observed. HRMS (ESI) <i>m</i>/<i>z</i> 420.2256 (calcd 420.2262 for C<sub>25</sub>H<sub>25</sub>D<sub>2</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>). Analyt. HPLC: <i>t</i><sub>R</sub> = 2.95 min (>99%).</div></div><div id="sec4_1_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> {(1<i>r</i>,1′<i>R</i>,4<i>R</i>)-4-Methoxy-6′-(pyrimidin-3-yl)-3′<i>H</i>,5″<i>H</i>-dispiro[cyclohexane-1,2′-indene-1′,4″-oxazol]-5″,5″-d<sub>2</sub>-2″-amine} (<b>22</b>)</h3><div class="NLM_p last">The title compound (27 mg, white solids, 73%) was prepared according to general procedure 1 using bromide <b>9</b> (37 mg, 0.10 mmol) and 3-pyridylboronic acid (25 mg, 0.20 mmol). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 1.26–1.43 (m, 3H), 1.50–1.64 (m, 3H), 1.96–2.08 (m, 2H), 2.92 (q, <i>J</i> = 15.6, 2H), 3.11–3.21 (m, 1H), 3.36 (s, 3H), 7.35 (d, <i>J</i> = 7.5, 1H), 7.45–7.52 (m, 3H), 8.07 (d, <i>J</i> = 7.9, 1H), 8.49 (d, <i>J</i> = 4.8, 1H), 8.76 (d, <i>J</i> = 2.2, 1H), 2 H not observed. HRMS (ESI) <i>m</i>/<i>z</i> 366.2151 (calcd 366.2155 for C<sub>22</sub>H<sub>23</sub>D<sub>2</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>). Analyt. HPLC: <i>t</i><sub>R</sub> = 2.59 min (99.3%).</div></div><div id="sec4_1_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> {(1<i>r</i>,1′<i>R</i>,4<i>R</i>)-4-Methoxy-6′-(5-methyl-pyridin-3-yl)-3′<i>H</i>,5″<i>H</i>-dispiro[cyclohexane-1,2′-indene-1′,4″-oxazol]-5″,5″-d<sub>2</sub>-2″-amine} (<b>23</b>)</h3><div class="NLM_p last">The title compound (14 mg, white solids, 16%) was prepared according to general procedure 1 using bromide <b>9</b> (82 mg, 0.23 mmol) and (5-methyl-3-pyridyl)boronic acid (31 mg, 0.23 mmol). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 1.31–1.46 (m, 3H), 1.51–1.69 (m, 3H), 2.02–2.12 (m, 2H), 2.43 (s, 3H), 3.03 (q, <i>J</i> = 16.1, 2H), 3.15–3.26 (m, 1H), 3.37 (s, 3H), 7.42 (d, <i>J</i> = 7.8, 1H), 7.63 (d, <i>J</i> = 7.8, 1H), 7.68 (s, 1H), 7.94 (s, 1H), 8.36 (s, 1H), 8.59 (s, 1H), 2H not observed. HRMS (ESI) <i>m</i>/<i>z</i> 380.2307 (calcd 380.2289 for C<sub>23</sub>H<sub>25</sub>D<sub>2</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>). Analyt. HPLC: <i>t</i><sub>R</sub> = 2.24 min (99.0%).</div></div><div id="sec4_1_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> {(1<i>r</i>,1′<i>R</i>,4<i>R</i>)-4-Methoxy-6′-(pyrimidin-5-yl)-3′<i>H</i>,5″<i>H</i>-dispiro[cyclohexane-1,2′-indene-1′,4″-oxazol]-5″,5″-d<sub>2</sub>-2″-amine} (<b>24</b>)</h3><div class="NLM_p last">The title compound (25 mg, off-white solids, 61%) was prepared according to general procedure 1 using bromide <b>9</b> (40 mg, 0.11 mmol) and pyrimidin-5-ylboronic acid (60 mg, 0.24 mmol). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD, 35 °C) δ ppm 1.20–1.45 (m, 3H), 1.50–1.65 (m, 3H), 1.99–2.00 (m, 2H), 2.95 (q, <i>J</i> = 16.0, 2H), 3.14–3.16 (m, 1H), 3.36 (s, 3H), 7.38 (d, <i>J</i> = 8.0, 1H), 7.55 (d, <i>J</i> = 7.0, 2H), 9.03 (s, 2H), 9.09 (s, 1H), 2H not observed. HRMS (ESI) <i>m</i>/<i>z</i> 367.2103 (calcd 367.2113 for C<sub>21</sub>H<sub>22</sub>D<sub>2</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup>). Analyt. HPLC: <i>t</i><sub>R</sub> = 2.83 min (97.8%).</div></div><div id="sec4_1_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> {(1<i>r</i>,3<i>R</i>,4<i>r</i>,5<i>S</i>)-4-Methoxy-3,5-dimethyl-6′-(pyrimidin-5-yl)-3′<i>H</i>,5″<i>H</i>-dispiro[cyclohexane-1,2′-indene-1′,4″-oxazol]-5″,5″-d<sub>2</sub>-2″-amine} (<b>25</b>, rac)</h3><div class="NLM_p last">The title compound (29 mg, solid) was prepared according to general procedure 1 using (1<i>r</i>,3<i>R</i>,4<i>r</i>,5<i>S</i>)-6′-bromo-4-methoxy-3,5-dimethyl-3′<i>H</i>,5″<i>H</i>-di-spiro[cyclohexane-1,2′-indene-1′,4″-oxazol]-5″,5″-d2-2″-amine (150 mg; see <a href="/doi/suppl/10.1021/acs.jmedchem.7b01716/suppl_file/jm7b01716_si_001.pdf" class="ext-link">Supporting Information</a>) and pyrimidin-5-ylboronic acid (95 mg). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 0.99–1.03 (m, 6H), 1.25–1.35 (m, 2H), 1.46–1.59 (m, 2H), 1.63–1.70 (m, 2H), 2.35 (br. t, <i>J</i> = 9.8, 1H), 2.82 (br d, <i>J</i> ≈ 15.2, 1H), 3.02 (br d, <i>J</i> ≈ 16.2, 1H), 3.45 (s, 3H), 4.25 (br. s, 2H), 7.33 (d, <i>J</i> = 6.2, 1H), 7.41–7.43 (m, 2H), 8.93 (s, 2H), 9.18 (s, 1H). HRMS (ESI) <i>m</i>/<i>z</i> 395.2416 (calcd 395.2418 for C<sub>23</sub>H<sub>26</sub>D<sub>2</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup>). Analyt. HPLC: <i>t</i><sub>R</sub> = 3.52 min (96.8%).</div></div><div id="sec4_1_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> {(1<i>R</i>,1′<i>R</i>,3<i>R</i>,4<i>R</i>)-4-Methoxy-3-methyl-6′-(pyrimidin-5-yl)-3′<i>H</i>,5″<i>H</i>-dispiro[cyclohexane-1,2′-indene-1′,4″-oxazol]-5″,5″-d<sub>2</sub>-2″-amine} (<b>26</b>)</h3><div class="NLM_p last">The title compound (28 mg, white solid) was prepared according to general procedure 1 using bromide <b>16</b> (27 mg, 0.07 mmol) and pyrimidin-5-ylboronic acid (20 mg, 0.16 mmol). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD, 35 °C) δ ppm 1.01 (d, <i>J</i> = 6.3, 3H), 1.2–1.5 (m, 3H), 1.55 (dq, <i>J</i> = 13.3, 3.3, 1H), 1.60–1.70 (m, 2H), 2.15–2.20 (m, 1H), 2.75–2.80 (m, 1H), 3.07 (q, <i>J</i> = 17.1, 2H,), 3.38 (s, 3H), 7.50 (d, <i>J</i> = 7.8, 1H), 7.71 (dd, <i>J</i> = 7.9, 1.8, 1H), 7.79 (, d, <i>J</i> = 1.4, 1H), 9.07 (br. s, 2H), 9.13 (br. s, 1H), 2H not observed. HRMS (ESI) <i>m</i>/<i>z</i> 381.2260 (calcd 381.2276 for C<sub>22</sub>H<sub>24</sub>D<sub>2</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup>). Analyt. HPLC: <i>t</i><sub>R</sub> = 2.85 min (98.9%).</div></div><div id="sec4_1_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> {(1<i>R</i>,1′<i>R</i>,3<i>R</i>,4<i>R</i>)-3-ethyl-4-methoxy-6′-(pyrimidin-5-yl)-3′<i>H</i>,5″<i>H</i>-dispiro[cyclohexane-1,2′-indene-1′,4″-oxazol]-5″,5″-d<sub>2</sub>-2″-amine} (<b>27</b>)</h3><div class="NLM_p last">The title compound (20 mg, solids) was prepared according to general procedure 1 using (1<i>R</i>,1′<i>R</i>,3<i>R</i>,4<i>R</i>)-6′-bromo-3-ethyl-4-methoxy-3′<i>H</i>,5″<i>H</i>-dispiro[cyclohexane-1,2′-indene-1′,4″-oxazol]-5″,5″-d2-2″-amine (35 mg, 0.09 mmol; see <a href="/doi/suppl/10.1021/acs.jmedchem.7b01716/suppl_file/jm7b01716_si_001.pdf" class="ext-link">Supporting Information</a>) and pyrimidin-5-ylboronic acid (40 mg, 0.32 mmol). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD, 35 °C) δ ppm 0.83 (t, <i>J</i> = 7.5, 3H), 1.10–1.50 (m, 5H), 1.55 (d, <i>J</i> = 9.3, 1H), 1.66 (d, <i>J</i> = 13.7, 1H), 1.75–1.85 (m, 1H), 2.13 (d, <i>J</i> = 9.2, 1H), 2.82 (td, <i>J</i> = 9.8, 4.3, 1H), 2.95 (q, <i>J</i> = 15.8, 2H), 3.37 (s, 3H), 7.39 (d, <i>J</i> = 8.2, 1H), 7.55 (m, 2H), 9.04 (s, 2H), 9.10 (s, 1H), 2H not observed. HRMS (ESI) <i>m</i>/<i>z</i> 395.2416 (calcd 395.2418 for C<sub>23</sub>H<sub>26</sub>D<sub>2</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup>). Analyt. HPLC: <i>t</i><sub>R</sub> = 3.11 min, (99.4%).</div></div><div id="sec4_1_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> {(1<i>S</i>,1′<i>R</i>,3<i>S</i>,4<i>S</i>)-4-Methoxy-3-methyl-6′-(pyrimidin-5-yl)-3′<i>H</i>,5″<i>H</i>-dispiro[cyclohexane-1,2′-indene-1′,4″-oxazol]-5″,5″-d<sub>2</sub>-2″-amine} (<b>28</b>)</h3><div class="NLM_p last">The title compound (22 mg, white solid) was prepared according to general procedure 1 using bromide <b>15</b> (27 mg, 0.07 mmol) and pyrimidin-5-ylboronic acid (30 mg, 0.24 mmol). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD, 35 °C) δ ppm 1.00 (d, <i>J</i> = 6.2, 3H), 1.12 (t, <i>J</i> = 12.4, 1H), 1.40 (dq, <i>J</i> = 12.9, 4.2, 1H), 1.50–1.70 (m, 4H), 2.15–2.20 (m, 1H), 2.75–2.80 (td, <i>J</i> = 6.3, 3.8, 1H), 3.07 (br. q, <i>J</i> = 16.8, 2H), 3.38 (s, 3H), 7.50 (d, <i>J</i> = 7.83, 1H), 7.71 (dd, <i>J</i> = 7.83, 1.6, 1H), 7.79 (d, <i>J</i> = 1.6, 1H), 9.07 (s, 2H), 9.13 (s, 1H), 2H not observed. HRMS (ESI) <i>m</i>/<i>z</i> 381.2260 (calcd 381.2276 for C<sub>22</sub>H<sub>24</sub>D<sub>2</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup>). Analyt. HPLC: <i>t</i><sub>R</sub> = 3.42 min (98.4%). [α]<sub class="stack">D</sub><sup class="stack">26.0</sup> +65.0° cm<sup>3</sup> g<sup>–1</sup> dm<sup>–1</sup> (<i>c</i> 1.00 g/100 mL in MeOH).</div></div><div id="sec4_1_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> {(1<i>S</i>,1′<i>R</i>,3<i>S</i>,4<i>S</i>)-3-Ethyl-4-methoxy-6′-(pyrimidin-5-yl)-3′<i>H</i>,5″<i>H</i>-dispiro[cyclohexane-1,2′-indene-1′,4″-oxazol]-5″,5″-d<sub>2</sub>-2″-amine} (<b>29</b>)</h3><div class="NLM_p">The title compound (18 mg, white solids) was prepared according to general procedure 1 using (1<i>S</i>,1′<i>R</i>,3<i>S</i>,4<i>S</i>)-6′-bromo-3-ethyl-4-methoxy-3′<i>H</i>,5″<i>H</i>-dispiro[cyclohexane-1,2′-indene-1′,4″-oxazol]-5″,5″-d2-2″-amine (35 mg, 0.09 mmol; see <a href="/doi/suppl/10.1021/acs.jmedchem.7b01716/suppl_file/jm7b01716_si_001.pdf" class="ext-link">Supporting Information</a>) and pyrimidin-5-ylboronic acid (30 mg, 0.24 mmol). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD, 35 °C) δ ppm 0.82 (t, <i>J</i> = 7.5, 3H), 0.97 (t, <i>J</i> = 12.8, 1H), 1.10–1.20 (m, 1H), 1.20–1.35 (m, 1H), 1.35–1.65 (m, 4H), 1.70–.80 (m, 1H), 2.11 (dq, <i>J</i> = 12.5, 4.2, 1H), 2.82 (td, <i>J</i> = 10.4, 4.2, 1H), 2.95 (q, <i>J</i> = 15.7, 2H), 3.37 (s, 3H), 7.39 (d, <i>J</i> = 8.2, 1H), 7.55 (m, 2H), 9.04 (s, 2H), 9.10 (s, 1H), 2H not observed. HRMS (ESI) <i>m</i>/<i>z</i> 395.2416 (calcd 395.2418 for C<sub>23</sub>H<sub>26</sub>D<sub>2</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup>). Analyt. HPLC: <i>t</i><sub>R</sub> = 3.19 min (>99%).</div><div class="NLM_p last">The intermediates leading to compounds <b>25</b>, <b>27</b>, and <b>29</b>, respectively, have been synthesized by analogy to the intermediates described above (experimental details available in the <a href="/doi/suppl/10.1021/acs.jmedchem.7b01716/suppl_file/jm7b01716_si_001.pdf" class="ext-link">Supporting Information</a>). Detailed protocols for the in vitro biological and metabolism asssays, crystallography, and pharmacokinetics are described in the <a href="/doi/suppl/10.1021/acs.jmedchem.7b01716/suppl_file/jm7b01716_si_001.pdf" class="ext-link">Supporting Information</a>.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i35"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01716" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85875" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85875" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b01716" class="ext-link">10.1021/acs.jmedchem.7b01716</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">General methods (experimental details for analytical methods); protocols describing the preparation of intermediates for the synthesis of compounds <b>25</b>, <b>27</b>, <b>29</b>; experimental details for the determination of the crystal structures of compounds <b>23</b> and <b>28</b>; protocols for all biological, in vitro metabolic and in vivo pharmacokinetic assays; molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01716/suppl_file/jm7b01716_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01716/suppl_file/jm7b01716_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01716/suppl_file/jm7b01716_si_001.pdf">jm7b01716_si_001.pdf (288.33 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01716/suppl_file/jm7b01716_si_002.csv">jm7b01716_si_002.csv (3.03 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The coordinates and structure factors of compounds <b>23</b> and <b>28</b> have been deposited to the Protein Data Bank with PDB codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EJ3">6EJ3</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EJ2">6EJ2</a>, respectively. Authors will release the atomic coordinates and experimental data upon article publication.</p><div class="testing" data-doi="10.1021/acs.jmedchem.7b01716" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36503" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36503" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Roland W. Bürli</span> - <span class="hlFld-Affiliation affiliation">Neuroscience,
IMED Biotech Unit, AstraZeneca, Cambridge CB21 6GH, U.K.</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7377-7628" title="Orcid link">http://orcid.org/0000-0001-7377-7628</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#1664797a777872387463647a7f56776c78736364793875797b"><span class="__cf_email__" data-cfemail="0674696a676862286473746a6f46677c68637374692865696b">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Patrik Johansson</span> - <span class="hlFld-Affiliation affiliation">Discovery
Sciences, IMED Biotech Unit, AstraZeneca, S-43183 Mölndal, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Karin Kaspersson</span> - <span class="hlFld-Affiliation affiliation">Discovery
Sciences, IMED Biotech Unit, AstraZeneca, S-43183 Mölndal, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ian K. Gurrell</span> - <span class="hlFld-Affiliation affiliation">Neuroscience,
IMED Biotech Unit, AstraZeneca, Cambridge CB21 6GH, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elisabeth Bäck</span> - <span class="hlFld-Affiliation affiliation">Discovery
Sciences, IMED Biotech Unit, AstraZeneca, S-43183 Mölndal, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Susanna Eketjäll</span> - <span class="hlFld-Affiliation affiliation">Cardiovascular
and Metabolic Diseases, IMED Biotech Unit, AstraZeneca, 141 57 Huddinge, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Clay W. Scott</span> - <span class="hlFld-Affiliation affiliation">Discovery
Safety, Drug Safety and Metabolism, IMED Biotech Unit, AstraZeneca, Waltham, Massachusetts 02451, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gvido Cebers</span> - <span class="hlFld-Affiliation affiliation">Neuroscience,
IMED Biotech Unit, AstraZeneca, Cambridge CB21 6GH, U.K.</span>; 
    <span>Present Address:
                        G.C.: UCB Biopharma, Chemin du Foriest 1, 1420 Braine-l’Alleud, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Philip Thorne</span> - <span class="hlFld-Affiliation affiliation">Charnwood
Molecular, Loughborough LE11 5DA, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael J. McKenzie</span> - <span class="hlFld-Affiliation affiliation">Charnwood
Molecular, Loughborough LE11 5DA, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Haydn Beaton</span> - <span class="hlFld-Affiliation affiliation">Charnwood
Molecular, Loughborough LE11 5DA, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul Davey</span> - <span class="hlFld-Affiliation affiliation">Oncology
Chemistry, IMED Biotech Unit, AstraZeneca, Cambridge CB4 0WG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Karin Kolmodin</span> - <span class="hlFld-Affiliation affiliation">Sprint
Bioscience, 141 57 Huddinge, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jörg Holenz</span> - <span class="hlFld-Affiliation affiliation">Neuroscience,
IMED Biotech Unit, AstraZeneca, Cambridge CB21 6GH, U.K.</span>; 
    <span>Present Address:
                        J.H.: GSK Neuroscience, 1250 South Collegeville Road, Collegeville, PA 19426, U.S</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark E. Duggan</span> - <span class="hlFld-Affiliation affiliation">Neuroscience,
IMED Biotech Unit, AstraZeneca, Cambridge CB21 6GH, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Samantha Budd Haeberlein</span> - <span class="hlFld-Affiliation affiliation">Neuroscience,
IMED Biotech Unit, AstraZeneca, Cambridge CB21 6GH, U.K.</span>; 
    <span>Present Address:
                        S.B.H.: Biogen, 225 Binney Street, Cambridge, MA 02142, U.S</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>Experimental design: R.W.B., P.J., I.K.G., J.H., M.E.D., G.C., K.K., S.B.H. Performed experiments: P.T., M.J.K., H.B., P.D., P.J., K.Ka., E.B., S.E., C.W.S. Data analysis: R.W.B., P.J., K.Ka., K.Ko., S.E., I.K.G., G.C., C.W.S. Wrote the manuscript: R.W.B., P.J.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e3783-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i41">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77153" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77153" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank Frederik Martin and Lyn Rosenbrier-Ribeiro for enabling the off-target testing of compound <b>28</b>, and Stephane Turcotte for the determination of the optical rotation of <b>28</b>.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">APP</td><td class="NLM_def"><p class="first last">amyloid precursor protein</p></td></tr><tr><td class="NLM_term">BACE</td><td class="NLM_def"><p class="first last">β-secretase</p></td></tr><tr><td class="NLM_term">Cl<sub>int</sub></td><td class="NLM_def"><p class="first last">intrinsic clearance</p></td></tr><tr><td class="NLM_term">HLM</td><td class="NLM_def"><p class="first last">human liver microsome</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">human ether-a-go-go-related gene</p></td></tr><tr><td class="NLM_term">MDR1-MDCK (ER)</td><td class="NLM_def"><p class="first last">multidrug resistant 1 transporter Madin–Darby canine kidney cells (efflux ratio, ratio of basolateral-to-apical/apical-to-basolateral flux)</p></td></tr><tr><td class="NLM_term">rHeps</td><td class="NLM_def"><p class="first last">rat hepatocytes</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i43">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22787" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22787" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 37 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vassar, R.</span></span> <span> </span><span class="NLM_article-title">BACE1 inhibitor drugs in clinical trials for Alzheimer’s disease</span>. <i>Alzheimer’s Res. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">89</span>, <span class="refDoi"> DOI: 10.1186/s13195-014-0089-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=10.1186%2Fs13195-014-0089-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=25621019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjtVCqtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=89&author=R.+Vassar&title=BACE1+inhibitor+drugs+in+clinical+trials+for+Alzheimer%E2%80%99s+disease&doi=10.1186%2Fs13195-014-0089-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">BACE1 inhibitor drugs in clinical trials for Alzheimer's disease</span></div><div class="casAuthors">Vassar, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's Research & Therapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">89/1-89/14, 14 pp.</span>CODEN:
                <span class="NLM_cas:coden">ARTLCD</span>;
        ISSN:<span class="NLM_cas:issn">1758-9193</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  β-Site amyloid precursor protein cleaving enzyme 1 (BACE1) is the β-secretase enzyme required for the prodn. of the neurotoxic β-amyloid (Aβ) peptide that is widely considered to have a crucial early role in the etiol. of Alzheimer's disease (AD).  As a result, BACE1 has emerged as a prime drug target for reducing the levels of Aβ in the AD brain, and the development of BACE1 inhibitors as therapeutic agents is being vigorously pursued.  It has proven difficult for the pharmaceutical industry to design BACE1 inhibitor drugs that pass the blood-brain barrier, however this challenge has recently been met and BACE1 inhibitors are now in human clin. trials to test for safety and efficacy in AD patients and individuals with pre-symptomatic AD.  Initial results suggest that some of these BACE1 inhibitor drugs are well tolerated, although others have dropped out because of toxicity and it is still too early to know whether any will be effective for the prevention or treatment of AD.  Addnl., based on newly identified BACE1 substrates and phenotypes of mice that lack BACE1, concerns have emerged about potential mechanism-based side effects of BACE1 inhibitor drugs with chronic administration.  It is hoped that a therapeutic window can be achieved that balances safety and efficacy.  This review summarizes the current state of progress in the development of BACE1 inhibitor drugs and the evaluation of their therapeutic potential for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqR-BPlLZzu7rVg90H21EOLACvtfcHk0lgfc7TkcSSgng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtVCqtL4%253D&md5=a9ec66c8f0254986406323efa56c6f5a</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1186%2Fs13195-014-0089-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13195-014-0089-7%26sid%3Dliteratum%253Aachs%26aulast%3DVassar%26aufirst%3DR.%26atitle%3DBACE1%2520inhibitor%2520drugs%2520in%2520clinical%2520trials%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Res.%2520Ther.%26date%3D2014%26volume%3D6%26spage%3D89%26doi%3D10.1186%2Fs13195-014-0089-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sadleir, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kandalepas, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buggia-Prévot, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thinakaran, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vassar, R.</span></span> <span> </span><span class="NLM_article-title">Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased Aβ generation in Alzheimer’s disease</span>. <i>Acta Neuropathol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>132</i></span>,  <span class="NLM_fpage">235</span>– <span class="NLM_lpage">256</span>, <span class="refDoi"> DOI: 10.1007/s00401-016-1558-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=10.1007%2Fs00401-016-1558-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=26993139" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=1%3ACAS%3A528%3ADC%252BC28XksVOgs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2016&pages=235-256&author=K.+R.+Sadleirauthor=P.+C.+Kandalepasauthor=V.+Buggia-Pr%C3%A9votauthor=D.+A.+Nicholsonauthor=G.+Thinakaranauthor=R.+Vassar&title=Presynaptic+dystrophic+neurites+surrounding+amyloid+plaques+are+sites+of+microtubule+disruption%2C+BACE1+elevation%2C+and+increased+A%CE%B2+generation+in+Alzheimer%E2%80%99s+disease&doi=10.1007%2Fs00401-016-1558-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased Aβ generation in Alzheimer's disease</span></div><div class="casAuthors">Sadleir, Katherine R.; Kandalepas, Patty C.; Buggia-Prevot, Virginie; Nicholson, Daniel A.; Thinakaran, Gopal; Vassar, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Acta Neuropathologica</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">235-256</span>CODEN:
                <span class="NLM_cas:coden">ANPTAL</span>;
        ISSN:<span class="NLM_cas:issn">0001-6322</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is characterized by amyloid plaques composed of the β-amyloid (Aβ) peptide surrounded by swollen presynaptic dystrophic neurites consisting of dysfunctional axons and terminals that accumulate the β-site amyloid precursor protein (APP) cleaving enzyme (BACE1) required for Aβ generation.  The cellular and mol. mechanisms that govern presynaptic dystrophic neurite formation are unclear, and elucidating these processes may lead to novel AD therapeutic strategies.  Previous studies suggest Aβ may disrupt microtubules, which we hypothesize have a crit. role in the development of presynaptic dystrophies.  To investigate this further, here we have assessed the effects of Aβ, particularly neurotoxic Aβ42, on microtubules during the formation of presynaptic dystrophic neurites in vitro and in vivo.  Live-cell imaging of primary neurons revealed that exposure to Aβ42 oligomers caused varicose and beaded neurites with extensive microtubule disruption, and inhibited anterograde and retrograde trafficking.  In brain sections from AD patients and the 5XFAD transgenic mouse model of amyloid pathol., dystrophic neurite halos with BACE1 elevation around amyloid plaques exhibited aberrant tubulin accumulations or voids.  At the ultrastructural level, peri-plaque dystrophies were strikingly devoid of microtubules and replete with multi-lamellar vesicles resembling autophagic intermediates.  Proteins of the microtubule motors, kinesin and dynein, and other neuronal proteins were aberrantly localized in peri-plaque dystrophies.  Inactive pro-cathepsin D also accumulated in peri-plaque dystrophies, indicating reduced lysosomal function.  Most importantly, BACE1 accumulation in peri-plaque dystrophies caused increased BACE1 cleavage of APP and Aβ generation.  Our study supports the hypothesis that Aβ induces microtubule disruption in presynaptic dystrophic neurites that surround plaques, thus impairing axonal transport and leading to accumulation of BACE1 and exacerbation of amyloid pathol. in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbSN7VOiJ1l7Vg90H21EOLACvtfcHk0lj1Oe-3N5TNUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XksVOgs78%253D&md5=d66c9c600721f1f63e7ae1c185b3b4ab</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2Fs00401-016-1558-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00401-016-1558-9%26sid%3Dliteratum%253Aachs%26aulast%3DSadleir%26aufirst%3DK.%2BR.%26aulast%3DKandalepas%26aufirst%3DP.%2BC.%26aulast%3DBuggia-Pr%25C3%25A9vot%26aufirst%3DV.%26aulast%3DNicholson%26aufirst%3DD.%2BA.%26aulast%3DThinakaran%26aufirst%3DG.%26aulast%3DVassar%26aufirst%3DR.%26atitle%3DPresynaptic%2520dystrophic%2520neurites%2520surrounding%2520amyloid%2520plaques%2520are%2520sites%2520of%2520microtubule%2520disruption%252C%2520BACE1%2520elevation%252C%2520and%2520increased%2520A%25CE%25B2%2520generation%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DActa%2520Neuropathol.%26date%3D2016%26volume%3D132%26spage%3D235%26epage%3D256%26doi%3D10.1007%2Fs00401-016-1558-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vassar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovacs, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, P. C.</span></span> <span> </span><span class="NLM_article-title">The β-secretase enzyme BACE in health and Alzheimer’s disease: regulation, cell biology, function, and therapeutic potential</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">12787</span>– <span class="NLM_lpage">12794</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.3657-09.2009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=10.1523%2FJNEUROSCI.3657-09.2009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=19828790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlSit7bP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=12787-12794&author=R.+Vassarauthor=D.+M.+Kovacsauthor=R.+Yanauthor=P.+C.+Wong&title=The+%CE%B2-secretase+enzyme+BACE+in+health+and+Alzheimer%E2%80%99s+disease%3A+regulation%2C+cell+biology%2C+function%2C+and+therapeutic+potential&doi=10.1523%2FJNEUROSCI.3657-09.2009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The β-secretase enzyme BACE in health and Alzheimer's disease: regulation, cell biology, function, and therapeutic potential</span></div><div class="casAuthors">Vassar, Robert; Kovacs, Dora M.; Yan, Riqiang; Wong, Philip C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">12787-12794</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">A review.  The β-amyloid (Aβ) peptide is the major constituent of amyloid plaques in Alzheimer's disease (AD) brain and is likely to play a central role in the pathogenesis of this devastating neurodegenerative disorder.  The β-secretase, β-site amyloid precursor protein cleaving enzyme (BACE1; also called Asp2, memapsin 2), is the enzyme responsible for initiating Aβ generation.  Thus, BACE is a prime drug target for the therapeutic inhibition of Aβ prodn. in AD.  Since its discovery 10 years ago, much has been learned about BACE.  This review summarizes BACE properties, describes BACE translation dysregulation in AD, and discusses BACE physiol. functions in sodium current, synaptic transmission, myelination, and schizophrenia.  The therapeutic potential of BACE will also be considered.  This is a summary of topics covered at a symposium held at the 39th annual meeting of the Society for Neuroscience and is not meant to be a comprehensive review of BACE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqGn8h_x-7_bVg90H21EOLACvtfcHk0lj1Oe-3N5TNUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlSit7bP&md5=a462ad002cf3801570725719d71647c6</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3657-09.2009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3657-09.2009%26sid%3Dliteratum%253Aachs%26aulast%3DVassar%26aufirst%3DR.%26aulast%3DKovacs%26aufirst%3DD.%2BM.%26aulast%3DYan%26aufirst%3DR.%26aulast%3DWong%26aufirst%3DP.%2BC.%26atitle%3DThe%2520%25CE%25B2-secretase%2520enzyme%2520BACE%2520in%2520health%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520regulation%252C%2520cell%2520biology%252C%2520function%252C%2520and%2520therapeutic%2520potential%26jtitle%3DJ.%2520Neurosci.%26date%3D2009%26volume%3D29%26spage%3D12787%26epage%3D12794%26doi%3D10.1523%2FJNEUROSCI.3657-09.2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Strooper, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vassar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golde, T.</span></span> <span> </span><span class="NLM_article-title">The secretases: enzymes with therapeutic potential in Alzheimer’s disease</span>. <i>Nat. Rev. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">99</span>– <span class="NLM_lpage">107</span>, <span class="refDoi"> DOI: 10.1038/nrneurol.2009.218</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=10.1038%2Fnrneurol.2009.218" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=20139999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1Ogt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=99-107&author=B.+De%0AStrooperauthor=R.+Vassarauthor=T.+Golde&title=The+secretases%3A+enzymes+with+therapeutic+potential+in+Alzheimer%E2%80%99s+disease&doi=10.1038%2Fnrneurol.2009.218"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The secretases: enzymes with therapeutic potential in Alzheimer disease</span></div><div class="casAuthors">De Strooper, Bart; Vassar, Robert; Golde, Todd</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neurology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">99-107</span>CODEN:
                <span class="NLM_cas:coden">NRNACP</span>;
        ISSN:<span class="NLM_cas:issn">1759-4758</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The three secretases that process amyloid precursor protein are central to the generation of amyloid-β, and the accumulation of this peptide in extracellular plaques is one of the hallmarks of Alzheimer disease.  In this Review, De Strooper et al. discuss the evidence that suggests that these enzymes are potential therapeutic targets for Alzheimer disease drug treatments.  The amyloid hypothesis has yielded a series of well-validated candidate drug targets with potential for the treatment of Alzheimer disease (AD).  Three proteases that are involved in the processing of amyloid precursor protein-α-secretase, β-secretase and γ-secretase-are of particular interest as they are central to the generation and modulation of amyloid-β peptide and can be targeted by small compds. in vitro and in vivo.  Given that these proteases also fulfill other important biol. roles, inhibiting their activity will clearly be inherently assocd. with mechanism-based toxicity.  Carefully detg. a suitable therapeutic window and optimizing the selectivity of the drug treatments towards amyloid precursor protein processing might be ways of overcoming this potential complication.  Secretase inhibitors are likely to be the first small-mol. therapies aimed at AD modification that will be fully tested in the clinic.  Success or failure of these first-generation AD therapies will have enormous consequences for further drug development efforts for AD and possibly other neurodegenerative conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQBldqS_TKy7Vg90H21EOLACvtfcHk0lhsQlWUpzXghA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1Ogt70%253D&md5=40135a0a59da6b70e4856a81ddfa6088</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrneurol.2009.218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrneurol.2009.218%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26aulast%3DVassar%26aufirst%3DR.%26aulast%3DGolde%26aufirst%3DT.%26atitle%3DThe%2520secretases%253A%2520enzymes%2520with%2520therapeutic%2520potential%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNat.%2520Rev.%2520Neurol.%26date%3D2010%26volume%3D6%26spage%3D99%26epage%3D107%26doi%3D10.1038%2Fnrneurol.2009.218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sisodia, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">St. George-Hyslop, P.
H.</span></span> <span> </span><span class="NLM_article-title">γ-Secretase, Notch, Aβ and Alzheimer’s disease: Where do the presenilins fit in?</span>. <i>Nat. Rev. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">281</span>– <span class="NLM_lpage">290</span>, <span class="refDoi"> DOI: 10.1038/nrn785</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=10.1038%2Fnrn785" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=11967558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=1%3ACAS%3A528%3ADC%252BD38Xjsl2kurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2002&pages=281-290&author=S.+S.+Sisodiaauthor=P.%0AH.+St.+George-Hyslop&title=%CE%B3-Secretase%2C+Notch%2C+A%CE%B2+and+Alzheimer%E2%80%99s+disease%3A+Where+do+the+presenilins+fit+in%3F&doi=10.1038%2Fnrn785"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">γ-SECRETASE, NOTCH, Aβ AND ALZHEIMER'S DISEASE: WHERE DO THE PRESENILINS FIT IN?</span></div><div class="casAuthors">Sisodia, Sangram S.; St George-Hyslop, Peter H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">281-290</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Investigations into the proteolytic processing of amyloid precursor protein (APP) have provided insights into both the pathogenesis of Alzheimer's disease and an unusual form of regulated proteolytic processing within the membrane-spanning domains of several proteins, including APP, Notch and ErbB4.  Some of the enzymes responsible for α- and β-secretase cleavage have been identified, and these seem to be conventional proteolytic events.  However, the mol. events that are involved in γ-secretase cleavage within the transmembrane domain of these proteins are much more complex.  The presenilins and nicastrin are required for this process, but the role of the presenilins remains unclear.  Although some data support the idea that the presenilins are in fact the active site of γ-secretase, other data indicate that they might have a more indirect role, for example, in transporting substrates to the correct subcellular compartments for γ-secretase cleavage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGre-3PaMlOvLrVg90H21EOLACvtfcHk0lhsQlWUpzXghA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xjsl2kurk%253D&md5=a8b77aa0be567febaa093412728aec12</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrn785&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn785%26sid%3Dliteratum%253Aachs%26aulast%3DSisodia%26aufirst%3DS.%2BS.%26aulast%3DSt.%2BGeorge-Hyslop%26aufirst%3DP.%2BH.%26atitle%3D%25CE%25B3-Secretase%252C%2520Notch%252C%2520A%25CE%25B2%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520Where%2520do%2520the%2520presenilins%2520fit%2520in%253F%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2002%26volume%3D3%26spage%3D281%26epage%3D290%26doi%3D10.1038%2Fnrn785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Willem, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahirovic, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Busche, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ovsepian, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chafai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kootar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hornburg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, L. D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daria, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hampel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giudici, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuscher, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wenninger-Weinzierl, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kremmer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heneka, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thal, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giedraitis, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lannfelt, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Livesey, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meissner, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herms, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konnerth, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marie, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haass, C.</span></span> <span> </span><span class="NLM_article-title">η-Secretase processing of APP inhibits neuronal activity in the hippocampus</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>526</i></span>,  <span class="NLM_fpage">443</span>– <span class="NLM_lpage">447</span>, <span class="refDoi"> DOI: 10.1038/nature14864</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=10.1038%2Fnature14864" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=26322584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVCis7%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=526&publication_year=2015&pages=443-447&author=M.+Willemauthor=S.+Tahirovicauthor=M.+A.+Buscheauthor=S.+V.+Ovsepianauthor=M.+Chafaiauthor=S.+Kootarauthor=D.+Hornburgauthor=L.+D.+B.+Evansauthor=S.+Mooreauthor=A.+Dariaauthor=H.+Hampelauthor=V.+M%C3%BCllerauthor=C.+Giudiciauthor=B.+Nuscherauthor=A.+Wenninger-Weinzierlauthor=E.+Kremmerauthor=M.+T.+Henekaauthor=D.+R.+Thalauthor=V.+Giedraitisauthor=L.+Lannfeltauthor=U.+M%C3%BCllerauthor=F.+J.+Liveseyauthor=F.+Meissnerauthor=J.+Hermsauthor=A.+Konnerthauthor=H.+Marieauthor=C.+Haass&title=%CE%B7-Secretase+processing+of+APP+inhibits+neuronal+activity+in+the+hippocampus&doi=10.1038%2Fnature14864"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">η-Secretase processing of APP inhibits neuronal activity in the hippocampus</span></div><div class="casAuthors">Willem, Michael; Tahirovic, Sabina; Busche, Marc Aurel; Ovsepian, Saak V.; Chafai, Magda; Kootar, Scherazad; Hornburg, Daniel; Evans, Lewis D. B.; Moore, Steven; Daria, Anna; Hampel, Heike; Mueller, Veronika; Giudici, Camilla; Nuscher, Brigitte; Wenninger-Weinzierl, Andrea; Kremmer, Elisabeth; Heneka, Michael T.; Thal, Dietmar R.; Giedraitis, Vilmantas; Lannfelt, Lars; Mueller, Ulrike; Livesey, Frederick J.; Meissner, Felix; Herms, Jochen; Konnerth, Arthur; Marie, Helene; Haass, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">526</span>
        (<span class="NLM_cas:issue">7573</span>),
    <span class="NLM_cas:pages">443-447</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Alzheimer disease (AD) is characterized by the accumulation of amyloid plaques, which are predominantly composed of amyloid-β peptide.  Two principal physiol. pathways either prevent or promote amyloid-β generation from its precursor, β-amyloid precursor protein (APP), in a competitive manner.  Although APP processing has been studied in great detail, unknown proteolytic events seem to hinder stoichiometric analyses of APP metab. in vivo.  Here we describe a new physiol. APP processing pathway, which generates proteolytic fragments capable of inhibiting neuronal activity within the hippocampus.  We identify higher mol. mass carboxy-terminal fragments (CTFs) of APP, termed CTF-η, in addn. to the long-known CTF-α and CTF-β fragments generated by the α- and β-secretases ADAM10 (a disintegrin and metalloproteinase 10) and BACE1 (β-site APP cleaving enzyme 1), resp.  CTF-η generation is mediated in part by membrane-bound matrix metalloproteinases such as MT5-MMP, referred to as η-secretase activity.  η-Secretase cleavage occurs primarily at amino acids 504-505 of APP695, releasing a truncated ectodomain.  After shedding of this ectodomain, CTF-η is further processed by ADAM10 and BACE1 to release long and short Aη peptides (termed Aη-α and Aη-β).  CTFs produced by η-secretase are enriched in dystrophic neurites in an AD mouse model and in human AD brains.  Genetic and pharmacol. inhibition of BACE1 activity results in robust accumulation of CTF-η and Aη-α.  In mice treated with a potent BACE1 inhibitor, hippocampal long-term potentiation was reduced.  Notably, when recombinant or synthetic Aη-α was applied on hippocampal slices ex vivo, long-term potentiation was lowered.  Furthermore, in vivo single-cell two-photon calcium imaging showed that hippocampal neuronal activity was attenuated by Aη-α.  These findings not only demonstrate a major functionally relevant APP processing pathway, but may also indicate potential translational relevance for therapeutic strategies targeting APP processing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_5ub5j4eaRbVg90H21EOLACvtfcHk0lhsQlWUpzXghA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVCis7%252FN&md5=e56ae17f893de088e80fe973d4885930</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnature14864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature14864%26sid%3Dliteratum%253Aachs%26aulast%3DWillem%26aufirst%3DM.%26aulast%3DTahirovic%26aufirst%3DS.%26aulast%3DBusche%26aufirst%3DM.%2BA.%26aulast%3DOvsepian%26aufirst%3DS.%2BV.%26aulast%3DChafai%26aufirst%3DM.%26aulast%3DKootar%26aufirst%3DS.%26aulast%3DHornburg%26aufirst%3DD.%26aulast%3DEvans%26aufirst%3DL.%2BD.%2BB.%26aulast%3DMoore%26aufirst%3DS.%26aulast%3DDaria%26aufirst%3DA.%26aulast%3DHampel%26aufirst%3DH.%26aulast%3DM%25C3%25BCller%26aufirst%3DV.%26aulast%3DGiudici%26aufirst%3DC.%26aulast%3DNuscher%26aufirst%3DB.%26aulast%3DWenninger-Weinzierl%26aufirst%3DA.%26aulast%3DKremmer%26aufirst%3DE.%26aulast%3DHeneka%26aufirst%3DM.%2BT.%26aulast%3DThal%26aufirst%3DD.%2BR.%26aulast%3DGiedraitis%26aufirst%3DV.%26aulast%3DLannfelt%26aufirst%3DL.%26aulast%3DM%25C3%25BCller%26aufirst%3DU.%26aulast%3DLivesey%26aufirst%3DF.%2BJ.%26aulast%3DMeissner%26aufirst%3DF.%26aulast%3DHerms%26aufirst%3DJ.%26aulast%3DKonnerth%26aufirst%3DA.%26aulast%3DMarie%26aufirst%3DH.%26aulast%3DHaass%26aufirst%3DC.%26atitle%3D%25CE%25B7-Secretase%2520processing%2520of%2520APP%2520inhibits%2520neuronal%2520activity%2520in%2520the%2520hippocampus%26jtitle%3DNature%26date%3D2015%26volume%3D526%26spage%3D443%26epage%3D447%26doi%3D10.1038%2Fnature14864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duong, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seyfried, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levey, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, K.</span></span> <span> </span><span class="NLM_article-title">δ-Secretase cleaves amyloid precursor protein and regulates the pathogenesis in Alzheimer’s disease</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">8762</span>– <span class="NLM_lpage">8778</span>, <span class="refDoi"> DOI: 10.1038/ncomms9762</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=10.1038%2Fncomms9762" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=26549211" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsl2gs73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=8762-8778&author=Z.+Zhangauthor=M.+Songauthor=X.+Liuauthor=S.+S.+Kangauthor=D.+M.+Duongauthor=N.+T.+Seyfriedauthor=X.+Caoauthor=L.+Chengauthor=Y.+E.+Sunauthor=S.+P.+Yuauthor=J.+Jiaauthor=A.+I.+Leveyauthor=K.+Ye&title=%CE%B4-Secretase+cleaves+amyloid+precursor+protein+and+regulates+the+pathogenesis+in+Alzheimer%E2%80%99s+disease&doi=10.1038%2Fncomms9762"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Delta-secretase cleaves amyloid precursor protein and regulates the pathogenesis in Alzheimer's disease</span></div><div class="casAuthors">Zhang, Zhentao; Song, Mingke; Liu, Xia; Su Kang, Seong; Duong, Duc M.; Seyfried, Nicholas T.; Cao, Xuebing; Cheng, Liming; Sun, Yi E.; Ping Yu, Shan; Jia, Jianping; Levey, Allan I.; Ye, Keqiang</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">8762</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The age-dependent deposition of amyloid-β peptides, derived from amyloid precursor protein (APP), is a neuropathol. hallmark of Alzheimer's disease (AD).  Despite age being the greatest risk factor for AD, the mol. mechanisms linking ageing to APP processing are unknown.  Here we show that asparagine endopeptidase (AEP), a pH-controlled cysteine proteinase, is activated during ageing and mediates APP proteolytic processing.  AEP cleaves APP at N373 and N585 residues, selectively influencing the amyloidogenic fragmentation of APP.  AEP is activated in normal mice in an age-dependent manner, and is strongly activated in 5XFAD transgenic mouse model and human AD brains.  Deletion of AEP from 5XFAD or APP/PS1 mice decreases senile plaque formation, ameliorates synapse loss, elevates long-term potentiation and protects memory.  Blockade of APP cleavage by AEP in mice alleviates pathol. and behavioral deficits.  Thus, AEP acts as a δ-secretase, contributing to the age-dependent pathogenic mechanisms in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7XX7eyTKfE7Vg90H21EOLACvtfcHk0lg_2AOV4CEQ2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsl2gs73L&md5=a107a6df97c929208a490ac590f7c0c8</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fncomms9762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms9762%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DSong%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DKang%26aufirst%3DS.%2BS.%26aulast%3DDuong%26aufirst%3DD.%2BM.%26aulast%3DSeyfried%26aufirst%3DN.%2BT.%26aulast%3DCao%26aufirst%3DX.%26aulast%3DCheng%26aufirst%3DL.%26aulast%3DSun%26aufirst%3DY.%2BE.%26aulast%3DYu%26aufirst%3DS.%2BP.%26aulast%3DJia%26aufirst%3DJ.%26aulast%3DLevey%26aufirst%3DA.%2BI.%26aulast%3DYe%26aufirst%3DK.%26atitle%3D%25CE%25B4-Secretase%2520cleaves%2520amyloid%2520precursor%2520protein%2520and%2520regulates%2520the%2520pathogenesis%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNat.%2520Commun.%26date%3D2015%26volume%3D6%26spage%3D8762%26epage%3D8778%26doi%3D10.1038%2Fncomms9762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mullan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawford, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houlden, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Axelman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lilius, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winblad, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lannfelt, L.</span></span> <span> </span><span class="NLM_article-title">A pathogenic mutation for probable Alzheimer’s disease in the APP gene at the N-terminus of β-amyloid</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">345</span>– <span class="NLM_lpage">347</span>, <span class="refDoi"> DOI: 10.1038/ng0892-345</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=10.1038%2Fng0892-345" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=1302033" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=1%3ACAS%3A528%3ADyaK38XlsVyms7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1992&pages=345-347&author=M.+Mullanauthor=F.+Crawfordauthor=H.+Houldenauthor=K.+Axelmanauthor=L.+Liliusauthor=B.+Winbladauthor=L.+Lannfelt&title=A+pathogenic+mutation+for+probable+Alzheimer%E2%80%99s+disease+in+the+APP+gene+at+the+N-terminus+of+%CE%B2-amyloid&doi=10.1038%2Fng0892-345"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of β-amyloid</span></div><div class="casAuthors">Mullan, Mike; Crawford, Fiona; Axelman, Karin; Houlden, Henry; Lilius, Lena; Winblad, Bengt; Lannfelt, Lars</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">345-7</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    </div><div class="casAbstract">Mutations at codon 717 in exon 17 of the β-amyloid precursor protein (APP) gene have previously been shown to segregate with early onset Alzheimer's disease in some families.  The authors have identified a double mutation at codons 670 and 671 (APP 70 transcript) in exon 16 which co-segregates with the disease in two large (probably related) early-onset Alzheimer's disease families from Sweden.  Two base pair transversions (G to T, A to C) from the normal sequence predict Lys to Asn and Met to Leu amino acid substitutions at codons 670 and 671 of the APP transcript.  This mutation occurs at the amino terminal of β-amyloid and may be pathogenic because it occurs at or close to the endosomal/lysosomal cleavage site of the mol.  Thus, pathogenic mutations in APP frame the β-amyloid sequence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgOJnPYRyWy7Vg90H21EOLACvtfcHk0lg_2AOV4CEQ2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XlsVyms7o%253D&md5=bb47f91ebc60786b1ef9b9c2461c71e5</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fng0892-345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng0892-345%26sid%3Dliteratum%253Aachs%26aulast%3DMullan%26aufirst%3DM.%26aulast%3DCrawford%26aufirst%3DF.%26aulast%3DHoulden%26aufirst%3DH.%26aulast%3DAxelman%26aufirst%3DK.%26aulast%3DLilius%26aufirst%3DL.%26aulast%3DWinblad%26aufirst%3DB.%26aulast%3DLannfelt%26aufirst%3DL.%26atitle%3DA%2520pathogenic%2520mutation%2520for%2520probable%2520Alzheimer%25E2%2580%2599s%2520disease%2520in%2520the%2520APP%2520gene%2520at%2520the%2520N-terminus%2520of%2520%25CE%25B2-amyloid%26jtitle%3DNat.%2520Genet.%26date%3D1992%26volume%3D1%26spage%3D345%26epage%3D347%26doi%3D10.1038%2Fng0892-345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di
Fede, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catania, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morbin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suardi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzoleni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merlin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giovagnoli, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prioni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erbetta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falcone, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobbi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colombo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bastone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beeg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manzoni, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francescucci, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spagnoli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Favero, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levy, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salmona, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tagliavini, F.</span></span> <span> </span><span class="NLM_article-title">A recessive mutation in the APP gene with dominant-negative effect on amyloidogenesis</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>323</i></span>,  <span class="NLM_fpage">1473</span>– <span class="NLM_lpage">1477</span>, <span class="refDoi"> DOI: 10.1126/science.1168979</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=10.1126%2Fscience.1168979" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=19286555" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=1%3ACAS%3A528%3ADC%252BD1MXivFSmu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=323&publication_year=2009&pages=1473-1477&author=G.+Di%0AFedeauthor=M.+Cataniaauthor=M.+Morbinauthor=G.+Rossiauthor=S.+Suardiauthor=G.+Mazzoleniauthor=M.+Merlinauthor=A.+R.+Giovagnoliauthor=S.+Prioniauthor=A.+Erbettaauthor=C.+Falconeauthor=M.+Gobbiauthor=L.+Colomboauthor=A.+Bastoneauthor=M.+Beegauthor=C.+Manzoniauthor=B.+Francescucciauthor=A.+Spagnoliauthor=L.+Cantuauthor=E.+Del+Faveroauthor=E.+Levyauthor=M.+Salmonaauthor=F.+Tagliavini&title=A+recessive+mutation+in+the+APP+gene+with+dominant-negative+effect+on+amyloidogenesis&doi=10.1126%2Fscience.1168979"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">A Recessive mutation in the APP gene with dominant-negative effect on amyloidogenesis</span></div><div class="casAuthors">Di Fede, Giuseppe; Catania, Marcella; Morbin, Michela; Rossi, Giacomina; Suardi, Silvia; Mazzoleni, Giulia; Merlin, Marco; Giovagnoli, Anna Rita; Prioni, Sara; Erbetta, Alessandra; Falcone, Chiara; Gobbi, Marco; Colombo, Laura; Bastone, Antonio; Beeg, Marten; Manzoni, Claudia; Francescucci, Bruna; Spagnoli, Alberto; Cantu, Laura; Del Favero, Elena; Levy, Efrat; Salmona, Mario; Tagliavini, Fabrizio</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">323</span>
        (<span class="NLM_cas:issue">5920</span>),
    <span class="NLM_cas:pages">1473-1477</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">β-Amyloid precursor protein (APP) mutations cause familial Alzheimer's disease with nearly complete penetrance.  We found an APP mutation [alanine-673→valine-673 (A673V)] that causes disease only in the homozygous state, whereas heterozygous carriers were unaffected, consistent with a recessive Mendelian trait of inheritance.  The A673V mutation affected APP processing, resulting in enhanced β-amyloid (Aβ) prodn. and formation of amyloid fibrils in vitro.  Co-incubation of mutated and wild-type peptides conferred instability on Aβ aggregates and inhibited amyloidogenesis and neurotoxicity.  The highly amyloidogenic effect of the A673V mutation in the homozygous state and its anti-amyloidogenic effect in the heterozygous state account for the autosomal recessive pattern of inheritance and have implications for genetic screening and the potential treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqL79MU6KuccrVg90H21EOLACvtfcHk0lg_2AOV4CEQ2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXivFSmu7k%253D&md5=c89b5231df3078387c1c0356210ac2fa</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1126%2Fscience.1168979&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1168979%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BFede%26aufirst%3DG.%26aulast%3DCatania%26aufirst%3DM.%26aulast%3DMorbin%26aufirst%3DM.%26aulast%3DRossi%26aufirst%3DG.%26aulast%3DSuardi%26aufirst%3DS.%26aulast%3DMazzoleni%26aufirst%3DG.%26aulast%3DMerlin%26aufirst%3DM.%26aulast%3DGiovagnoli%26aufirst%3DA.%2BR.%26aulast%3DPrioni%26aufirst%3DS.%26aulast%3DErbetta%26aufirst%3DA.%26aulast%3DFalcone%26aufirst%3DC.%26aulast%3DGobbi%26aufirst%3DM.%26aulast%3DColombo%26aufirst%3DL.%26aulast%3DBastone%26aufirst%3DA.%26aulast%3DBeeg%26aufirst%3DM.%26aulast%3DManzoni%26aufirst%3DC.%26aulast%3DFrancescucci%26aufirst%3DB.%26aulast%3DSpagnoli%26aufirst%3DA.%26aulast%3DCantu%26aufirst%3DL.%26aulast%3DDel%2BFavero%26aufirst%3DE.%26aulast%3DLevy%26aufirst%3DE.%26aulast%3DSalmona%26aufirst%3DM.%26aulast%3DTagliavini%26aufirst%3DF.%26atitle%3DA%2520recessive%2520mutation%2520in%2520the%2520APP%2520gene%2520with%2520dominant-negative%2520effect%2520on%2520amyloidogenesis%26jtitle%3DScience%26date%3D2009%26volume%3D323%26spage%3D1473%26epage%3D1477%26doi%3D10.1126%2Fscience.1168979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jonsson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atwal, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinberg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snaedal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonsson, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjornsson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefansson, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sulem, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gudbjartsson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maloney, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoyte, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhangale, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huttenlocher, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjornsdottir, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreassen, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonsson, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palotie, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behrens, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnusson, O. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorsteinsdottir, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watts, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefansson, K.</span></span> <span> </span><span class="NLM_article-title">A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>488</i></span>,  <span class="NLM_fpage">96</span>– <span class="NLM_lpage">99</span>, <span class="refDoi"> DOI: 10.1038/nature11283</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=10.1038%2Fnature11283" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=22801501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFWmt73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=488&publication_year=2012&pages=96-99&author=T.+Jonssonauthor=J.+K.+Atwalauthor=S.+Steinbergauthor=J.+Snaedalauthor=P.+V.+Jonssonauthor=S.+Bjornssonauthor=H.+Stefanssonauthor=P.+Sulemauthor=D.+Gudbjartssonauthor=J.+Maloneyauthor=K.+Hoyteauthor=A.+Gustafsonauthor=Y.+Liuauthor=Y.+Luauthor=T.+Bhangaleauthor=R.+R.+Grahamauthor=J.+Huttenlocherauthor=G.+Bjornsdottirauthor=O.+A.+Andreassenauthor=E.+G.+Jonssonauthor=A.+Palotieauthor=T.+W.+Behrensauthor=O.+T.+Magnussonauthor=A.+Kongauthor=U.+Thorsteinsdottirauthor=R.+J.+Wattsauthor=K.+Stefansson&title=A+mutation+in+APP+protects+against+Alzheimer%E2%80%99s+disease+and+age-related+cognitive+decline&doi=10.1038%2Fnature11283"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">A mutation in APP protects against Alzheimer's disease and age-related cognitive decline</span></div><div class="casAuthors">Jonsson, Thorlakur; Atwal, Jasvinder K.; Steinberg, Stacy; Snaedal, Jon; Jonsson, Palmi V.; Bjornsson, Sigurbjorn; Stefansson, Hreinn; Sulem, Patrick; Gudbjartsson, Daniel; Maloney, Janice; Hoyte, Kwame; Gustafson, Amy; Liu, Yichin; Lu, Yanmei; Bhangale, Tushar; Graham, Robert R.; Huttenlocher, Johanna; Bjornsdottir, Gyda; Andreassen, Ole A.; Joensson, Erik G.; Palotie, Aarno; Behrens, Timothy W.; Magnusson, Olafur T.; Kong, Augustine; Thorsteinsdottir, Unnur; Watts, Ryan J.; Stefansson, Kari</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">488</span>
        (<span class="NLM_cas:issue">7409</span>),
    <span class="NLM_cas:pages">96-99</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The prevalence of dementia in the Western world in people over the age of 60 has been estd. to be greater than 5%, about two-thirds of which are due to Alzheimer's disease.  The age-specific prevalence of Alzheimer's disease nearly doubles every 5 years after age 65, leading to a prevalence of greater than 25% in those over the age of 90 (ref. 3).  Here, to search for low-frequency variants in the amyloid-β precursor protein (APP) gene with a significant effect on the risk of Alzheimer's disease, we studied coding variants in APP in a set of whole-genome sequence data from 1795 Icelanders.  We found a coding mutation (A673T) in the APP gene that protects against Alzheimer's disease and cognitive decline in the elderly without Alzheimer's disease.  This substitution is adjacent to the aspartyl protease β-site in APP, and results in an approx. 40% redn. in the formation of amyloidogenic peptides in vitro.  The strong protective effect of the A673T substitution against Alzheimer's disease provides proof of principle for the hypothesis that reducing the β-cleavage of APP may protect against the disease.  Furthermore, as the A673T allele also protects against cognitive decline in the elderly without Alzheimer's disease, the two may be mediated through the same or similar mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4AFwQCLRQOLVg90H21EOLACvtfcHk0ljuRWvdwlmiMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFWmt73M&md5=4db9cb2e3842d5a9d4af4ce102249b70</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnature11283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11283%26sid%3Dliteratum%253Aachs%26aulast%3DJonsson%26aufirst%3DT.%26aulast%3DAtwal%26aufirst%3DJ.%2BK.%26aulast%3DSteinberg%26aufirst%3DS.%26aulast%3DSnaedal%26aufirst%3DJ.%26aulast%3DJonsson%26aufirst%3DP.%2BV.%26aulast%3DBjornsson%26aufirst%3DS.%26aulast%3DStefansson%26aufirst%3DH.%26aulast%3DSulem%26aufirst%3DP.%26aulast%3DGudbjartsson%26aufirst%3DD.%26aulast%3DMaloney%26aufirst%3DJ.%26aulast%3DHoyte%26aufirst%3DK.%26aulast%3DGustafson%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DBhangale%26aufirst%3DT.%26aulast%3DGraham%26aufirst%3DR.%2BR.%26aulast%3DHuttenlocher%26aufirst%3DJ.%26aulast%3DBjornsdottir%26aufirst%3DG.%26aulast%3DAndreassen%26aufirst%3DO.%2BA.%26aulast%3DJonsson%26aufirst%3DE.%2BG.%26aulast%3DPalotie%26aufirst%3DA.%26aulast%3DBehrens%26aufirst%3DT.%2BW.%26aulast%3DMagnusson%26aufirst%3DO.%2BT.%26aulast%3DKong%26aufirst%3DA.%26aulast%3DThorsteinsdottir%26aufirst%3DU.%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26aulast%3DStefansson%26aufirst%3DK.%26atitle%3DA%2520mutation%2520in%2520APP%2520protects%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520age-related%2520cognitive%2520decline%26jtitle%3DNature%26date%3D2012%26volume%3D488%26spage%3D96%26epage%3D99%26doi%3D10.1038%2Fnature11283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Öhlrich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prokopcova, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H. J. M.</span></span> <span> </span><span class="NLM_article-title">The evolution of amidine-based brain penetrant BACE1 inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">2033</span>– <span class="NLM_lpage">2045</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.03.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=10.1016%2Fj.bmcl.2014.03.025" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=2033-2045&author=D.+%C3%96hlrichauthor=H.+Prokopcovaauthor=H.+J.+M.+Gijsen&title=The+evolution+of+amidine-based+brain+penetrant+BACE1+inhibitors&doi=10.1016%2Fj.bmcl.2014.03.025"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.03.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.03.025%26sid%3Dliteratum%253Aachs%26aulast%3D%25C3%2596hlrich%26aufirst%3DD.%26aulast%3DProkopcova%26aufirst%3DH.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26atitle%3DThe%2520evolution%2520of%2520amidine-based%2520brain%2520penetrant%2520BACE1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D2033%26epage%3D2045%26doi%3D10.1016%2Fj.bmcl.2014.03.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cebers, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Budd Haeberlein, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldwater, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ereshefsky, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maltby, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eketjäll, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kugler, A. R.</span></span> <span> </span><span class="NLM_article-title">AZD3293: pharmacokinetic and pharmacodynamic effects in healthy subjects and patients with Alzheimer’s disease</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">1039</span>– <span class="NLM_lpage">1053</span>, <span class="refDoi"> DOI: 10.3233/JAD-160701</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=10.3233%2FJAD-160701" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=27767991" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVyrt7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2017&pages=1039-1053&author=G.+Cebersauthor=R.+C.+Alexanderauthor=S.+Budd+Haeberleinauthor=D.+Hanauthor=R.+Goldwaterauthor=L.+Ereshefskyauthor=T.+Olssonauthor=N.+Yeauthor=L.+Rosenauthor=M.+Russellauthor=J.+Maltbyauthor=S.+Eketj%C3%A4llauthor=A.+R.+Kugler&title=AZD3293%3A+pharmacokinetic+and+pharmacodynamic+effects+in+healthy+subjects+and+patients+with+Alzheimer%E2%80%99s+disease&doi=10.3233%2FJAD-160701"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">AZD3293: Pharmacokinetic and Pharmacodynamic Effects in Healthy Subjects and Patients with Alzheimer's Disease</span></div><div class="casAuthors">Cebers, Gvido; Alexander, Robert C.; Haeberlein, Samantha Budd; Han, David; Goldwater, Ronald; Ereshefsky, Larry; Olsson, Tina; Ye, Naidong; Rosen, Laura; Russell, Muir; Maltby, Justine; Eketjaell, Susanna; Kugler, Alan R.; Murphy, M. Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1039-1053</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">AZD3293 (LY3314814) is a promising new potentially disease-modifying BACE1 (β-secretase) inhibitor in Phase III clin. development for the treatment of Alzheimer's disease.  Reported here are the first two Phase I studies: (1) a single ascending dose study evaluating doses of 1-750mg with a food-effect component (n=72), and (2) a 2-wk multiple ascending dose study evaluating doses of 15 or 50mg once daily (QD) or 70mg once weekly (QW) in elderly subjects (Part 1, n=31), and 15, 50, or 150mg QD in patients with mild to moderate Alzheimer's disease (Part 2, n=16).  AZD3293 was generally well tolerated up to the highest doses given.  No notable food effects were obsd.  PK following multiple doses (Part 2) were tmax of 1 to 3h and mean t1/2 of 16 to 21h across the 15 to 150mg dose range.  For single doses of ≥5mg, a ≥70% redn. was obsd. in mean plasma Aβ40 and Aβ42 concns., with prolonged suppression for up to 3 wk at the highest dose level studied.  Following multiple doses, robust redns. in plasma (≥64% at 15mg and ≥78% at ≥50mg) and cerebrospinal fluid (≥51% at 15mg and ≥76% at ≥50mg) Aβ peptides were seen, including prolonged suppression even with a QW dosing regimen.  AZD3293 is the only BACE1 inhibitor for which prolonged suppression of plasma Aβ with a QW dosing schedule has been reported.  Two Phase III studies of AZD3293 (AMARANTH, NCT02245737; and DAYBREAK-ALZ, NCT02783573) are now ongoing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHGDodXrxjXLVg90H21EOLACvtfcHk0ljuRWvdwlmiMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVyrt7%252FK&md5=2b190c11cc8d905c734982ecec4a1e10</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.3233%2FJAD-160701&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-160701%26sid%3Dliteratum%253Aachs%26aulast%3DCebers%26aufirst%3DG.%26aulast%3DAlexander%26aufirst%3DR.%2BC.%26aulast%3DBudd%2BHaeberlein%26aufirst%3DS.%26aulast%3DHan%26aufirst%3DD.%26aulast%3DGoldwater%26aufirst%3DR.%26aulast%3DEreshefsky%26aufirst%3DL.%26aulast%3DOlsson%26aufirst%3DT.%26aulast%3DYe%26aufirst%3DN.%26aulast%3DRosen%26aufirst%3DL.%26aulast%3DRussell%26aufirst%3DM.%26aulast%3DMaltby%26aufirst%3DJ.%26aulast%3DEketj%25C3%25A4ll%26aufirst%3DS.%26aulast%3DKugler%26aufirst%3DA.%2BR.%26atitle%3DAZD3293%253A%2520pharmacokinetic%2520and%2520pharmacodynamic%2520effects%2520in%2520healthy%2520subjects%2520and%2520patients%2520with%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2017%26volume%3D55%26spage%3D1039%26epage%3D1053%26doi%3D10.3233%2FJAD-160701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, R.</span></span> <span> </span><span class="NLM_article-title">Physiological functions of the β-Site amyloid precursor protein cleaving enzyme 1 and 2</span>.  <i>Front. Mol. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume">10</span>. DOI: <span class="refDoi"> DOI: 10.3389/fnmol.2017.00097</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=10.3389%2Ffnmol.2017.00097" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2017&author=R.+Yan&title=Physiological+functions+of+the+%CE%B2-Site+amyloid+precursor+protein+cleaving+enzyme+1+and+2&doi=10.3389%2Ffnmol.2017.00097"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.3389%2Ffnmol.2017.00097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnmol.2017.00097%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DR.%26atitle%3DPhysiological%2520functions%2520of%2520the%2520%25CE%25B2-Site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520and%25202%26jtitle%3DFront.%2520Mol.%2520Neurosci.%26date%3D2017%26volume%3D10%26doi%3D10.3389%2Ffnmol.2017.00097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rochin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurbain, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serneels, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fort, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watt, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leblanc, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marks, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeStrooper, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raposo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Niel, G.</span></span> <span> </span><span class="NLM_article-title">BACE2 processes PMEL to form the melanosome amyloid matrix in pigment cells</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">10658</span>– <span class="NLM_lpage">10663</span>, <span class="refDoi"> DOI: 10.1073/pnas.1220748110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=10.1073%2Fpnas.1220748110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=23754390" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFejs7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=10658-10663&author=L.+Rochinauthor=I.+Hurbainauthor=L.+Serneelsauthor=C.+Fortauthor=B.+Wattauthor=P.+Leblancauthor=M.+S.+Marksauthor=B.+DeStrooperauthor=G.+Raposoauthor=G.+van+Niel&title=BACE2+processes+PMEL+to+form+the+melanosome+amyloid+matrix+in+pigment+cells&doi=10.1073%2Fpnas.1220748110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">BACE2 processes PMEL to form the melanosome amyloid matrix in pigment cells</span></div><div class="casAuthors">Rochin, Leila; Hurbain, Ilse; Serneels, Lutgarde; Fort, Cecile; Watt, Brenda; Leblanc, Pascal; Marks, Michael S.; De Strooper, Bart; Raposo, Graca; van Niel, Guillaume</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">10658-10663,S10658/1-S10658/7</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Amyloids are often assocd. with pathol. processes such as in Alzheimer's disease (AD), but can also underlie physiol. processes such as pigmentation.  Formation of pathol. and functional amyloidogenic substrates can require precursor processing by proteases, as exemplified by the generation of Aβ peptide from amyloid precursor protein (APP) by beta-site APP cleaving enzyme (BACE)1 and γ-secretase.  Proteolytic processing of the pigment cell-specific Melanocyte Protein (PMEL) is also required to form functional amyloid fibrils during melanogenesis, but the enzymes involved are incompletely characterized.  Here we show that the BACE1 homolog BACE2 processes PMEL to generate functional amyloids.  BACE2 is highly expressed in pigment cells and Bace2-/- but not Bace1-/- mice display coat color defects, implying a specific role for BACE2 during melanogenesis.  By using biochem. and morphol. analyses, combined with RNA silencing, pharmacol. inhibition, and BACE2 overexpression in a human melanocytic cell line, we show that BACE2 cleaves the integral membrane form of PMEL within the juxtamembrane domain, releasing the PMEL luminal domain into endosomal precursors for the formation of amyloid fibrils and downstream melanosome morphogenesis.  These studies identify an amyloidogenic substrate of BACE2, reveal an important physiol. role for BACE2 in pigmentation, and highlight analogies in the generation of PMEL-derived functional amyloids and APP-derived pathol. amyloids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLBEney5KFyLVg90H21EOLACvtfcHk0liNpMhb64u0dQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFejs7rK&md5=3deb3f80dca6a32748aa6fe2e50c2df1</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1220748110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1220748110%26sid%3Dliteratum%253Aachs%26aulast%3DRochin%26aufirst%3DL.%26aulast%3DHurbain%26aufirst%3DI.%26aulast%3DSerneels%26aufirst%3DL.%26aulast%3DFort%26aufirst%3DC.%26aulast%3DWatt%26aufirst%3DB.%26aulast%3DLeblanc%26aufirst%3DP.%26aulast%3DMarks%26aufirst%3DM.%2BS.%26aulast%3DDeStrooper%26aufirst%3DB.%26aulast%3DRaposo%26aufirst%3DG.%26aulast%3Dvan%2BNiel%26aufirst%3DG.%26atitle%3DBACE2%2520processes%2520PMEL%2520to%2520form%2520the%2520melanosome%2520amyloid%2520matrix%2520in%2520pigment%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D10658%26epage%3D10663%26doi%3D10.1073%2Fpnas.1220748110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cebers, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lejeune, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attalla, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soderberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Budd Haeberlein, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kugler, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingersoll, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Platz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, C. W.</span></span> <span> </span><span class="NLM_article-title">Reversible and species-specific depigmentation effects of AZD3293, a BACE inhibitor for the treatment of Alzheimer’s disease, are related to BACE2 inhibition and confined to epidermis and hair</span>. <i>J. Prev. Alzheimer’s Dis.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">202</span>– <span class="NLM_lpage">218</span>, <span class="refDoi"> DOI: 10.14283/jpad.2016.119</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=10.14283%2Fjpad.2016.119" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=29199322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=1%3ACAS%3A280%3ADC%252BC1M3ntlKisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2016&pages=202-218&author=G.+Cebersauthor=T.+Lejeuneauthor=B.+Attallaauthor=M.+Soderbergauthor=R.+C.+Alexanderauthor=S.+Budd+Haeberleinauthor=A.+R.+Kuglerauthor=E.+W.+Ingersollauthor=S.+Platzauthor=C.+W.+Scott&title=Reversible+and+species-specific+depigmentation+effects+of+AZD3293%2C+a+BACE+inhibitor+for+the+treatment+of+Alzheimer%E2%80%99s+disease%2C+are+related+to+BACE2+inhibition+and+confined+to+epidermis+and+hair&doi=10.14283%2Fjpad.2016.119"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Reversible and Species-Specific Depigmentation Effects of AZD3293, a BACE Inhibitor for the Treatment of Alzheimer's Disease, Are Related to BACE2 Inhibition and Confined to Epidermis and Hair</span></div><div class="casAuthors">Cebers G; Lejeune T; Attalla B; Soderberg M; Alexander R C; Budd Haeberlein S; Kugler A R; Ingersoll E W; Platz S; Scott C W</div><div class="citationInfo"><span class="NLM_cas:title">The journal of prevention of Alzheimer's disease</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">202-218</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  AZD3293 (also known as LY3314814) is a novel, potent, non-selective BACE1/BACE2 inhibitor currently in Phase 3 clinical development for the treatment of Alzheimer's disease.  OBJECTIVES:  The purpose of these studies was to characterize the effects, putative mechanism, and reversibility of hypopigmentation following treatment with AZD3293 in pigmented Long-Evans rats, Beagle dogs, human cell cultures, and humans.  DESIGN:  Nonclinical studies were conducted in Long-Evans pigmented rats, and both young and older Beagle dogs using a variety of oral dose levels of AZD3293 or AZD3839 (BACE inhibition reference compound; used in older dogs only) for dosing durations of 13 to 26 weeks.  In vitro studies of normal human epidermal melanocytes and reconstituted human epidermis were also conducted.  Skin biopsy data from a multiple-dose Phase 1 clinical study of AZD3293 (NCT01795339) are also reported.  SETTING:  Nonclinical in vivo and in vitro studies were conducted in laboratory settings in the US, Canada, and France; the multiple dose clinical study was conducted in a specialized inpatient setting in the US.  PARTICIPANTS:  Beagle dogs: 13-week study N=36 young (8-10 mo) animals; 39-week study N=64 young animals; and a second 13-week study N=32 older (30-32 mo) animals.  Long-Evans rats: N=68 animals.  Multiple-dose clinical study: only data for subjects enrolled in Part 2 of this study are included in this report (N=16).  INTERVENTIONS:  AZD3293 was the primary intervention used in these studies.  AZD3839, a relatively BACE1-selective reference inhibitor compound was used in one group in the 13 week study in older Beagle dogs and one in vitro assessment.  Finally, AZ1340, another relatively BACE1-selective reference inhibitor compound was used only in one in vitro assessment.  MEASUREMENTS:  Measurements for the nonclinical studies in dogs and rats included macroscopic observation and assessment of skin biopsies via histopathology, immunochemistry, and electron microscopy.  Measurements for the in vitro studies included melanocyte premelanosome protein (PMEL) processing, cytotoxicity, melanin synthesis, Pmel17 labeling, and melanocyte dendricity.  Measurements in the clinical study included scoring of melanin content in skin biopsies taken before and after dosing with AZD3293 over 14 days at dose levels up to 150 mg.  RESULTS:  Depigmentation in rats and dogs was limited to skin, hair, and mucosa with no effects on other pigmented tissues.  At a cellular level depigmentation was observed within a week of treatment, whereas the appearance of depigmentation in skin and hair did not become apparent until, at earliest, 4 weeks of treatment.  The depigmentation effects were reversible, not associated with degenerative or inflammatory changes, and were dose- and species-dependent in severity.  Full recovery of melanization was observed at the microscopic (cellular) level and at least partial recovery was seen in the macroscopic appearance of animals by the end of the 12-week recovery period in both rats and dogs.  Interestingly, no changes in melanin production or melanocyte morphology were seen in human primary melanocytes or reconstituted human epidermis in vitro.  Finally, there were no changes in melanization level in skin biopsies following 12 days of daily AZD3293 treatment at doses of AZD3293 up to 150 mg/day in human subjects.  CONCLUSIONS:  AZD3293, a novel, potent, non-selective BACE1/BACE2 inhibitor is in development as a potentially disease-modifying treatment for Alzheimer's disease.  Chronic nonclinical studies in Beagle dogs and pigmented rats showed macroscopic and microscopic hypopigmentation effects of AZD3293 that were limited to skin, hair, and mucosa.  These effects were shown to be reversible in both species.  Analysis of data from nonclinical and in vitro studies suggests that hypopigmentation is caused by BACE2 inhibition resulting in accumulation of a premelanosome protein fragment, which interrupts the normal production of melanin.  No macroscopic or microscopic reports of hypopigmentation were observed in a Phase 1 clinical study following 13 doses of AZD3293 over 14 days at dose levels up to 150 mg/day.  These data suggest that hypopigmentation is species-specific and humans appear to be least sensitive to the depigmentation effect caused by BACE2 inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSnMZvqjWSFT7t7lRqEFUJVfW6udTcc2eakMTmn2UxQprntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M3ntlKisw%253D%253D&md5=8eaa57d7d8e3bb8bfad9244ffb5ae16a</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.14283%2Fjpad.2016.119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.14283%252Fjpad.2016.119%26sid%3Dliteratum%253Aachs%26aulast%3DCebers%26aufirst%3DG.%26aulast%3DLejeune%26aufirst%3DT.%26aulast%3DAttalla%26aufirst%3DB.%26aulast%3DSoderberg%26aufirst%3DM.%26aulast%3DAlexander%26aufirst%3DR.%2BC.%26aulast%3DBudd%2BHaeberlein%26aufirst%3DS.%26aulast%3DKugler%26aufirst%3DA.%2BR.%26aulast%3DIngersoll%26aufirst%3DE.%2BW.%26aulast%3DPlatz%26aufirst%3DS.%26aulast%3DScott%26aufirst%3DC.%2BW.%26atitle%3DReversible%2520and%2520species-specific%2520depigmentation%2520effects%2520of%2520AZD3293%252C%2520a%2520BACE%2520inhibitor%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%252C%2520are%2520related%2520to%2520BACE2%2520inhibition%2520and%2520confined%2520to%2520epidermis%2520and%2520hair%26jtitle%3DJ.%2520Prev.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2016%26volume%3D3%26spage%3D202%26epage%3D218%26doi%3D10.14283%2Fjpad.2016.119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shimshek, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolly, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamurovic, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balavenkatraman, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morawiec, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreutzer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schelle, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jucker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertschi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Theil, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bigot, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beltz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machauer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brzak, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrot, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, U.</span></span> <span> </span><span class="NLM_article-title">Pharmacological BACE1 and BACE2 inhibition induces hair depigmentation by inhibiting PMEL17 processing in mice</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">21917</span>, <span class="refDoi"> DOI: 10.1038/srep21917</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=10.1038%2Fsrep21917" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=26912421" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjt1eku7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=21917&author=D.+R.+Shimshekauthor=L.+H.+Jacobsonauthor=C.+Kollyauthor=N.+Zamurovicauthor=K.+K.+Balavenkatramanauthor=L.+Morawiecauthor=R.+Kreutzerauthor=J.+Schelleauthor=M.+Juckerauthor=B.+Bertschiauthor=D.+Theilauthor=A.+Heierauthor=K.+Bigotauthor=K.+Beltzauthor=R.+Machauerauthor=I.+Brzakauthor=L.+Perrotauthor=U.+Neumann&title=Pharmacological+BACE1+and+BACE2+inhibition+induces+hair+depigmentation+by+inhibiting+PMEL17+processing+in+mice&doi=10.1038%2Fsrep21917"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological BACE1 and BACE2 inhibition induces hair depigmentation by inhibiting PMEL17 processing in mice</span></div><div class="casAuthors">Shimshek, Derya R.; Jacobson, Laura H.; Kolly, Carine; Zamurovic, Natasa; Balavenkatraman, Kamal Kumar; Morawiec, Laurent; Kreutzer, Robert; Schelle, Juliane; Jucker, Mathias; Bertschi, Barbara; Theil, Diethilde; Heier, Annabelle; Bigot, Karine; Beltz, Karen; Machauer, Rainer; Brzak, Irena; Perrot, Ludovic; Neumann, Ulf</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">21917</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Melanocytes of the hair follicle produce melanin and are essential in detg. the differences in hair color.  Pigment cell-specific MELanocyte Protein (PMEL17) plays a crucial role in melanogenesis.  One of the crit. steps is the amyloid-like functional oligomerization of PMEL17.  Beta Site APP Cleaving Enzyme-2 (BACE2) and γ-secretase have been shown to be key players in generating the proteolytic fragments of PMEL17.  The β-secretase (BACE1) is responsible for the generation of amyloid-β (Aβ) fragments in the brain and is therefore proposed as a therapeutic target for Alzheimer's disease (AD).  Currently BACE1 inhibitors, most of which lack selectivity over BACE2, have demonstrated efficacious redn. of amyloid-β peptides in animals and the CSF of humans.  BACE2 knock-out mice have a deficiency in PMEL17 proteolytic processing leading to impaired melanin storage and hair depigmentation.  Here, we confirm BACE2-mediated inhibition of PMEL17 proteolytic processing in vitro in mouse and human melanocytes.  Furthermore, we show that wildtype as well as bace2+/- and bace2-/- mice treated with a potent dual BACE1/BACE2 inhibitor NB-360 display dose-dependent appearance of irreversibly depigmented hair.  Retinal pigmented epithelium showed no morphol. changes.  Our data demonstrates that BACE2 as well as addnl. BACE1 inhibition affects melanosome maturation and induces hair depigmentation in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtlQ-3Lxc4CLVg90H21EOLACvtfcHk0liNpMhb64u0dQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjt1eku7Y%253D&md5=e3641d48cc7fcf08c4502b5899a49066</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fsrep21917&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep21917%26sid%3Dliteratum%253Aachs%26aulast%3DShimshek%26aufirst%3DD.%2BR.%26aulast%3DJacobson%26aufirst%3DL.%2BH.%26aulast%3DKolly%26aufirst%3DC.%26aulast%3DZamurovic%26aufirst%3DN.%26aulast%3DBalavenkatraman%26aufirst%3DK.%2BK.%26aulast%3DMorawiec%26aufirst%3DL.%26aulast%3DKreutzer%26aufirst%3DR.%26aulast%3DSchelle%26aufirst%3DJ.%26aulast%3DJucker%26aufirst%3DM.%26aulast%3DBertschi%26aufirst%3DB.%26aulast%3DTheil%26aufirst%3DD.%26aulast%3DHeier%26aufirst%3DA.%26aulast%3DBigot%26aufirst%3DK.%26aulast%3DBeltz%26aufirst%3DK.%26aulast%3DMachauer%26aufirst%3DR.%26aulast%3DBrzak%26aufirst%3DI.%26aulast%3DPerrot%26aufirst%3DL.%26aulast%3DNeumann%26aufirst%3DU.%26atitle%3DPharmacological%2520BACE1%2520and%2520BACE2%2520inhibition%2520induces%2520hair%2520depigmentation%2520by%2520inhibiting%2520PMEL17%2520processing%2520in%2520mice%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D21917%26doi%3D10.1038%2Fsrep21917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Van
Bebber, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hruscha, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willem, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haass, C.</span></span> <span> </span><span class="NLM_article-title">Loss of BACE2 in zebrafish affects melanocyte migration and is distinct from BACE1 knock out phenotypes</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">471</span>– <span class="NLM_lpage">481</span>, <span class="refDoi"> DOI: 10.1111/jnc.12198</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=10.1111%2Fjnc.12198" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=23406323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslWqs7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2013&pages=471-481&author=F.+Van%0ABebberauthor=A.+Hruschaauthor=M.+Willemauthor=B.+Schmidauthor=C.+Haass&title=Loss+of+BACE2+in+zebrafish+affects+melanocyte+migration+and+is+distinct+from+BACE1+knock+out+phenotypes&doi=10.1111%2Fjnc.12198"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Loss of Bace2 in zebrafish affects melanocyte migration and is distinct from Bace1 knock out phenotypes</span></div><div class="casAuthors">van Bebber, Frauke; Hruscha, Alexander; Willem, Michael; Schmid, Bettina; Haass, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">3&4</span>),
    <span class="NLM_cas:pages">471-481</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Alzheimer's disease is the most frequent dementia.  Pathol., Alzheimer's disease is characterized by the accumulation of senile plaques composed of amyloid β-peptide (Aβ).  Two proteases, β- and γ-secretase proteolytically generate Aβ from its precursor, the β-amyloid precursor protein (APP).  Inhibition of β-secretase, also referred to as beta-site APP cleaving enzyme (BACE1) or γ-secretase is therefore of prime interest for the development of amyloid-lowering drugs.  To assess the in vivo function of zebrafish Bace1 (zBace1), we generated zBace1 knock out fish by zinc finger nuclease-mediated genome editing.  Bace1 mutants (bace1-/-) are hypomyelinated in the PNS while the CNS is not affected.  Moreover, the no. of mechanosensory neuromasts is elevated in bace1-/-.  Mutations in zebrafish Bace2 (zBace2) revealed a distinct melanocyte migration phenotype, which is not obsd. in bace1-/-.  Double homozygous bace1-/-;bace2-/- fish do not enhance the single mutant phenotypes indicating non-redundant distinct physiol. functions.  Single homozygous bace1 mutants as well as double homozygous bace1 and bace2 mutants are viable and fertile suggesting that Bace1 is a promising drug target without major side effects.  The identification of a specific bace2 -/- assocd. phenotype further allows improving selective Bace1 inhibitors and to distinguish between Bace 1 and Bace 2 inhibition in vivo.  Inhibition of BACE1 protease activity has therapeutic importance for Alzheimer's disease.  Anal. of BACE1 and BACE2 knock-out zebrafish revealed that they exhibit distinct phenotypes.  Bace1 mutants display hypomyelination in the PNS and supernumerary neuromasts while in bace2 mutants the shape and migration of melanocytes is affected.  These phenotypes are not further enhanced in the viable double mutants.  Our data suggest that blocking BACE1 activity is a safe therapeutic approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6hPBx6BmbmLVg90H21EOLACvtfcHk0ljaCZF8ykGg-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslWqs7bL&md5=9a8f81383e56f96dfa821c98182a739f</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1111%2Fjnc.12198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjnc.12198%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BBebber%26aufirst%3DF.%26aulast%3DHruscha%26aufirst%3DA.%26aulast%3DWillem%26aufirst%3DM.%26aulast%3DSchmid%26aufirst%3DB.%26aulast%3DHaass%26aufirst%3DC.%26atitle%3DLoss%2520of%2520BACE2%2520in%2520zebrafish%2520affects%2520melanocyte%2520migration%2520and%2520is%2520distinct%2520from%2520BACE1%2520knock%2520out%2520phenotypes%26jtitle%3DJ.%2520Neurochem.%26date%3D2013%26volume%3D127%26spage%3D471%26epage%3D481%26doi%3D10.1111%2Fjnc.12198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rulifson, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopecky, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samayoa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuruda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Homann, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baribault, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamane, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiltzius, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span> <span> </span><span class="NLM_article-title">Identification of human islet amyloid polypeptide as a BACE2 substrate</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">e0147254</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0147254</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=10.1371%2Fjournal.pone.0147254" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=26840340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=1%3ACAS%3A528%3ADC%252BC28XnslOqtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=e0147254&author=I.+C.+Rulifsonauthor=P.+Caoauthor=L.+Miaoauthor=D.+Kopeckyauthor=L.+Huangauthor=R.+D.+Whiteauthor=K.+Samayoaauthor=J.+Gardnerauthor=X.+Wuauthor=K.+Chenauthor=T.+Tsurudaauthor=O.+Homannauthor=H.+Baribaultauthor=H.+Yamaneauthor=T.+Carlsonauthor=J.+Wiltziusauthor=Y.+Li&title=Identification+of+human+islet+amyloid+polypeptide+as+a+BACE2+substrate&doi=10.1371%2Fjournal.pone.0147254"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of human islet amyloid polypeptide as a BACE2 substrate</span></div><div class="casAuthors">Rulifson, Ingrid C.; Cao, Ping; Miao, Li; Kopecky, David; Huang, Linda; White, Ryan D.; Samayoa, Kim; Gardner, Jonitha; Wu, Xiaosu; Chen, Kui; Tsuruda, Trace; Homann, Oliver; Baribault, Helene; Yamane, Harvey; Carlson, Tim; Wiltzius, Jed; Li, Yang</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e0147254/1-e0147254/23</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Pancreatic amyloid formation by islet amyloid polypeptide (IAPP) is a hallmark pathol. feature of type 2 diabetes.  IAPP is stored in the secretory granules of pancreatic beta-cells and co-secreted with insulin to maintain glucose homeostasis.  IAPP is innocuous under homeostatic conditions but imbalances in prodn. or processing of IAPP may result in homodimer formation leading to the rapid prodn. of cytotoxic oligomers and amyloid fibrils.  The consequence is beta-cell dysfunction and the accumulation of proteinaceous plaques in and around pancreatic islets.  Beta-site APP-cleaving enzyme 2, BACE2, is an aspartyl protease commonly assocd. with BACE1, a related homolog responsible for amyloid processing in the brain and strongly implicated in Alzheimer's disease.  Herein, we identify two distinct sites of the mature human IAPP sequence that are susceptible to BACE2-mediated proteolytic activity.  The result of proteolysis is modulation of human IAPP fibrillation and human IAPP protein degrdn.  These results suggest a potential therapeutic role for BACE2 in type 2 diabetes-assocd. hyperamylinemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXxpM4hmm1pLVg90H21EOLACvtfcHk0ljaCZF8ykGg-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnslOqtL4%253D&md5=ab081153a95c7462bd208bac8779bd1d</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0147254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0147254%26sid%3Dliteratum%253Aachs%26aulast%3DRulifson%26aufirst%3DI.%2BC.%26aulast%3DCao%26aufirst%3DP.%26aulast%3DMiao%26aufirst%3DL.%26aulast%3DKopecky%26aufirst%3DD.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DWhite%26aufirst%3DR.%2BD.%26aulast%3DSamayoa%26aufirst%3DK.%26aulast%3DGardner%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DTsuruda%26aufirst%3DT.%26aulast%3DHomann%26aufirst%3DO.%26aulast%3DBaribault%26aufirst%3DH.%26aulast%3DYamane%26aufirst%3DH.%26aulast%3DCarlson%26aufirst%3DT.%26aulast%3DWiltzius%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DY.%26atitle%3DIdentification%2520of%2520human%2520islet%2520amyloid%2520polypeptide%2520as%2520a%2520BACE2%2520substrate%26jtitle%3DPLoS%2520One%26date%3D2016%26volume%3D11%26spage%3De0147254%26doi%3D10.1371%2Fjournal.pone.0147254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jeppsson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eketjäll, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlström, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustavsson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsson, L.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radesäter, A.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ploeger, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cebers, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolmodin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swahn, B.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Berg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bueters, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fälting, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of AZD3839, a potent and selective BACE1 inhibitor clinical candidate for the treatment of Alzheimer’s Disease</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>287</i></span>,  <span class="NLM_fpage">41245</span>– <span class="NLM_lpage">41257</span>, <span class="refDoi"> DOI: 10.1074/jbc.M112.409110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=10.1074%2Fjbc.M112.409110" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=41245-41257&author=F.+Jeppssonauthor=S.+Eketj%C3%A4llauthor=J.+Jansonauthor=S.+Karlstr%C3%B6mauthor=S.+Gustavssonauthor=L.-L.+Olssonauthor=A.-C.+Rades%C3%A4terauthor=B.+Ploegerauthor=G.+Cebersauthor=K.+Kolmodinauthor=B.-M.+Swahnauthor=S.+von+Bergauthor=T.+Buetersauthor=J.+F%C3%A4lting&title=Discovery+of+AZD3839%2C+a+potent+and+selective+BACE1+inhibitor+clinical+candidate+for+the+treatment+of+Alzheimer%E2%80%99s+Disease&doi=10.1074%2Fjbc.M112.409110"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.409110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.409110%26sid%3Dliteratum%253Aachs%26aulast%3DJeppsson%26aufirst%3DF.%26aulast%3DEketj%25C3%25A4ll%26aufirst%3DS.%26aulast%3DJanson%26aufirst%3DJ.%26aulast%3DKarlstr%25C3%25B6m%26aufirst%3DS.%26aulast%3DGustavsson%26aufirst%3DS.%26aulast%3DOlsson%26aufirst%3DL.-L.%26aulast%3DRades%25C3%25A4ter%26aufirst%3DA.-C.%26aulast%3DPloeger%26aufirst%3DB.%26aulast%3DCebers%26aufirst%3DG.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DSwahn%26aufirst%3DB.-M.%26aulast%3Dvon%2BBerg%26aufirst%3DS.%26aulast%3DBueters%26aufirst%3DT.%26aulast%3DF%25C3%25A4lting%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520AZD3839%252C%2520a%2520potent%2520and%2520selective%2520BACE1%2520inhibitor%2520clinical%2520candidate%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D41245%26epage%3D41257%26doi%3D10.1074%2Fjbc.M112.409110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vuillard, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cleasby, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yon, J.</span></span> <span> </span><span class="NLM_article-title">Apo and inhibitor complex structures of BACE (β-secretase)</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>343</i></span>,  <span class="NLM_fpage">407</span>– <span class="NLM_lpage">416</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2004.08.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=10.1016%2Fj.jmb.2004.08.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=15451669" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnvVyqt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=343&publication_year=2004&pages=407-416&author=S.+Patelauthor=L.+Vuillardauthor=A.+Cleasbyauthor=C.+W.+Murrayauthor=J.+Yon&title=Apo+and+inhibitor+complex+structures+of+BACE+%28%CE%B2-secretase%29&doi=10.1016%2Fj.jmb.2004.08.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Apo and Inhibitor Complex Structures of BACE (β-secretase)</span></div><div class="casAuthors">Patel, Sahil; Vuillard, Laurent; Cleasby, Anne; Murray, Christopher W.; Yon, Jeff</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">343</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">407-416</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Human BACE, also known as β-secretase, shows promise as a potential therapeutic target for Alzheimer's disease.  The authors detd. the apo structure of BACE to 1.75 Å, and a structure of a hydroxyethylamine inhibitor complex derived by soaking.  These show significant active-site movements compared to previously described BACE structures.  Addnl., the structures reveal two pockets that could be targeted by structure-based drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpH0afg2-ZxjLVg90H21EOLACvtfcHk0ljaCZF8ykGg-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnvVyqt7w%253D&md5=b14e17f86a4729fb8ee66d84ee6c1fab</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2004.08.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2004.08.018%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DVuillard%26aufirst%3DL.%26aulast%3DCleasby%26aufirst%3DA.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DYon%26aufirst%3DJ.%26atitle%3DApo%2520and%2520inhibitor%2520complex%2520structures%2520of%2520BACE%2520%2528%25CE%25B2-secretase%2529%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2004%26volume%3D343%26spage%3D407%26epage%3D416%26doi%3D10.1016%2Fj.jmb.2004.08.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tosaki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaneko, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hisano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakurai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nukina, N.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of an active form of BACE1, an enzyme responsible for amyloid beta protein production</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">3663</span>– <span class="NLM_lpage">3671</span>, <span class="refDoi"> DOI: 10.1128/MCB.02185-07</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=10.1128%2FMCB.02185-07" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=18378702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=1%3ACAS%3A528%3ADC%252BD1cXms1elsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=3663-3671&author=H.+Shimizuauthor=A.+Tosakiauthor=K.+Kanekoauthor=T.+Hisanoauthor=T.+Sakuraiauthor=N.+Nukina&title=Crystal+structure+of+an+active+form+of+BACE1%2C+an+enzyme+responsible+for+amyloid+beta+protein+production&doi=10.1128%2FMCB.02185-07"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of an active form of BACE1, an enzyme responsible for amyloid β protein production</span></div><div class="casAuthors">Shimizu, Hideaki; Tosaki, Asako; Kaneko, Kumi; Hisano, Tamao; Sakurai, Takashi; Nukina, Nobuyuki</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3663-3671</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">β-Secretase (BACE1) is a transmembrane aspartic protease that cleaves the β-amyloid precursor protein and generates the amyloid β peptide (Aβ).  BACE1 cycles between the cell surface and the endosomal system many times and becomes activated interconvertibly during its cellular trafficking, leading to the prodn. of Aβ.  Here, the authors report the crystal structure of the catalytically active form of human BACE1.  The active form had novel structural features involving the conformation of the flap and subsites that promote substrate binding.  The functionally essential residues and water mols. were well-defined and play a key role in the iterative activation of BACE1.  The authors further describe the crystal structure of the dehydrated form of BACE1, showing that BACE1 activity is dependent on the dynamics of a catalytically required Asp-bound water mol., which directly affects its catalytic properties.  These findings provide insight into a novel regulation of BACE1 activity and elucidate how BACE1 modulates its activity during cellular trafficking.  The crystal structure of BACE1 complexed with its inhibitor, OM 99-2, was also described and discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr44oqN8OB8JLVg90H21EOLACvtfcHk0liYFCPzTc1qXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXms1elsro%253D&md5=6cc9634690fa04789c18358432937c74</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1128%2FMCB.02185-07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.02185-07%26sid%3Dliteratum%253Aachs%26aulast%3DShimizu%26aufirst%3DH.%26aulast%3DTosaki%26aufirst%3DA.%26aulast%3DKaneko%26aufirst%3DK.%26aulast%3DHisano%26aufirst%3DT.%26aulast%3DSakurai%26aufirst%3DT.%26aulast%3DNukina%26aufirst%3DN.%26atitle%3DCrystal%2520structure%2520of%2520an%2520active%2520form%2520of%2520BACE1%252C%2520an%2520enzyme%2520responsible%2520for%2520amyloid%2520beta%2520protein%2520production%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2008%26volume%3D28%26spage%3D3663%26epage%3D3671%26doi%3D10.1128%2FMCB.02185-07" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gravenfors, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viklund, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blid, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ginman, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlström, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kihlström, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolmodin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindström, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Berg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Kieseritzky, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slivo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swahn, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsson, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eketjäll, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fälting, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeppsson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strömberg, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahm, F.</span></span> <span> </span><span class="NLM_article-title">New aminoimidazoles as β-secretase (BACE-1) inhibitors showing amyloid-β (Aβ) lowering in brain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">9297</span>– <span class="NLM_lpage">9311</span>, <span class="refDoi"> DOI: 10.1021/jm300991n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300991n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVagtLfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9297-9311&author=Y.+Gravenforsauthor=J.+Viklundauthor=J.+Blidauthor=T.+Ginmanauthor=S.+Karlstr%C3%B6mauthor=J.+Kihlstr%C3%B6mauthor=K.+Kolmodinauthor=J.+Lindstr%C3%B6mauthor=S.+von+Bergauthor=F.+von+Kieseritzkyauthor=K.+Bogarauthor=C.+Slivoauthor=B.+M.+Swahnauthor=L.+L.+Olssonauthor=P.+Johanssonauthor=S.+Eketj%C3%A4llauthor=J.+F%C3%A4ltingauthor=F.+Jeppssonauthor=K.+Str%C3%B6mbergauthor=J.+Jansonauthor=F.+Rahm&title=New+aminoimidazoles+as+%CE%B2-secretase+%28BACE-1%29+inhibitors+showing+amyloid-%CE%B2+%28A%CE%B2%29+lowering+in+brain&doi=10.1021%2Fjm300991n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">New Aminoimidazoles as β-Secretase (BACE-1) Inhibitors Showing Amyloid-β (Aβ) Lowering in Brain</span></div><div class="casAuthors">Gravenfors, Ylva; Viklund, Jenny; Blid, Jan; Ginman, Tobias; Karlstroem, Sofia; Kihlstroem, Jacob; Kolmodin, Karin; Lindstroem, Johan; von Berg, Stefan; von Kieseritzky, Fredrik; Bogar, Krisztian; Slivo, Can; Swahn, Britt-Marie; Olsson, Lise-Lotte; Johansson, Patrik; Eketjaell, Susanna; Faelting, Johanna; Jeppsson, Fredrik; Stroemberg, Kia; Janson, Juliette; Rahm, Fredrik</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9297-9311</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Amino-2H-imidazoles are described as a new class of BACE-1 inhibitors for the treatment of Alzheimer's disease.  Synthetic methods, crystal structures, and structure-activity relationships for target activity, permeability, and hERG activity are reported and discussed.  Compd. (S)-1m (I) was one of the most promising compds. in this report, with high potency in the cellular assay and a good overall profile.  When guinea pigs were treated with compd. (S)-1m, a concn. and time dependent decrease in Aβ40 and Aβ42 levels in plasma, brain, and CSF was obsd.  The max. redn. of brain Aβ was 40-50%, 1.5 h after oral dosing (100 μmol/kg).  The results presented highlight the potential of this new class of BACE-1 inhibitors with good target potency and with low effect on hERG, in combination with a fair CNS exposure in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdDDOKlDOgVbVg90H21EOLACvtfcHk0liJOUPkZvYm1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVagtLfI&md5=65b5aae9d7b5aa83df67a7e4a1f03da0</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm300991n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300991n%26sid%3Dliteratum%253Aachs%26aulast%3DGravenfors%26aufirst%3DY.%26aulast%3DViklund%26aufirst%3DJ.%26aulast%3DBlid%26aufirst%3DJ.%26aulast%3DGinman%26aufirst%3DT.%26aulast%3DKarlstr%25C3%25B6m%26aufirst%3DS.%26aulast%3DKihlstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DLindstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3Dvon%2BBerg%26aufirst%3DS.%26aulast%3Dvon%2BKieseritzky%26aufirst%3DF.%26aulast%3DBogar%26aufirst%3DK.%26aulast%3DSlivo%26aufirst%3DC.%26aulast%3DSwahn%26aufirst%3DB.%2BM.%26aulast%3DOlsson%26aufirst%3DL.%2BL.%26aulast%3DJohansson%26aufirst%3DP.%26aulast%3DEketj%25C3%25A4ll%26aufirst%3DS.%26aulast%3DF%25C3%25A4lting%26aufirst%3DJ.%26aulast%3DJeppsson%26aufirst%3DF.%26aulast%3DStr%25C3%25B6mberg%26aufirst%3DK.%26aulast%3DJanson%26aufirst%3DJ.%26aulast%3DRahm%26aufirst%3DF.%26atitle%3DNew%2520aminoimidazoles%2520as%2520%25CE%25B2-secretase%2520%2528BACE-1%2529%2520inhibitors%2520showing%2520amyloid-%25CE%25B2%2520%2528A%25CE%25B2%2529%2520lowering%2520in%2520brain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9297%26epage%3D9311%26doi%3D10.1021%2Fjm300991n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Geschwindner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulander, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansson, P.</span></span> <span> </span><span class="NLM_article-title">Ligand binding thermodynamics in drug discovery: still a hot tip?</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">6321</span>– <span class="NLM_lpage">6335</span>, <span class="refDoi"> DOI: 10.1021/jm501511f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501511f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=1%3ACAS%3A528%3ADC%252BC2MXntFGitbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6321-6335&author=S.+Geschwindnerauthor=J.+Ulanderauthor=P.+Johansson&title=Ligand+binding+thermodynamics+in+drug+discovery%3A+still+a+hot+tip%3F&doi=10.1021%2Fjm501511f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand Binding Thermodynamics in Drug Discovery: Still a Hot Tip?</span></div><div class="casAuthors">Geschwindner, Stefan; Ulander, Johan; Johansson, Patrik</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6321-6335</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The use of ligand binding thermodn. has been proposed as a potential success factor to accelerate drug discovery.  However, despite the intuitive appeal of optimizing binding enthalpy, a no. of factors complicate routine use of thermodn. data.  On a macroscopic level, a range of exptl. parameters including temp. and buffer choice significantly influence the obsd. thermodn. signatures.  On a microscopic level, solute effects, structural flexibility, and cooperativity lead to nonlinear changes in enthalpy.  This multifactorial character hides essential enthalpy contributions of intermol. contacts, making them exptl. nonobservable.  In this perspective, we present three case studies, reflect on some key factors affecting thermodn. signatures, and investigate their relation to the hydrophobic effect, enthalpy-entropy compensation, lipophilic ligand efficiency, and promiscuity.  The studies highlight that enthalpy and entropy cannot be used as direct end points but can together with calcns. increase our understanding of ligand binding and identify interesting outliers that do not behave as expected.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr47fgLvr2PP7Vg90H21EOLACvtfcHk0liJOUPkZvYm1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXntFGitbs%253D&md5=686b213b9488bc51d2d6a07e391c6644</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm501511f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501511f%26sid%3Dliteratum%253Aachs%26aulast%3DGeschwindner%26aufirst%3DS.%26aulast%3DUlander%26aufirst%3DJ.%26aulast%3DJohansson%26aufirst%3DP.%26atitle%3DLigand%2520binding%2520thermodynamics%2520in%2520drug%2520discovery%253A%2520still%2520a%2520hot%2520tip%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D6321%26epage%3D6335%26doi%3D10.1021%2Fjm501511f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ostermann, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eder, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eidhoff, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zink, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassiepen, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Worpenberg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maibaum, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simic, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hommel, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerhartz, B.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of human BACE2 in complex with a hydroxyethylamine transition state inhibitor</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>355</i></span>,  <span class="NLM_fpage">249</span>– <span class="NLM_lpage">261</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2005.10.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=10.1016%2Fj.jmb.2005.10.027" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=2006&pages=249-261&author=N.+Ostermannauthor=J.+Ederauthor=U.+Eidhoffauthor=F.+Zinkauthor=U.+Hassiepenauthor=S.+Worpenbergauthor=J.+Maibaumauthor=O.+Simicauthor=U.+Hommelauthor=B.+Gerhartz&title=Crystal+structure+of+human+BACE2+in+complex+with+a+hydroxyethylamine+transition+state+inhibitor&doi=10.1016%2Fj.jmb.2005.10.027"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2005.10.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2005.10.027%26sid%3Dliteratum%253Aachs%26aulast%3DOstermann%26aufirst%3DN.%26aulast%3DEder%26aufirst%3DJ.%26aulast%3DEidhoff%26aufirst%3DU.%26aulast%3DZink%26aufirst%3DF.%26aulast%3DHassiepen%26aufirst%3DU.%26aulast%3DWorpenberg%26aufirst%3DS.%26aulast%3DMaibaum%26aufirst%3DJ.%26aulast%3DSimic%26aufirst%3DO.%26aulast%3DHommel%26aufirst%3DU.%26aulast%3DGerhartz%26aufirst%3DB.%26atitle%3DCrystal%2520structure%2520of%2520human%2520BACE2%2520in%2520complex%2520with%2520a%2520hydroxyethylamine%2520transition%2520state%2520inhibitor%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2006%26volume%3D355%26spage%3D249%26epage%3D261%26doi%3D10.1016%2Fj.jmb.2005.10.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumalo, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soliman, M. E.</span></span> <span> </span><span class="NLM_article-title">A comparative molecular dynamics study on BACE1 and BACE2 flap flexibility</span>. <i>J. Recept. Signal Transduction Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">505</span>– <span class="NLM_lpage">514</span>, <span class="refDoi"> DOI: 10.3109/10799893.2015.1130058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=10.3109%2F10799893.2015.1130058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=26804314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=1%3ACAS%3A280%3ADC%252BC28njs12nsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2016&pages=505-514&author=H.+M.+Kumaloauthor=M.+E.+Soliman&title=A+comparative+molecular+dynamics+study+on+BACE1+and+BACE2+flap+flexibility&doi=10.3109%2F10799893.2015.1130058"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">A comparative molecular dynamics study on BACE1 and BACE2 flap flexibility</span></div><div class="casAuthors">Kumalo H M; Soliman Mahmoud E</div><div class="citationInfo"><span class="NLM_cas:title">Journal of receptor and signal transduction research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">505-14</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Beta-amyloid precursor protein cleavage enzyme1 (BACE1) and beta-amyloid precursor protein cleavage enzyme2 (BACE2), members of aspartyl protease family, are close homologs and have high similarity in their protein crystal structures.  However, their enzymatic properties are different, which leads to different clinical outcomes.  In this study, we performed sequence analysis and all-atom molecular dynamic (MD) simulations for both enzymes in their ligand-free states in order to compare their dynamical flap behaviors.  This is to enhance our understanding of the relationship between sequence, structure and the dynamics of this protein family.  Sequence analysis shows that in BACE1 and BACE2, most of the ligand-binding sites are conserved, indicative of their enzymatic property as aspartyl protease members.  The other conserved residues are more or less unsystematically localized throughout the structure.  Herein, we proposed and applied different combined parameters to define the asymmetric flap motion; the distance, d1, between the flap tip and the flexible region; the dihedral angle, φ, to account for the twisting motion and the TriCα angle, θ2 and θ1.  All four combined parameters were found to appropriately define the observed "twisting" motion during the flaps different conformational states.  Additional analysis of the parameters indicated that the flaps can exist in an ensemble of conformations, i.e. closed, semi-open and open conformations for both systems.  However, the behavior of the flap tips during simulations is different between BACE1 and BACE2.  The BACE1 active site cavity is more spacious as compared to that of BACE2.  The analysis of 10S loop and 113S loop showed a similar trend to that of flaps, with the BACE1 loops being more flexible and less stable than those of BACE2.  We believe that the results, methods and perspectives highlighted in this report would assist researchers in the discovery of BACE inhibitors as potential Alzheimer's disease therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQHqCw7fPU_ktLIORRPd5lbfW6udTcc2eZoH45Bf7A1P7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28njs12nsw%253D%253D&md5=e2c5e147e4c1dd1ca4a960399ff1b703</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.3109%2F10799893.2015.1130058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10799893.2015.1130058%26sid%3Dliteratum%253Aachs%26aulast%3DKumalo%26aufirst%3DH.%2BM.%26aulast%3DSoliman%26aufirst%3DM.%2BE.%26atitle%3DA%2520comparative%2520molecular%2520dynamics%2520study%2520on%2520BACE1%2520and%2520BACE2%2520flap%2520flexibility%26jtitle%3DJ.%2520Recept.%2520Signal%2520Transduction%2520Res.%26date%3D2016%26volume%3D36%26spage%3D505%26epage%3D514%26doi%3D10.3109%2F10799893.2015.1130058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hitchcock, A. S.</span></span> <span> </span><span class="NLM_article-title">Structural modifications that alter the P-glycoprotein efflux properties of compounds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">4877</span>– <span class="NLM_lpage">4895</span>, <span class="refDoi"> DOI: 10.1021/jm201136z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201136z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=1%3ACAS%3A528%3ADC%252BC38XlsFKlt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4877-4895&author=A.+S.+Hitchcock&title=Structural+modifications+that+alter+the+P-glycoprotein+efflux+properties+of+compounds&doi=10.1021%2Fjm201136z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Modifications that Alter the P-Glycoprotein Efflux Properties of Compounds</span></div><div class="casAuthors">Hitchcock, Stephen A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4877-4895</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This perspective is focused on structural modifications and strategies that can be applied during compd. optimization in order to modulate the P-glycoprotein efflux properties of small mols. with a particular emphasis on implications for CNS penetration. The precise mol. interactions that confer P-glycoprotein efflux remain relatively poorly defined. The promiscuous nature of P-glycoprotein efflux renders the rational circumvention of efflux, while simultaneously optimizing compds. for eficacy, safety, and pharmacokinetic properties, an extremely challenging undertaking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3_5RBtwgb-rVg90H21EOLACvtfcHk0liQ2K-sCKxo6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlsFKlt7s%253D&md5=6c5dffbb11db6fa893ff3c50fe7778cc</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm201136z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201136z%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DA.%2BS.%26atitle%3DStructural%2520modifications%2520that%2520alter%2520the%2520P-glycoprotein%2520efflux%2520properties%2520of%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4877%26epage%3D4895%26doi%3D10.1021%2Fjm201136z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wager, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoest, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villalobos, A.</span></span> <span> </span><span class="NLM_article-title">Central nervous system multiparameter optimization desirability: application in drug discovery</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">767</span>– <span class="NLM_lpage">775</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.6b00029</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.6b00029" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=1%3ACAS%3A528%3ADC%252BC28XksVSktbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=767-775&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Central+nervous+system+multiparameter+optimization+desirability%3A+application+in+drug+discovery&doi=10.1021%2Facschemneuro.6b00029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Central Nervous System Multiparameter Optimization Desirability: Application in Drug Discovery</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">767-775</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Significant progress has been made in prospectively designing mols. using the central nervous system multiparameter optimization (CNS MPO) desirability tool, as evidenced by the anal. reported herein of a second wave of drug candidates that originated after the development and implementation of this tool.  This simple-to-use design algorithm has expanded design space for CNS candidates and has further demonstrated the advantages of utilizing a flexible, multiparameter approach in drug discovery rather than individual parameters and hard cutoffs of physicochem. properties.  The CNS MPO tool has helped to increase the percentage of compds. nominated for clin. development that exhibit alignment of ADME attributes, cross the blood-brain barrier, and reside in lower-risk safety space (low ClogP and high TPSA).  The use of this tool has played a role in reducing the no. of compds. submitted to exploratory toxicity studies and increasing the survival of our drug candidates through regulatory toxicol. into First in Human studies.  Overall, the CNS MPO algorithm has helped to improve the prioritization of design ideas and the quality of the compds. nominated for clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp46WD7qMaX6bVg90H21EOLACvtfcHk0liQ2K-sCKxo6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XksVSktbw%253D&md5=061c3aef6c88758cbaee1a2abb34796a</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.6b00029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.6b00029%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DCentral%2520nervous%2520system%2520multiparameter%2520optimization%2520desirability%253A%2520application%2520in%2520drug%2520discovery%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2016%26volume%3D7%26spage%3D767%26epage%3D775%26doi%3D10.1021%2Facschemneuro.6b00029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittington, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, V. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dineen, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epstein, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graceffa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiang, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Louie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahl, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fremeau, R. T.</span></span> <span> </span><span class="NLM_article-title">Structure- and property-based design of aminooxazoline xanthenes as selective, orally efficacious, and CNS penetrable BACE inhibitors for the treatment of Alzheimer’s Disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">9156</span>– <span class="NLM_lpage">9169</span>, <span class="refDoi"> DOI: 10.1021/jm300598e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300598e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1yhsLjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9156-9169&author=H.+Huangauthor=D.+S.+Laauthor=A.+C.+Chengauthor=D.+A.+Whittingtonauthor=V.+F.+Patelauthor=K.+Chenauthor=T.+A.+Dineenauthor=O.+Epsteinauthor=R.+Graceffaauthor=D.+Hickmanauthor=Y.-H.+Kiangauthor=S.+Louieauthor=Y.+Luoauthor=R.+C.+Wahlauthor=P.+H.+Wenauthor=S.+Woodauthor=R.+T.+Fremeau&title=Structure-+and+property-based+design+of+aminooxazoline+xanthenes+as+selective%2C+orally+efficacious%2C+and+CNS+penetrable+BACE+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+Disease&doi=10.1021%2Fjm300598e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Structure- and property-based design of aminooxazoline xanthenes as selective, orally efficacious, and CNS penetrable BACE inhibitors for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Huang, Hongbing; La, Daniel S.; Cheng, Alan C.; Whittington, Douglas A.; Patel, Vinod F.; Chen, Kui; Dineen, Thomas A.; Epstein, Oleg; Graceffa, Russell; Hickman, Dean; Kiang, Y.-H.; Louie, Steven; Luo, Yi; Wahl, Robert C.; Wen, Paul H.; Wood, Stephen; Fremeau, Robert T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9156-9169</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A structure- and property-based drug design approach was employed to identify aminooxazoline xanthenes as potent and selective human β-secretase inhibitors.  These compds. exhibited good isolated enzyme, cell potency, and selectivity against the structurally related aspartyl protease cathepsin D.  Our efforts resulted in the identification of a potent, orally bioavailable CNS penetrant compd. that exhibited in vivo efficacy.  A single oral dose of compd. (I) resulted in a significant redn. of CNS Aβ40 in naive rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDEYfU4moxMbVg90H21EOLACvtfcHk0lhth04p1pKUXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1yhsLjJ&md5=0ecd50ec1ea82a058e499bb712c45272</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm300598e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300598e%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DCheng%26aufirst%3DA.%2BC.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DEpstein%26aufirst%3DO.%26aulast%3DGraceffa%26aufirst%3DR.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DKiang%26aufirst%3DY.-H.%26aulast%3DLouie%26aufirst%3DS.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWood%26aufirst%3DS.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26atitle%3DStructure-%2520and%2520property-based%2520design%2520of%2520aminooxazoline%2520xanthenes%2520as%2520selective%252C%2520orally%2520efficacious%252C%2520and%2520CNS%2520penetrable%2520BACE%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9156%26epage%3D9169%26doi%3D10.1021%2Fjm300598e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Judd, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartberger, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunn, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epstein, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fremeau, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harried, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hitchcock, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minatti, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, V. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vargas, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahl, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittington, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, S.</span></span> <span> </span><span class="NLM_article-title">An orally available BACE1 inhibitor that affords robust CNS Aβ reduction without cardiovascular liabilities</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">210</span>– <span class="NLM_lpage">215</span>, <span class="refDoi"> DOI: 10.1021/ml500458t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500458t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFyhtLzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=210-215&author=Y.+Chengauthor=J.+Brownauthor=T.+C.+Juddauthor=P.+Lopezauthor=W.+Qianauthor=T.+S.+Powersauthor=J.+J.+Chenauthor=M.+D.+Bartbergerauthor=K.+Chenauthor=R.+T.+Dunnauthor=O.+Epsteinauthor=R.+T.+Fremeauauthor=S.+Harriedauthor=D.+Hickmanauthor=S.+A.+Hitchcockauthor=Y.+Luoauthor=A.+E.+Minattiauthor=V.+F.+Patelauthor=H.+M.+Vargasauthor=R.+C.+Wahlauthor=M.+M.+Weissauthor=P.+H.+Wenauthor=R.+D.+Whiteauthor=D.+A.+Whittingtonauthor=X.+M.+Zhengauthor=S.+Wood&title=An+orally+available+BACE1+inhibitor+that+affords+robust+CNS+A%CE%B2+reduction+without+cardiovascular+liabilities&doi=10.1021%2Fml500458t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">An Orally Available BACE1 Inhibitor That Affords Robust CNS Aβ Reduction without Cardiovascular Liabilities</span></div><div class="casAuthors">Cheng, Yuan; Brown, James; Judd, Ted C.; Lopez, Patricia; Qian, Wenyuan; Powers, Timothy S.; Chen, Jian Jeffrey; Bartberger, Michael D.; Chen, Kui; Dunn, Robert T.; Epstein, Oleg; Fremeau, Robert T.; Harried, Scott; Hickman, Dean; Hitchcock, Stephen A.; Luo, Yi; Minatti, Ana Elena; Patel, Vinod F.; Vargas, Hugo M.; Wahl, Robert C.; Weiss, Matthew M.; Wen, Paul H.; White, Ryan D.; Whittington, Douglas A.; Zheng, Xiao Mei; Wood, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">210-215</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">BACE1 inhibition to prevent Aβ peptide formation is considered to be a potential route to a disease-modifying treatment for Alzheimer's disease.  Previous efforts in our lab. using a combined structure- and property-based approach have resulted in the identification of aminooxazoline xanthenes as potent BACE1 inhibitors.  Herein, we report further optimization leading to the discovery of inhibitor 15 as an orally available and highly efficacious BACE1 inhibitor that robustly reduces CSF and brain Aβ levels in both rats and nonhuman primates.  In addn., compd. 15 exhibited low activity on the hERG ion channel and was well tolerated in an integrated cardiovascular safety model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbH-0fLNUlbrVg90H21EOLACvtfcHk0lhth04p1pKUXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFyhtLzI&md5=bd8e5a33d06a51646873c4c43d01b003</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fml500458t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500458t%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DJudd%26aufirst%3DT.%2BC.%26aulast%3DLopez%26aufirst%3DP.%26aulast%3DQian%26aufirst%3DW.%26aulast%3DPowers%26aufirst%3DT.%2BS.%26aulast%3DChen%26aufirst%3DJ.%2BJ.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DDunn%26aufirst%3DR.%2BT.%26aulast%3DEpstein%26aufirst%3DO.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26aulast%3DHarried%26aufirst%3DS.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DMinatti%26aufirst%3DA.%2BE.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26aulast%3DVargas%26aufirst%3DH.%2BM.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWhite%26aufirst%3DR.%2BD.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DZheng%26aufirst%3DX.%2BM.%26aulast%3DWood%26aufirst%3DS.%26atitle%3DAn%2520orally%2520available%2520BACE1%2520inhibitor%2520that%2520affords%2520robust%2520CNS%2520A%25CE%25B2%2520reduction%2520without%2520cardiovascular%2520liabilities%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D210%26epage%3D215%26doi%3D10.1021%2Fml500458t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eketjäll, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaspersson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogstedt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeppsson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fälting, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Budd Haeberlein, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kugler, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cebers, G.</span></span> <span> </span><span class="NLM_article-title">AZD3293: a novel, orally active BACE1 Inhibitor with high potency and permeability and markedly slow off-rate kinetics</span>. <i>J. Alzheimer’s Dis.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">1109</span>– <span class="NLM_lpage">1123</span>, <span class="refDoi"> DOI: 10.3233/JAD-150834</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=10.3233%2FJAD-150834" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=26890753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=1%3ACAS%3A280%3ADC%252BC28jhvFWqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2016&pages=1109-1123&author=S.+Eketj%C3%A4llauthor=J.+Jansonauthor=K.+Kasperssonauthor=A.+Bogstedtauthor=F.+Jeppssonauthor=J.+F%C3%A4ltingauthor=S.+Budd+Haeberleinauthor=A.+R.+Kuglerauthor=R.+C.+Alexanderauthor=G.+Cebers&title=AZD3293%3A+a+novel%2C+orally+active+BACE1+Inhibitor+with+high+potency+and+permeability+and+markedly+slow+off-rate+kinetics&doi=10.3233%2FJAD-150834"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">AZD3293: A Novel, Orally Active BACE1 Inhibitor with High Potency and Permeability and Markedly Slow Off-Rate Kinetics</span></div><div class="casAuthors">Eketjall Susanna; Janson Juliette; Bogstedt Anna; Eketjall Susanna; Janson Juliette; Bogstedt Anna; Kaspersson Karin; Jeppsson Fredrik; Falting Johanna; Jeppsson Fredrik; Haeberlein Samantha Budd; Kugler Alan R; Alexander Robert C; Cebers Gvido</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's disease : JAD</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1109-23</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">A growing body of pathological, biomarker, genetic, and mechanistic data suggests that amyloid accumulation, as a result of changes in production, processing, and/or clearance of brain amyloid-β peptide (Aβ) concentrations, plays a key role in the pathogenesis of Alzheimer's disease (AD).  Beta-secretase 1 (BACE1) mediates the first step in the processing of amyloid-β protein precursor (AβPP) to Aβ peptides, with the soluble N terminal fragment of AβPP (sAβPPβ) as a direct product, and BACE1 inhibition is an attractive target for therapeutic intervention to reduce the production of Aβ.  Here, we report the in vitro and in vivo pharmacological profile of AZD3293, a potent, highly permeable, orally active, blood-brain barrier (BBB) penetrating, BACE1 inhibitor with unique slow off-rate kinetics.  The in vitro potency of AZD3293 was demonstrated in several cellular models, including primary cortical neurons.  In vivo in mice, guinea pigs, and dogs, AZD3293 displayed significant dose- and time-dependent reductions in plasma, cerebrospinal fluid, and brain concentrations of Aβ40, Aβ42, and sAβPPβ.  The in vitro potency of AZD3293 in mouse and guinea pig primary cortical neuronal cells was correlated to the in vivo potency expressed as free AZD3293 concentrations in mouse and guinea pig brains.  In mice and dogs, the slow off-rate from BACE1 may have translated into a prolongation of the observed effect beyond the turnover rate of Aβ.  The preclinical data strongly support the clinical development of AZD3293, and patients with AD are currently being recruited into a combined Phase 2/3 study to test the disease-modifying properties of AZD3293.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT8YDBirvcLa6qcneEtCi92fW6udTcc2ebzPAaV8gvayLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28jhvFWqtA%253D%253D&md5=afb144f0247c7dd1ecf2ccd8bebcafa4</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.3233%2FJAD-150834&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-150834%26sid%3Dliteratum%253Aachs%26aulast%3DEketj%25C3%25A4ll%26aufirst%3DS.%26aulast%3DJanson%26aufirst%3DJ.%26aulast%3DKaspersson%26aufirst%3DK.%26aulast%3DBogstedt%26aufirst%3DA.%26aulast%3DJeppsson%26aufirst%3DF.%26aulast%3DF%25C3%25A4lting%26aufirst%3DJ.%26aulast%3DBudd%2BHaeberlein%26aufirst%3DS.%26aulast%3DKugler%26aufirst%3DA.%2BR.%26aulast%3DAlexander%26aufirst%3DR.%2BC.%26aulast%3DCebers%26aufirst%3DG.%26atitle%3DAZD3293%253A%2520a%2520novel%252C%2520orally%2520active%2520BACE1%2520Inhibitor%2520with%2520high%2520potency%2520and%2520permeability%2520and%2520markedly%2520slow%2520off-rate%2520kinetics%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2016%26volume%3D50%26spage%3D1109%26epage%3D1123%26doi%3D10.3233%2FJAD-150834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mullard, A.</span></span> <span> </span><span class="NLM_article-title">Deuterated drugs draw heavier backing</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">219</span>– <span class="NLM_lpage">221</span>, <span class="refDoi"> DOI: 10.1038/nrd.2016.63</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=10.1038%2Fnrd.2016.63" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=27032821" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=1%3ACAS%3A528%3ADC%252BC28XltlWjtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=219-221&author=A.+Mullard&title=Deuterated+drugs+draw+heavier+backing&doi=10.1038%2Fnrd.2016.63"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Deuterated drugs draw heavier backing</span></div><div class="casAuthors">Mullard, Asher</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">219-221</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The FDA is considering a first approval of a deuterated drug, and large pharmaceutical companies have started to incorporate 'heavy hydrogen' into novel candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvu-ucz_PqFbVg90H21EOLACvtfcHk0lgwtcNXi8uPMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XltlWjtLk%253D&md5=8c61bbc57d480f91b59d197894a771d5</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.63&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.63%26sid%3Dliteratum%253Aachs%26aulast%3DMullard%26aufirst%3DA.%26atitle%3DDeuterated%2520drugs%2520draw%2520heavier%2520backing%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2016%26volume%3D15%26spage%3D219%26epage%3D221%26doi%3D10.1038%2Fnrd.2016.63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tebbe, F. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parshall, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, G. S.</span></span> <span> </span><span class="NLM_article-title">Olefin homologation with titanium methylene compounds</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1978</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">3611</span>– <span class="NLM_lpage">3613</span>, <span class="refDoi"> DOI: 10.1021/ja00479a061</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00479a061" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=1%3ACAS%3A528%3ADyaE1cXlt12lsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=1978&pages=3611-3613&author=F.+N.+Tebbeauthor=G.+W.+Parshallauthor=G.+S.+Reddy&title=Olefin+homologation+with+titanium+methylene+compounds&doi=10.1021%2Fja00479a061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Olefin homologation with titanium methylene compounds</span></div><div class="casAuthors">Tebbe, F. N.; Parshall, G. W.; Reddy, G. S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1978</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3611-13</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">The synthesis and chem. of Cp2TiCH2AlClMe2 (I, Cp = η5-cyclopentadienyl) and Cp2TiCH2AlMe3 is described.  Thus, treating Cp2TiCl2 with AlMe3 at room temp. 60 h gave I.  I transfers the methylene group to olefins to produce new olefins or, in small yields, cyclopropanes.  It reacts with ketones, esters, and aldehydes to produce terminal olefins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvl65Ec5YKErVg90H21EOLACvtfcHk0lgwtcNXi8uPMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXlt12lsbg%253D&md5=a99e760e1a5992dfbfb7d5aa0cd60f40</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fja00479a061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00479a061%26sid%3Dliteratum%253Aachs%26aulast%3DTebbe%26aufirst%3DF.%2BN.%26aulast%3DParshall%26aufirst%3DG.%2BW.%26aulast%3DReddy%26aufirst%3DG.%2BS.%26atitle%3DOlefin%2520homologation%2520with%2520titanium%2520methylene%2520compounds%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1978%26volume%3D100%26spage%3D3611%26epage%3D3613%26doi%3D10.1021%2Fja00479a061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="note"><p class="first last">The crystal structures of compounds <b>23</b> and <b>28</b> were deposited at the Protein Data Bank with the PDB codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EJ3">6EJ3</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EJ2">6EJ2</a>, respectively.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ginman, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viklund, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malmström, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blid, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emond, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forsblom, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kers, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lake, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sehgelmeble, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sterky, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindgren, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeppsson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fälting, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gravenfors, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahm, F.</span></span> <span> </span><span class="NLM_article-title">Core refinement toward permeable β-secretase (BACE-1) inhibitors with low hERG activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">4181</span>– <span class="NLM_lpage">4205</span>, <span class="refDoi"> DOI: 10.1021/jm3011349</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3011349" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Wgsb3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4181-4205&author=T.+Ginmanauthor=J.+Viklundauthor=J.+Malmstr%C3%B6mauthor=J.+Blidauthor=R.+Emondauthor=R.+Forsblomauthor=A.+Johanssonauthor=A.+Kersauthor=F.+Lakeauthor=F.+Sehgelmebleauthor=K.+J.+Sterkyauthor=M.+Berghauthor=A.+Lindgrenauthor=P.+Johanssonauthor=F.+Jeppssonauthor=J.+F%C3%A4ltingauthor=Y.+Gravenforsauthor=F.+Rahm&title=Core+refinement+toward+permeable+%CE%B2-secretase+%28BACE-1%29+inhibitors+with+low+hERG+activity&doi=10.1021%2Fjm3011349"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Core Refinement toward Permeable β-Secretase (BACE-1) Inhibitors with Low hERG Activity</span></div><div class="casAuthors">Ginman, Tobias; Viklund, Jenny; Malmstroem, Jonas; Blid, Jan; Emond, Rikard; Forsblom, Rickard; Johansson, Anh; Kers, Annika; Lake, Fredrik; Sehgelmeble, Fernando; Sterky, Karin J.; Bergh, Margareta; Lindgren, Anders; Johansson, Patrik; Jeppsson, Fredrik; Faelting, Johanna; Gravenfors, Ylva; Rahm, Fredrik</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4181-4205</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">By use of iterative design aided by predictive models for target affinity, brain permeability, and hERG activity, novel and diverse compds. based on cyclic amidine and guanidine cores were synthesized with the goal of finding BACE-1 inhibitors as a treatment for Alzheimer's disease (e.g., I and II).  Since synthesis feasibility had low priority in the design of the cores, an extensive synthesis effort was needed to make the relevant compds.  Syntheses of these compds. are reported, together with physicochem. properties and structure-activity relationships based on in vitro data.  Four crystal structures of diverse amidines binding in the active site are deposited and discussed.  Inhibitors of BACE-1 with 3 μM to 32 nM potencies in cells are shown, together with data on in vivo brain exposure levels for four compds.  The results presented show the importance of the core structure for the profile of the final compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3tOcYPI6wPrVg90H21EOLACvtfcHk0lgwtcNXi8uPMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Wgsb3F&md5=71c61b60748ed41a5b177f68ffa157d4</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm3011349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3011349%26sid%3Dliteratum%253Aachs%26aulast%3DGinman%26aufirst%3DT.%26aulast%3DViklund%26aufirst%3DJ.%26aulast%3DMalmstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DBlid%26aufirst%3DJ.%26aulast%3DEmond%26aufirst%3DR.%26aulast%3DForsblom%26aufirst%3DR.%26aulast%3DJohansson%26aufirst%3DA.%26aulast%3DKers%26aufirst%3DA.%26aulast%3DLake%26aufirst%3DF.%26aulast%3DSehgelmeble%26aufirst%3DF.%26aulast%3DSterky%26aufirst%3DK.%2BJ.%26aulast%3DBergh%26aufirst%3DM.%26aulast%3DLindgren%26aufirst%3DA.%26aulast%3DJohansson%26aufirst%3DP.%26aulast%3DJeppsson%26aufirst%3DF.%26aulast%3DF%25C3%25A4lting%26aufirst%3DJ.%26aulast%3DGravenfors%26aufirst%3DY.%26aulast%3DRahm%26aufirst%3DF.%26atitle%3DCore%2520refinement%2520toward%2520permeable%2520%25CE%25B2-secretase%2520%2528BACE-1%2529%2520inhibitors%2520with%2520low%2520hERG%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4181%26epage%3D4205%26doi%3D10.1021%2Fjm3011349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bridgland-Taylor, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hargreaves, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Easter, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orme, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henthorn, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Small, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heapy, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abi-Gerges, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Persson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albertson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valentin, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollard, C. E.</span></span> <span> </span><span class="NLM_article-title">Optimisation and validation of a medium-throughput electrophysiology-based hERG assay using IonWorks HT</span>. <i>J. Pharmacol. Toxicol. Methods</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">189</span>– <span class="NLM_lpage">199</span>, <span class="refDoi"> DOI: 10.1016/j.vascn.2006.02.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=10.1016%2Fj.vascn.2006.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=16563806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=1%3ACAS%3A528%3ADC%252BD28XptFChtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2006&pages=189-199&author=M.+H.+Bridgland-Taylorauthor=A.+C.+Hargreavesauthor=A.+Easterauthor=A.+Ormeauthor=D.+C.+Henthornauthor=M.+Dingauthor=A.+M.+Davisauthor=B.+G.+Smallauthor=C.+G.+Heapyauthor=N.+Abi-Gergesauthor=F.+Perssonauthor=I.+Jacobsonauthor=M.+Sullivanauthor=N.+Albertsonauthor=T.+G.+Hammondauthor=E.+Sullivanauthor=J.-P.+Valentinauthor=C.+E.+Pollard&title=Optimisation+and+validation+of+a+medium-throughput+electrophysiology-based+hERG+assay+using+IonWorks+HT&doi=10.1016%2Fj.vascn.2006.02.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization and validation of a medium-throughput electrophysiology-based hERG assay using IonWorks HT</span></div><div class="casAuthors">Bridgland-Taylor, M. H.; Hargreaves, A. C.; Easter, A.; Orme, A.; Henthorn, D. C.; Ding, M.; Davis, A. M.; Small, B. G.; Heapy, C. G.; Abi-Gerges, N.; Persson, F.; Jacobson, I.; Sullivan, M.; Albertson, N.; Hammond, T. G.; Sullivan, E.; Valentin, J.-P.; Pollard, C. E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological and Toxicological Methods</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">189-199</span>CODEN:
                <span class="NLM_cas:coden">JPTMEZ</span>;
        ISSN:<span class="NLM_cas:issn">1056-8719</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Introduction: Regulatory and competitive pressure to reduce the QT interval prolongation risk of potential new drugs has led to focus on methods to test for inhibition of the human ether-a-go-go-related gene (hERG)-encoded K+ channel, the primary mol. target underlying this safety issue.  Here we describe the validation of a method that combines medium-throughput with direct assessment of channel function.  Methods: The electrophysiol. and pharmacol. properties of hERG were compared using two methods: conventional, low-throughput electrophysiol. and planar-array-based, medium-throughput electrophysiol. (IonWorks HT).  A pharmacol. comparison was also made between IonWorks HT and an indirect assay (Rb+ efflux).  Results: Basic electrophysiol. properties of hERG were similar whether recorded conventionally (HEK cells) or using IonWorks HT (CHO cells): for example, tail current V1/2 - 12.1 ± 5.0 mV (32) for conventional and - 9.5 ± 6.0 mV (46) for IonWorks HT (mean ± S.D. (n)).  A key finding was that as the no. of cells per well was increased in IonWorks HT, the potency reported for a given compd. decreased.  Using the lowest possible cell concn. (250,000 cells/mL) and 89 compds. spanning a broad potency range, the pIC50 values from IonWorks HT (CHO-hERG) were found to correlate well with those obtained using conventional methodol. (HEK-hERG)(r = 0.90; p < 0.001).  Further validation using CHO-hERG cells with both methods confirmed the correlation (r = 0.94; p < 0.001).  In contrast, a comparison of IonWorks HT and Rb+ efflux data with 649 compds. using CHO-hERG cells showed that the indirect assay consistently reported compds. as being, on av., 6-fold less potent, though the differences varied depending on chem. series.  Discussion: The main finding of this work is that providing a relatively low cell concn. is used in IonWorks HT, the potency information generated correlates well with that detd. using conventional electrophysiol.  The effect on potency of increasing cell concn. may relate to a reduced free concn. of test compd. owing to partitioning into cell membranes.  In summary, the IonWorks HT hERG assay can generate pIC50 values based on a direct assessment of channel function in a timeframe short enough to influence chem. design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTcBXhwRw0nLVg90H21EOLACvtfcHk0li4feEopMEByg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XptFChtbw%253D&md5=730258a42517947c0b972ca87cef46b6</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.vascn.2006.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vascn.2006.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DBridgland-Taylor%26aufirst%3DM.%2BH.%26aulast%3DHargreaves%26aufirst%3DA.%2BC.%26aulast%3DEaster%26aufirst%3DA.%26aulast%3DOrme%26aufirst%3DA.%26aulast%3DHenthorn%26aufirst%3DD.%2BC.%26aulast%3DDing%26aufirst%3DM.%26aulast%3DDavis%26aufirst%3DA.%2BM.%26aulast%3DSmall%26aufirst%3DB.%2BG.%26aulast%3DHeapy%26aufirst%3DC.%2BG.%26aulast%3DAbi-Gerges%26aufirst%3DN.%26aulast%3DPersson%26aufirst%3DF.%26aulast%3DJacobson%26aufirst%3DI.%26aulast%3DSullivan%26aufirst%3DM.%26aulast%3DAlbertson%26aufirst%3DN.%26aulast%3DHammond%26aufirst%3DT.%2BG.%26aulast%3DSullivan%26aufirst%3DE.%26aulast%3DValentin%26aufirst%3DJ.-P.%26aulast%3DPollard%26aufirst%3DC.%2BE.%26atitle%3DOptimisation%2520and%2520validation%2520of%2520a%2520medium-throughput%2520electrophysiology-based%2520hERG%2520assay%2520using%2520IonWorks%2520HT%26jtitle%3DJ.%2520Pharmacol.%2520Toxicol.%2520Methods%26date%3D2006%26volume%3D54%26spage%3D189%26epage%3D199%26doi%3D10.1016%2Fj.vascn.2006.02.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hunt, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watts, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vigers, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metcalf, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunawardana, I. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burkard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geck
Do, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutcher, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rana, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kallan, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeLisle, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzi, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regal, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sammond, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groneberg, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Purkey, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyssikatos, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marlow, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, T. P.</span></span> <span> </span><span class="NLM_article-title">Spirocyclic β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors: from hit to lowering of cerebrospinal fluid (CSF) amyloid β in a higher species</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">3379</span>– <span class="NLM_lpage">3403</span>, <span class="refDoi"> DOI: 10.1021/jm4002154</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4002154" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=1%3ACAS%3A528%3ADC%252BC3sXkslagsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3379-3403&author=K.+W.+Huntauthor=A.+W.+Cookauthor=R.+J.+Wattsauthor=C.+T.+Clarkauthor=G.+Vigersauthor=D.+Smithauthor=A.+T.+Metcalfauthor=I.+W.+Gunawardanaauthor=M.+Burkardauthor=A.+A.+Coxauthor=M.+K.+Geck%0ADoauthor=D.+Dutcherauthor=A.+A.+Thomasauthor=S.+Ranaauthor=N.+C.+Kallanauthor=R.+K.+DeLisleauthor=J.+P.+Rizziauthor=K.+Regalauthor=D.+Sammondauthor=R.+Gronebergauthor=M.+Siuauthor=H.+Purkeyauthor=J.+P.+Lyssikatosauthor=A.+Marlowauthor=X.+Liuauthor=T.+P.+Tang&title=Spirocyclic+%CE%B2-site+amyloid+precursor+protein+cleaving+enzyme+1+%28BACE1%29+inhibitors%3A+from+hit+to+lowering+of+cerebrospinal+fluid+%28CSF%29+amyloid+%CE%B2+in+a+higher+species&doi=10.1021%2Fjm4002154"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Spirocyclic β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors: From Hit to Lowering of Cerebrospinal Fluid (CSF) Amyloid β in a Higher Species</span></div><div class="casAuthors">Hunt, Kevin W.; Cook, Adam W.; Watts, Ryan J.; Clark, Christopher T.; Vigers, Guy; Smith, Darin; Metcalf, Andrew T.; Gunawardana, Indrani W.; Burkard, Michael; Cox, April A.; Geck Do, Mary K.; Dutcher, Darrin; Thomas, Allen A.; Rana, Sumeet; Kallan, Nicholas C.; DeLisle, Robert K.; Rizzi, James P.; Regal, Kelly; Sammond, Douglas; Groneberg, Robert; Siu, Michael; Purkey, Hans; Lyssikatos, Joseph P.; Marlow, Allison; Liu, Xingrong; Tang, Tony P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3379-3403</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A hallmark of Alzheimer's disease is the brain deposition of amyloid beta (Aβ), a peptide of 36-43 amino acids that is likely a primary driver of neurodegeneration.  Aβ is produced by the sequential cleavage of APP by BACE1 and γ-secretase; therefore, inhibition of BACE1 represents an attractive therapeutic target to slow or prevent Alzheimer's disease.  Herein are described BACE1 inhibitors with limited mol. flexibility and mol. wt. that decrease CSF Aβ in vivo, despite efflux.  Starting with spirocycle I, the authors explore structure-activity relationships of core changes, P3 moieties, and Asp binding functional groups in order to optimize BACE1 affinity, cathepsin D selectivity, and blood-brain barrier (BBB) penetration.  Using wild type guinea pig and rat, they demonstrate a PK/PD relationship between free drug concns. in the brain and CSF Aβ lowering.  Optimization of brain exposure led to the discovery of (R)-II which reduced CSF Aβ in rodents and in monkey.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYTaFN1ZrY-bVg90H21EOLACvtfcHk0li4feEopMEByg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXkslagsLg%253D&md5=b0f610967870013abee4a4bf4ce28b7f</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm4002154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4002154%26sid%3Dliteratum%253Aachs%26aulast%3DHunt%26aufirst%3DK.%2BW.%26aulast%3DCook%26aufirst%3DA.%2BW.%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26aulast%3DClark%26aufirst%3DC.%2BT.%26aulast%3DVigers%26aufirst%3DG.%26aulast%3DSmith%26aufirst%3DD.%26aulast%3DMetcalf%26aufirst%3DA.%2BT.%26aulast%3DGunawardana%26aufirst%3DI.%2BW.%26aulast%3DBurkard%26aufirst%3DM.%26aulast%3DCox%26aufirst%3DA.%2BA.%26aulast%3DGeck%2BDo%26aufirst%3DM.%2BK.%26aulast%3DDutcher%26aufirst%3DD.%26aulast%3DThomas%26aufirst%3DA.%2BA.%26aulast%3DRana%26aufirst%3DS.%26aulast%3DKallan%26aufirst%3DN.%2BC.%26aulast%3DDeLisle%26aufirst%3DR.%2BK.%26aulast%3DRizzi%26aufirst%3DJ.%2BP.%26aulast%3DRegal%26aufirst%3DK.%26aulast%3DSammond%26aufirst%3DD.%26aulast%3DGroneberg%26aufirst%3DR.%26aulast%3DSiu%26aufirst%3DM.%26aulast%3DPurkey%26aufirst%3DH.%26aulast%3DLyssikatos%26aufirst%3DJ.%2BP.%26aulast%3DMarlow%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DTang%26aufirst%3DT.%2BP.%26atitle%3DSpirocyclic%2520%25CE%25B2-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520%2528BACE1%2529%2520inhibitors%253A%2520from%2520hit%2520to%2520lowering%2520of%2520cerebrospinal%2520fluid%2520%2528CSF%2529%2520amyloid%2520%25CE%25B2%2520in%2520a%2520higher%2520species%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3379%26epage%3D3403%26doi%3D10.1021%2Fjm4002154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunt, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newhouse, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watts, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vigers, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rhodes, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otten, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burkard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geck
Do, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutcher, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rana, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeLisle, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regal, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groneberg, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scearce-Levie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Purkey, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyssikatos, J. P.</span></span> <span> </span><span class="NLM_article-title">8-Tetrahydropyran-2-yl chromans: highly selective β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">10112</span>– <span class="NLM_lpage">10129</span>, <span class="refDoi"> DOI: 10.1021/jm5015132</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5015132" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=10112-10129&author=A.+A.+Thomasauthor=K.+W.+Huntauthor=B.+Newhouseauthor=R.+J.+Wattsauthor=X.+Liuauthor=G.+Vigersauthor=D.+Smithauthor=S.+P.+Rhodesauthor=K.+D.+Brownauthor=J.+N.+Ottenauthor=M.+Burkardauthor=A.+A.+Coxauthor=M.+K.+Geck%0ADoauthor=D.+Dutcherauthor=S.+Ranaauthor=R.+K.+DeLisleauthor=K.+Regalauthor=A.+D.+Wrightauthor=R.+Gronebergauthor=J.+Liaoauthor=K.+Scearce-Levieauthor=M.+Siuauthor=H.+E.+Purkeyauthor=J.+P.+Lyssikatos&title=8-Tetrahydropyran-2-yl+chromans%3A+highly+selective+%CE%B2-site+amyloid+precursor+protein+cleaving+enzyme+1+%28BACE1%29+inhibitors&doi=10.1021%2Fjm5015132"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm5015132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5015132%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DA.%2BA.%26aulast%3DHunt%26aufirst%3DK.%2BW.%26aulast%3DNewhouse%26aufirst%3DB.%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DVigers%26aufirst%3DG.%26aulast%3DSmith%26aufirst%3DD.%26aulast%3DRhodes%26aufirst%3DS.%2BP.%26aulast%3DBrown%26aufirst%3DK.%2BD.%26aulast%3DOtten%26aufirst%3DJ.%2BN.%26aulast%3DBurkard%26aufirst%3DM.%26aulast%3DCox%26aufirst%3DA.%2BA.%26aulast%3DGeck%2BDo%26aufirst%3DM.%2BK.%26aulast%3DDutcher%26aufirst%3DD.%26aulast%3DRana%26aufirst%3DS.%26aulast%3DDeLisle%26aufirst%3DR.%2BK.%26aulast%3DRegal%26aufirst%3DK.%26aulast%3DWright%26aufirst%3DA.%2BD.%26aulast%3DGroneberg%26aufirst%3DR.%26aulast%3DLiao%26aufirst%3DJ.%26aulast%3DScearce-Levie%26aufirst%3DK.%26aulast%3DSiu%26aufirst%3DM.%26aulast%3DPurkey%26aufirst%3DH.%2BE.%26aulast%3DLyssikatos%26aufirst%3DJ.%2BP.%26atitle%3D8-Tetrahydropyran-2-yl%2520chromans%253A%2520highly%2520selective%2520%25CE%25B2-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520%2528BACE1%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D10112%26epage%3D10129%26doi%3D10.1021%2Fjm5015132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':[],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 16 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Kazuki Fujimoto, Shuhei Yoshida, Genta Tadano, Naoya Asada, Kouki Fuchino, Shinji Suzuki, Eriko Matsuoka, Takahiko Yamamoto, Shiho Yamamoto, Shigeru Ando, Naoki Kanegawa, Yutaka Tonomura, Hisanori Ito, Diederik Moechars, Frederik J. R. Rombouts, Harrie J. M. Gijsen, <span class="NLM_string-name hlFld-ContribAuthor">Ken-ichi Kusakabe</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based Approaches to Improving Selectivity through Utilizing Explicit Water Molecules: Discovery of Selective β-Secretase (BACE1) Inhibitors over BACE2. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (6)
                                     , 3075-3085. <a href="https://doi.org/10.1021/acs.jmedchem.0c01858" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01858</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01858&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01858%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BApproaches%252Bto%252BImproving%252BSelectivity%252Bthrough%252BUtilizing%252BExplicit%252BWater%252BMolecules%25253A%252BDiscovery%252Bof%252BSelective%252B%2525CE%2525B2-Secretase%252B%252528BACE1%252529%252BInhibitors%252Bover%252BBACE2%26aulast%3DFujimoto%26aufirst%3DKazuki%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D26102020%26date%3D15032021%26volume%3D64%26issue%3D6%26spage%3D3075%26epage%3D3085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jianzhong Chen, Baohua Yin, Wei Wang, <span class="NLM_string-name hlFld-ContribAuthor">Haibo Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Effects of Disulfide Bonds on Binding of Inhibitors to β-Amyloid Cleaving Enzyme 1 Decoded by Multiple Replica Accelerated Molecular Dynamics Simulations. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2020,</strong> <em>11 </em>
                                    (12)
                                     , 1811-1826. <a href="https://doi.org/10.1021/acschemneuro.0c00234" title="DOI URL">https://doi.org/10.1021/acschemneuro.0c00234</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.0c00234&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.0c00234%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DEffects%252Bof%252BDisulfide%252BBonds%252Bon%252BBinding%252Bof%252BInhibitors%252Bto%252B%2525CE%2525B2-Amyloid%252BCleaving%252BEnzyme%252B1%252BDecoded%252Bby%252BMultiple%252BReplica%252BAccelerated%252BMolecular%252BDynamics%252BSimulations%26aulast%3DChen%26aufirst%3DJianzhong%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D21042020%26date%3D27052020%26date%3D08062020%26date%3D27052020%26volume%3D11%26issue%3D12%26spage%3D1811%26epage%3D1826" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jianzhong Chen, Jinan Wang, Baohua Yin, Laixue Pang, Wei Wang, <span class="NLM_string-name hlFld-ContribAuthor">Weiliang Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Mechanism of Binding Selectivity of Inhibitors toward BACE1 and BACE2 Revealed by Multiple Short Molecular Dynamics Simulations and Free-Energy Predictions. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2019,</strong> <em>10 </em>
                                    (10)
                                     , 4303-4318. <a href="https://doi.org/10.1021/acschemneuro.9b00348" title="DOI URL">https://doi.org/10.1021/acschemneuro.9b00348</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.9b00348&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.9b00348%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DMolecular%252BMechanism%252Bof%252BBinding%252BSelectivity%252Bof%252BInhibitors%252Btoward%252BBACE1%252Band%252BBACE2%252BRevealed%252Bby%252BMultiple%252BShort%252BMolecular%252BDynamics%252BSimulations%252Band%252BFree-Energy%252BPredictions%26aulast%3DChen%26aufirst%3DJianzhong%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D19062019%26date%3D23092019%26date%3D02102019%26date%3D23092019%26volume%3D10%26issue%3D10%26spage%3D4303%26epage%3D4318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kazuki Fujimoto, Eriko Matsuoka, Naoya Asada, Genta Tadano, Takahiko Yamamoto, Kenji Nakahara, Kouki Fuchino, Hisanori Ito, Naoki Kanegawa, Diederik Moechars, Harrie J. M. Gijsen, <span class="NLM_string-name hlFld-ContribAuthor">Ken-ichi Kusakabe</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based Design of Selective β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors: Targeting the Flap to Gain Selectivity over BACE2. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (10)
                                     , 5080-5095. <a href="https://doi.org/10.1021/acs.jmedchem.9b00309" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00309</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00309%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BDesign%252Bof%252BSelective%252B%2525CE%2525B2-Site%252BAmyloid%252BPrecursor%252BProtein%252BCleaving%252BEnzyme%252B1%252B%252528BACE1%252529%252BInhibitors%25253A%252BTargeting%252Bthe%252BFlap%252Bto%252BGain%252BSelectivity%252Bover%252BBACE2%26aulast%3DFujimoto%26aufirst%3DKazuki%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D16022019%26date%3D13052019%26date%3D25042019%26volume%3D62%26issue%3D10%26spage%3D5080%26epage%3D5095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jack A. Henderson, Robert C. Harris, Cheng-Chieh Tsai, <span class="NLM_string-name hlFld-ContribAuthor">Jana Shen</span>. </span><span class="cited-content_cbyCitation_article-title">How Ligand Protonation State Controls Water in Protein–Ligand Binding. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Physical Chemistry Letters</span><span> <strong>2018,</strong> <em>9 </em>
                                    (18)
                                     , 5440-5444. <a href="https://doi.org/10.1021/acs.jpclett.8b02440" title="DOI URL">https://doi.org/10.1021/acs.jpclett.8b02440</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jpclett.8b02440&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jpclett.8b02440%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Physical%2520Chemistry%2520Letters%26atitle%3DHow%252BLigand%252BProtonation%252BState%252BControls%252BWater%252Bin%252BProtein%2525E2%252580%252593Ligand%252BBinding%26aulast%3DHenderson%26aufirst%3DJack%2BA.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D08082018%26date%3D06092018%26date%3D10092018%26date%3D06092018%26volume%3D9%26issue%3D18%26spage%3D5440%26epage%3D5444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kayode Ezekiel  Adewole</span>, <span class="hlFld-ContribAuthor ">Ahmed Adebayo  Ishola</span>. </span><span class="cited-content_cbyCitation_article-title">BACE1 and cholinesterase inhibitory activities of compounds from Cajanus cajan and Citrus reticulata: an in silico study. </span><span class="cited-content_cbyCitation_journal-name">In Silico Pharmacology</span><span> <strong>2021,</strong> <em>9 </em>
                                    (1)
                                     <a href="https://doi.org/10.1007/s40203-020-00067-6" title="DOI URL">https://doi.org/10.1007/s40203-020-00067-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40203-020-00067-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40203-020-00067-6%26sid%3Dliteratum%253Aachs%26jtitle%3DIn%2520Silico%2520Pharmacology%26atitle%3DBACE1%252Band%252Bcholinesterase%252Binhibitory%252Bactivities%252Bof%252Bcompounds%252Bfrom%252BCajanus%252Bcajan%252Band%252BCitrus%252Breticulata%25253A%252Ban%252Bin%252Bsilico%252Bstudy%26aulast%3DAdewole%26aufirst%3DKayode%2BEzekiel%26date%3D2021%26date%3D2021%26volume%3D9%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Helmut M.  Hügel</span>, <span class="hlFld-ContribAuthor ">Nilamuni H.  de Silva</span>, <span class="hlFld-ContribAuthor ">Aimen  Siddiqui</span>, <span class="hlFld-ContribAuthor ">Ewan  Blanch</span>, <span class="hlFld-ContribAuthor ">Anthony  Lingham</span>. </span><span class="cited-content_cbyCitation_article-title">Natural spirocyclic alkaloids and polyphenols as multi target dementia leads. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2021,</strong> <em>43 </em>, 116270. <a href="https://doi.org/10.1016/j.bmc.2021.116270" title="DOI URL">https://doi.org/10.1016/j.bmc.2021.116270</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2021.116270&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2021.116270%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DNatural%252Bspirocyclic%252Balkaloids%252Band%252Bpolyphenols%252Bas%252Bmulti%252Btarget%252Bdementia%252Bleads%26aulast%3DH%25C3%25BCgel%26aufirst%3DHelmut%2BM.%26date%3D2021%26volume%3D43%26spage%3D116270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ting  Wu</span>, <span class="hlFld-ContribAuthor ">Qinghai  Zhou</span>, <span class="hlFld-ContribAuthor ">Wenjun  Tang</span>. </span><span class="cited-content_cbyCitation_article-title">Enantioselective α‐Carbonylative Arylation for Facile Construction of Chiral Spirocyclic β,β′‐Diketones. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2021,</strong> <em>133 </em>
                                    (18)
                                     , 10066-10071. <a href="https://doi.org/10.1002/ange.202101668" title="DOI URL">https://doi.org/10.1002/ange.202101668</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.202101668&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.202101668%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DEnantioselective%252B%2525CE%2525B1%2525E2%252580%252590Carbonylative%252BArylation%252Bfor%252BFacile%252BConstruction%252Bof%252BChiral%252BSpirocyclic%252B%2525CE%2525B2%25252C%2525CE%2525B2%2525E2%252580%2525B2%2525E2%252580%252590Diketones%26aulast%3DWu%26aufirst%3DTing%26date%3D2021%26date%3D2021%26volume%3D133%26issue%3D18%26spage%3D10066%26epage%3D10071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ting  Wu</span>, <span class="hlFld-ContribAuthor ">Qinghai  Zhou</span>, <span class="hlFld-ContribAuthor ">Wenjun  Tang</span>. </span><span class="cited-content_cbyCitation_article-title">Enantioselective α‐Carbonylative Arylation for Facile Construction of Chiral Spirocyclic β,β′‐Diketones. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2021,</strong> <em>60 </em>
                                    (18)
                                     , 9978-9983. <a href="https://doi.org/10.1002/anie.202101668" title="DOI URL">https://doi.org/10.1002/anie.202101668</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.202101668&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.202101668%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DEnantioselective%252B%2525CE%2525B1%2525E2%252580%252590Carbonylative%252BArylation%252Bfor%252BFacile%252BConstruction%252Bof%252BChiral%252BSpirocyclic%252B%2525CE%2525B2%25252C%2525CE%2525B2%2525E2%252580%2525B2%2525E2%252580%252590Diketones%26aulast%3DWu%26aufirst%3DTing%26date%3D2021%26date%3D2021%26volume%3D60%26issue%3D18%26spage%3D9978%26epage%3D9983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cristian  Privat</span>, <span class="hlFld-ContribAuthor ">José M.  Granadino-Roldán</span>, <span class="hlFld-ContribAuthor ">Jordi  Bonet</span>, <span class="hlFld-ContribAuthor ">Maria  Santos Tomas</span>, <span class="hlFld-ContribAuthor ">Juan J.  Perez</span>, <span class="hlFld-ContribAuthor ">Jaime  Rubio-Martinez</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment dissolved molecular dynamics: a systematic and efficient method to locate binding sites. </span><span class="cited-content_cbyCitation_journal-name">Physical Chemistry Chemical Physics</span><span> <strong>2021,</strong> <em>23 </em>
                                    (4)
                                     , 3123-3134. <a href="https://doi.org/10.1039/D0CP05471B" title="DOI URL">https://doi.org/10.1039/D0CP05471B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0CP05471B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0CP05471B%26sid%3Dliteratum%253Aachs%26jtitle%3DPhysical%2520Chemistry%2520Chemical%2520Physics%26atitle%3DFragment%252Bdissolved%252Bmolecular%252Bdynamics%25253A%252Ba%252Bsystematic%252Band%252Befficient%252Bmethod%252Bto%252Blocate%252Bbinding%252Bsites%26aulast%3DPrivat%26aufirst%3DCristian%26date%3D2021%26date%3D2021%26volume%3D23%26issue%3D4%26spage%3D3123%26epage%3D3134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haizhou  Zhu</span>, <span class="hlFld-ContribAuthor ">Venkateshwara  Dronamraju</span>, <span class="hlFld-ContribAuthor ">Wei  Xie</span>, <span class="hlFld-ContribAuthor ">Swati S.  More</span>. </span><span class="cited-content_cbyCitation_article-title">Sulfur-containing therapeutics in the treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2021,</strong> <em>30 </em>
                                    (2)
                                     , 305-352. <a href="https://doi.org/10.1007/s00044-020-02687-1" title="DOI URL">https://doi.org/10.1007/s00044-020-02687-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-020-02687-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-020-02687-1%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DSulfur-containing%252Btherapeutics%252Bin%252Bthe%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DZhu%26aufirst%3DHaizhou%26date%3D2021%26date%3D2021%26volume%3D30%26issue%3D2%26spage%3D305%26epage%3D352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kundlik  Gadhave</span>, <span class="hlFld-ContribAuthor ">Bhuvaneshwari R.  Gehi</span>, <span class="hlFld-ContribAuthor ">Prateek  Kumar</span>, <span class="hlFld-ContribAuthor ">Bin  Xue</span>, <span class="hlFld-ContribAuthor ">Vladimir N.  Uversky</span>, <span class="hlFld-ContribAuthor ">Rajanish  Giri</span>. </span><span class="cited-content_cbyCitation_article-title">The dark side of Alzheimer’s disease: unstructured biology of proteins from the amyloid cascade signaling pathway. </span><span class="cited-content_cbyCitation_journal-name">Cellular and Molecular Life Sciences</span><span> <strong>2020,</strong> <em>77 </em>
                                    (20)
                                     , 4163-4208. <a href="https://doi.org/10.1007/s00018-019-03414-9" title="DOI URL">https://doi.org/10.1007/s00018-019-03414-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00018-019-03414-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00018-019-03414-9%26sid%3Dliteratum%253Aachs%26jtitle%3DCellular%2520and%2520Molecular%2520Life%2520Sciences%26atitle%3DThe%252Bdark%252Bside%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%25253A%252Bunstructured%252Bbiology%252Bof%252Bproteins%252Bfrom%252Bthe%252Bamyloid%252Bcascade%252Bsignaling%252Bpathway%26aulast%3DGadhave%26aufirst%3DKundlik%26date%3D2020%26date%3D2020%26volume%3D77%26issue%3D20%26spage%3D4163%26epage%3D4208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Speranta  Avram</span>, <span class="hlFld-ContribAuthor ">Maria  Mernea</span>, <span class="hlFld-ContribAuthor ">Carmen  Limban</span>, <span class="hlFld-ContribAuthor ">Florin  Borcan</span>, <span class="hlFld-ContribAuthor ">Carmen  Chifiriuc</span>. </span><span class="cited-content_cbyCitation_article-title">Potential Therapeutic Approaches to Alzheimer’s Disease By Bioinformatics, Cheminformatics And Predicted Adme-Tox Tools. </span><span class="cited-content_cbyCitation_journal-name">Current Neuropharmacology</span><span> <strong>2020,</strong> <em>18 </em>
                                    (8)
                                     , 696-719. <a href="https://doi.org/10.2174/1570159X18666191230120053" title="DOI URL">https://doi.org/10.2174/1570159X18666191230120053</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1570159X18666191230120053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1570159X18666191230120053%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Neuropharmacology%26atitle%3DPotential%252BTherapeutic%252BApproaches%252Bto%252BAlzheimer%2525E2%252580%252599s%252BDisease%252BBy%252BBioinformatics%25252C%252BCheminformatics%252BAnd%252BPredicted%252BAdme-Tox%252BTools%26aulast%3DAvram%26aufirst%3DSperanta%26date%3D2020%26volume%3D18%26issue%3D8%26spage%3D696%26epage%3D719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shipeng  Li</span>, <span class="hlFld-ContribAuthor ">Hexiang  Zhao</span>, <span class="hlFld-ContribAuthor ">Jinghui  Li</span>, <span class="hlFld-ContribAuthor ">Jiajia  Hao</span>, <span class="hlFld-ContribAuthor ">Hualin  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">A series of molecular modeling techniques to reveal selective mechanisms of inhibitors to β-Site amyloid precursor protein cleaving enzyme 1 (BACE1) and β-site amyloid precursor protein cleaving enzyme 2 (BACE2). </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2020,</strong> <em> </em>, 1-14. <a href="https://doi.org/10.1080/07391102.2020.1754917" title="DOI URL">https://doi.org/10.1080/07391102.2020.1754917</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2020.1754917&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2020.1754917%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DA%252Bseries%252Bof%252Bmolecular%252Bmodeling%252Btechniques%252Bto%252Breveal%252Bselective%252Bmechanisms%252Bof%252Binhibitors%252Bto%252B%2525CE%2525B2-Site%252Bamyloid%252Bprecursor%252Bprotein%252Bcleaving%252Benzyme%252B1%252B%252528BACE1%252529%252Band%252B%2525CE%2525B2-site%252Bamyloid%252Bprecursor%252Bprotein%252Bcleaving%252Benzyme%252B2%252B%252528BACE2%252529%26aulast%3DLi%26aufirst%3DShipeng%26date%3D2020%26date%3D2020%26spage%3D1%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Franca M.  Cordero</span>, <span class="hlFld-ContribAuthor ">Luisa  Lascialfari</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Machetti</span>. </span><span class="cited-content_cbyCitation_article-title">Five-Membered Ring Systems: With O & N Atoms. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 399-429. <a href="https://doi.org/10.1016/B978-0-12-819962-6.00011-7" title="DOI URL">https://doi.org/10.1016/B978-0-12-819962-6.00011-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-819962-6.00011-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-819962-6.00011-7%26sid%3Dliteratum%253Aachs%26atitle%3DFive-Membered%252BRing%252BSystems%25253A%252BWith%252BO%252B%252526%252BN%252BAtoms%26aulast%3DCordero%26aufirst%3DFranca%2BM.%26date%3D2020%26spage%3D399%26epage%3D429%26pub%3DElsevier%26date%3D2020%26volume%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chien-Chi  Hsiao</span>, <span class="hlFld-ContribAuthor ">Frederik  Rombouts</span>, <span class="hlFld-ContribAuthor ">Harrie J.M.  Gijsen</span>. </span><span class="cited-content_cbyCitation_article-title">New evolutions in the BACE1 inhibitor field from 2014 to 2018. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (6)
                                     , 761-777. <a href="https://doi.org/10.1016/j.bmcl.2018.12.049" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.12.049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.12.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.12.049%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DNew%252Bevolutions%252Bin%252Bthe%252BBACE1%252Binhibitor%252Bfield%252Bfrom%252B2014%252Bto%252B2018%26aulast%3DHsiao%26aufirst%3DChien-Chi%26date%3D2019%26volume%3D29%26issue%3D6%26spage%3D761%26epage%3D777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/medium/jm-2017-01716g_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/large/jm-2017-01716g_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01716&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/medium/jm-2017-01716g_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/large/jm-2017-01716g_0001.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures and biochemical activities for AZ3839 and lanabecestat (AZD3293).<a onclick="showRef(event, 'ref12 ref19'); return false;" href="javascript:void(0);" class="ref ref12 ref19">(12,19)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/large/jm-2017-01716g_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01716&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/medium/jm-2017-01716g_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/large/jm-2017-01716g_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Crystal structures of BACE inhibitors with variable BACE1 selectivity bound to BACE1: red (<3-fold), yellow (3- to 10-fold), green (>10-fold). The most selective compounds were found to induce a conformational change of the BACE1 flap and/or to interact with a well-conserved H<sub>2</sub>O keeping the BACE1 S3 subpocket in an open conformation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/large/jm-2017-01716g_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01716&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/medium/jm-2017-01716g_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/large/jm-2017-01716g_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Left: Structure of less active enantiomer <b>17</b>. Right: Generic structure for compounds <b>18</b>–<b>24</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/large/jm-2017-01716g_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01716&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/medium/jm-2017-01716g_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/large/jm-2017-01716g_0009.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>17</b>–<b>24</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/large/jm-2017-01716g_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01716&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents: (a) Tebbe’s reagent, THF, 0 °C, 95%; (b) Ph<sub>3</sub>CD<sub>3</sub>PI, <i>n</i>-BuLi, −30 °C, 85%; (c) AgNCO, I<sub>2</sub>, THF, CH<sub>3</sub>CN, 22 °C, then THF, NH<sub>4</sub>OH, 84% (<b>4</b>), or 82% (<b>5</b>); (d) chiral SFC; (e) arylbromide, 1,1-bis(di-<i>tert</i>-butylphosphino)ferrocene palladium dichloride, K<sub>2</sub>CO<sub>3</sub>, H<sub>2</sub>O, 1,4-dioxane, 100 °C.</p></p></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/medium/jm-2017-01716g_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/large/jm-2017-01716g_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Cocrystal structure of compound <b>23</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EJ3">6EJ3</a>) bound to BACE1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/large/jm-2017-01716g_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01716&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/medium/jm-2017-01716g_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/large/jm-2017-01716g_0005.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Structures <b>25</b>–<b>29</b> for <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/large/jm-2017-01716g_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01716&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/medium/jm-2017-01716g_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/large/jm-2017-01716g_0010.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds Shown in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/large/jm-2017-01716g_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01716&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents: (a) methyl acrylate, CH<sub>3</sub>I, KO<sup><i>t</i></sup>Bu, THF, then LiOH·H<sub>2</sub>O, THF, H<sub>2</sub>O, 44% (2 steps); (b) CeCl<sub>3</sub>·7H<sub>2</sub>O, NaBH<sub>4</sub>, THF, −70 °C, 56%; (c) CH<sub>3</sub>I, NaH, DMF, 0 °C, 67%; (d) Ph<sub>3</sub>CD<sub>3</sub>PI, <i>n</i>-BuLi, THF, −30 °C, 76%; (e) AgNCO, I<sub>2</sub>, THF, CH<sub>3</sub>CN, 22 °C, then THF, NH<sub>4</sub>OH, 84%; (f) aryl bromide, 1,1-bis(di-<i>tert</i>-butylphosphino)ferrocene palladium dichloride, K<sub>2</sub>CO<sub>3</sub>, H<sub>2</sub>O, 1,4-dioxane, 100 °C.</p></p></figure><figure data-id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/medium/jm-2017-01716g_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/large/jm-2017-01716g_0006.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Cocrystal structure of compound <b>28</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EJ2">6EJ2</a>) bound to the active site of BACE1. Top: Inhibitor <b>28</b> bound to the active site. Middle: Methylcyclohexyl inducing an open flap conformation. Bottom: Pyrimidyl nitrogen engaging in the H-bond network within the S3 subpocket.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/large/jm-2017-01716g_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01716&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/medium/jm-2017-01716g_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/large/jm-2017-01716g_0007.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Comparison of compound <b>28</b> with lanabecestat (AZD3293, IC<sub>50(BACE1)</sub> = 0.6 nM; IC<sub>50(BACE2)</sub> = 0.9 nM) on PMEL processing. Human melanocyte (MNT1) cells were incubated with different concentrations of BACE inhibitors or vehicle (0.1% DMSO) and processed to identify parent PMEL (P1) and proteolytically cleaved Mβ fragment. Mβ fragment accumulates when BACE2 is inhibited.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/large/jm-2017-01716g_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01716&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/medium/jm-2017-01716g_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/large/jm-2017-01716g_0008.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. PK/PD study in mice following 50 mg/kg oral administration (po). Top: Free brain and plasma exposure of compound <b>28</b> over time. Bottom: Aβ<sub>40</sub> and Aβ<sub>42</sub> levels in brain and peripheral Aβ<sub>40</sub> levels over time.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01716/20180420/images/large/jm-2017-01716g_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01716&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i43">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84215" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84215" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 37 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vassar, R.</span></span> <span> </span><span class="NLM_article-title">BACE1 inhibitor drugs in clinical trials for Alzheimer’s disease</span>. <i>Alzheimer’s Res. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">89</span>, <span class="refDoi"> DOI: 10.1186/s13195-014-0089-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=10.1186%2Fs13195-014-0089-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=25621019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjtVCqtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=89&author=R.+Vassar&title=BACE1+inhibitor+drugs+in+clinical+trials+for+Alzheimer%E2%80%99s+disease&doi=10.1186%2Fs13195-014-0089-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">BACE1 inhibitor drugs in clinical trials for Alzheimer's disease</span></div><div class="casAuthors">Vassar, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's Research & Therapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">89/1-89/14, 14 pp.</span>CODEN:
                <span class="NLM_cas:coden">ARTLCD</span>;
        ISSN:<span class="NLM_cas:issn">1758-9193</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  β-Site amyloid precursor protein cleaving enzyme 1 (BACE1) is the β-secretase enzyme required for the prodn. of the neurotoxic β-amyloid (Aβ) peptide that is widely considered to have a crucial early role in the etiol. of Alzheimer's disease (AD).  As a result, BACE1 has emerged as a prime drug target for reducing the levels of Aβ in the AD brain, and the development of BACE1 inhibitors as therapeutic agents is being vigorously pursued.  It has proven difficult for the pharmaceutical industry to design BACE1 inhibitor drugs that pass the blood-brain barrier, however this challenge has recently been met and BACE1 inhibitors are now in human clin. trials to test for safety and efficacy in AD patients and individuals with pre-symptomatic AD.  Initial results suggest that some of these BACE1 inhibitor drugs are well tolerated, although others have dropped out because of toxicity and it is still too early to know whether any will be effective for the prevention or treatment of AD.  Addnl., based on newly identified BACE1 substrates and phenotypes of mice that lack BACE1, concerns have emerged about potential mechanism-based side effects of BACE1 inhibitor drugs with chronic administration.  It is hoped that a therapeutic window can be achieved that balances safety and efficacy.  This review summarizes the current state of progress in the development of BACE1 inhibitor drugs and the evaluation of their therapeutic potential for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqR-BPlLZzu7rVg90H21EOLACvtfcHk0lg2k14UbOdECw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtVCqtL4%253D&md5=a9ec66c8f0254986406323efa56c6f5a</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1186%2Fs13195-014-0089-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13195-014-0089-7%26sid%3Dliteratum%253Aachs%26aulast%3DVassar%26aufirst%3DR.%26atitle%3DBACE1%2520inhibitor%2520drugs%2520in%2520clinical%2520trials%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Res.%2520Ther.%26date%3D2014%26volume%3D6%26spage%3D89%26doi%3D10.1186%2Fs13195-014-0089-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sadleir, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kandalepas, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buggia-Prévot, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thinakaran, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vassar, R.</span></span> <span> </span><span class="NLM_article-title">Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased Aβ generation in Alzheimer’s disease</span>. <i>Acta Neuropathol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>132</i></span>,  <span class="NLM_fpage">235</span>– <span class="NLM_lpage">256</span>, <span class="refDoi"> DOI: 10.1007/s00401-016-1558-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=10.1007%2Fs00401-016-1558-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=26993139" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=1%3ACAS%3A528%3ADC%252BC28XksVOgs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2016&pages=235-256&author=K.+R.+Sadleirauthor=P.+C.+Kandalepasauthor=V.+Buggia-Pr%C3%A9votauthor=D.+A.+Nicholsonauthor=G.+Thinakaranauthor=R.+Vassar&title=Presynaptic+dystrophic+neurites+surrounding+amyloid+plaques+are+sites+of+microtubule+disruption%2C+BACE1+elevation%2C+and+increased+A%CE%B2+generation+in+Alzheimer%E2%80%99s+disease&doi=10.1007%2Fs00401-016-1558-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased Aβ generation in Alzheimer's disease</span></div><div class="casAuthors">Sadleir, Katherine R.; Kandalepas, Patty C.; Buggia-Prevot, Virginie; Nicholson, Daniel A.; Thinakaran, Gopal; Vassar, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Acta Neuropathologica</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">235-256</span>CODEN:
                <span class="NLM_cas:coden">ANPTAL</span>;
        ISSN:<span class="NLM_cas:issn">0001-6322</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is characterized by amyloid plaques composed of the β-amyloid (Aβ) peptide surrounded by swollen presynaptic dystrophic neurites consisting of dysfunctional axons and terminals that accumulate the β-site amyloid precursor protein (APP) cleaving enzyme (BACE1) required for Aβ generation.  The cellular and mol. mechanisms that govern presynaptic dystrophic neurite formation are unclear, and elucidating these processes may lead to novel AD therapeutic strategies.  Previous studies suggest Aβ may disrupt microtubules, which we hypothesize have a crit. role in the development of presynaptic dystrophies.  To investigate this further, here we have assessed the effects of Aβ, particularly neurotoxic Aβ42, on microtubules during the formation of presynaptic dystrophic neurites in vitro and in vivo.  Live-cell imaging of primary neurons revealed that exposure to Aβ42 oligomers caused varicose and beaded neurites with extensive microtubule disruption, and inhibited anterograde and retrograde trafficking.  In brain sections from AD patients and the 5XFAD transgenic mouse model of amyloid pathol., dystrophic neurite halos with BACE1 elevation around amyloid plaques exhibited aberrant tubulin accumulations or voids.  At the ultrastructural level, peri-plaque dystrophies were strikingly devoid of microtubules and replete with multi-lamellar vesicles resembling autophagic intermediates.  Proteins of the microtubule motors, kinesin and dynein, and other neuronal proteins were aberrantly localized in peri-plaque dystrophies.  Inactive pro-cathepsin D also accumulated in peri-plaque dystrophies, indicating reduced lysosomal function.  Most importantly, BACE1 accumulation in peri-plaque dystrophies caused increased BACE1 cleavage of APP and Aβ generation.  Our study supports the hypothesis that Aβ induces microtubule disruption in presynaptic dystrophic neurites that surround plaques, thus impairing axonal transport and leading to accumulation of BACE1 and exacerbation of amyloid pathol. in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbSN7VOiJ1l7Vg90H21EOLACvtfcHk0lg2k14UbOdECw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XksVOgs78%253D&md5=d66c9c600721f1f63e7ae1c185b3b4ab</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2Fs00401-016-1558-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00401-016-1558-9%26sid%3Dliteratum%253Aachs%26aulast%3DSadleir%26aufirst%3DK.%2BR.%26aulast%3DKandalepas%26aufirst%3DP.%2BC.%26aulast%3DBuggia-Pr%25C3%25A9vot%26aufirst%3DV.%26aulast%3DNicholson%26aufirst%3DD.%2BA.%26aulast%3DThinakaran%26aufirst%3DG.%26aulast%3DVassar%26aufirst%3DR.%26atitle%3DPresynaptic%2520dystrophic%2520neurites%2520surrounding%2520amyloid%2520plaques%2520are%2520sites%2520of%2520microtubule%2520disruption%252C%2520BACE1%2520elevation%252C%2520and%2520increased%2520A%25CE%25B2%2520generation%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DActa%2520Neuropathol.%26date%3D2016%26volume%3D132%26spage%3D235%26epage%3D256%26doi%3D10.1007%2Fs00401-016-1558-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vassar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovacs, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, P. C.</span></span> <span> </span><span class="NLM_article-title">The β-secretase enzyme BACE in health and Alzheimer’s disease: regulation, cell biology, function, and therapeutic potential</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">12787</span>– <span class="NLM_lpage">12794</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.3657-09.2009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=10.1523%2FJNEUROSCI.3657-09.2009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=19828790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlSit7bP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=12787-12794&author=R.+Vassarauthor=D.+M.+Kovacsauthor=R.+Yanauthor=P.+C.+Wong&title=The+%CE%B2-secretase+enzyme+BACE+in+health+and+Alzheimer%E2%80%99s+disease%3A+regulation%2C+cell+biology%2C+function%2C+and+therapeutic+potential&doi=10.1523%2FJNEUROSCI.3657-09.2009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The β-secretase enzyme BACE in health and Alzheimer's disease: regulation, cell biology, function, and therapeutic potential</span></div><div class="casAuthors">Vassar, Robert; Kovacs, Dora M.; Yan, Riqiang; Wong, Philip C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">12787-12794</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">A review.  The β-amyloid (Aβ) peptide is the major constituent of amyloid plaques in Alzheimer's disease (AD) brain and is likely to play a central role in the pathogenesis of this devastating neurodegenerative disorder.  The β-secretase, β-site amyloid precursor protein cleaving enzyme (BACE1; also called Asp2, memapsin 2), is the enzyme responsible for initiating Aβ generation.  Thus, BACE is a prime drug target for the therapeutic inhibition of Aβ prodn. in AD.  Since its discovery 10 years ago, much has been learned about BACE.  This review summarizes BACE properties, describes BACE translation dysregulation in AD, and discusses BACE physiol. functions in sodium current, synaptic transmission, myelination, and schizophrenia.  The therapeutic potential of BACE will also be considered.  This is a summary of topics covered at a symposium held at the 39th annual meeting of the Society for Neuroscience and is not meant to be a comprehensive review of BACE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqGn8h_x-7_bVg90H21EOLACvtfcHk0li3H1wa2ZJFNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlSit7bP&md5=a462ad002cf3801570725719d71647c6</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3657-09.2009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3657-09.2009%26sid%3Dliteratum%253Aachs%26aulast%3DVassar%26aufirst%3DR.%26aulast%3DKovacs%26aufirst%3DD.%2BM.%26aulast%3DYan%26aufirst%3DR.%26aulast%3DWong%26aufirst%3DP.%2BC.%26atitle%3DThe%2520%25CE%25B2-secretase%2520enzyme%2520BACE%2520in%2520health%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520regulation%252C%2520cell%2520biology%252C%2520function%252C%2520and%2520therapeutic%2520potential%26jtitle%3DJ.%2520Neurosci.%26date%3D2009%26volume%3D29%26spage%3D12787%26epage%3D12794%26doi%3D10.1523%2FJNEUROSCI.3657-09.2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Strooper, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vassar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golde, T.</span></span> <span> </span><span class="NLM_article-title">The secretases: enzymes with therapeutic potential in Alzheimer’s disease</span>. <i>Nat. Rev. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">99</span>– <span class="NLM_lpage">107</span>, <span class="refDoi"> DOI: 10.1038/nrneurol.2009.218</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=10.1038%2Fnrneurol.2009.218" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=20139999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1Ogt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=99-107&author=B.+De%0AStrooperauthor=R.+Vassarauthor=T.+Golde&title=The+secretases%3A+enzymes+with+therapeutic+potential+in+Alzheimer%E2%80%99s+disease&doi=10.1038%2Fnrneurol.2009.218"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The secretases: enzymes with therapeutic potential in Alzheimer disease</span></div><div class="casAuthors">De Strooper, Bart; Vassar, Robert; Golde, Todd</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neurology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">99-107</span>CODEN:
                <span class="NLM_cas:coden">NRNACP</span>;
        ISSN:<span class="NLM_cas:issn">1759-4758</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The three secretases that process amyloid precursor protein are central to the generation of amyloid-β, and the accumulation of this peptide in extracellular plaques is one of the hallmarks of Alzheimer disease.  In this Review, De Strooper et al. discuss the evidence that suggests that these enzymes are potential therapeutic targets for Alzheimer disease drug treatments.  The amyloid hypothesis has yielded a series of well-validated candidate drug targets with potential for the treatment of Alzheimer disease (AD).  Three proteases that are involved in the processing of amyloid precursor protein-α-secretase, β-secretase and γ-secretase-are of particular interest as they are central to the generation and modulation of amyloid-β peptide and can be targeted by small compds. in vitro and in vivo.  Given that these proteases also fulfill other important biol. roles, inhibiting their activity will clearly be inherently assocd. with mechanism-based toxicity.  Carefully detg. a suitable therapeutic window and optimizing the selectivity of the drug treatments towards amyloid precursor protein processing might be ways of overcoming this potential complication.  Secretase inhibitors are likely to be the first small-mol. therapies aimed at AD modification that will be fully tested in the clinic.  Success or failure of these first-generation AD therapies will have enormous consequences for further drug development efforts for AD and possibly other neurodegenerative conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQBldqS_TKy7Vg90H21EOLACvtfcHk0li3H1wa2ZJFNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1Ogt70%253D&md5=40135a0a59da6b70e4856a81ddfa6088</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrneurol.2009.218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrneurol.2009.218%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26aulast%3DVassar%26aufirst%3DR.%26aulast%3DGolde%26aufirst%3DT.%26atitle%3DThe%2520secretases%253A%2520enzymes%2520with%2520therapeutic%2520potential%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNat.%2520Rev.%2520Neurol.%26date%3D2010%26volume%3D6%26spage%3D99%26epage%3D107%26doi%3D10.1038%2Fnrneurol.2009.218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sisodia, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">St. George-Hyslop, P.
H.</span></span> <span> </span><span class="NLM_article-title">γ-Secretase, Notch, Aβ and Alzheimer’s disease: Where do the presenilins fit in?</span>. <i>Nat. Rev. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">281</span>– <span class="NLM_lpage">290</span>, <span class="refDoi"> DOI: 10.1038/nrn785</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=10.1038%2Fnrn785" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=11967558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=1%3ACAS%3A528%3ADC%252BD38Xjsl2kurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2002&pages=281-290&author=S.+S.+Sisodiaauthor=P.%0AH.+St.+George-Hyslop&title=%CE%B3-Secretase%2C+Notch%2C+A%CE%B2+and+Alzheimer%E2%80%99s+disease%3A+Where+do+the+presenilins+fit+in%3F&doi=10.1038%2Fnrn785"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">γ-SECRETASE, NOTCH, Aβ AND ALZHEIMER'S DISEASE: WHERE DO THE PRESENILINS FIT IN?</span></div><div class="casAuthors">Sisodia, Sangram S.; St George-Hyslop, Peter H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">281-290</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Investigations into the proteolytic processing of amyloid precursor protein (APP) have provided insights into both the pathogenesis of Alzheimer's disease and an unusual form of regulated proteolytic processing within the membrane-spanning domains of several proteins, including APP, Notch and ErbB4.  Some of the enzymes responsible for α- and β-secretase cleavage have been identified, and these seem to be conventional proteolytic events.  However, the mol. events that are involved in γ-secretase cleavage within the transmembrane domain of these proteins are much more complex.  The presenilins and nicastrin are required for this process, but the role of the presenilins remains unclear.  Although some data support the idea that the presenilins are in fact the active site of γ-secretase, other data indicate that they might have a more indirect role, for example, in transporting substrates to the correct subcellular compartments for γ-secretase cleavage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGre-3PaMlOvLrVg90H21EOLACvtfcHk0li3H1wa2ZJFNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xjsl2kurk%253D&md5=a8b77aa0be567febaa093412728aec12</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrn785&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn785%26sid%3Dliteratum%253Aachs%26aulast%3DSisodia%26aufirst%3DS.%2BS.%26aulast%3DSt.%2BGeorge-Hyslop%26aufirst%3DP.%2BH.%26atitle%3D%25CE%25B3-Secretase%252C%2520Notch%252C%2520A%25CE%25B2%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520Where%2520do%2520the%2520presenilins%2520fit%2520in%253F%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2002%26volume%3D3%26spage%3D281%26epage%3D290%26doi%3D10.1038%2Fnrn785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Willem, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahirovic, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Busche, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ovsepian, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chafai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kootar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hornburg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, L. D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daria, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hampel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giudici, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuscher, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wenninger-Weinzierl, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kremmer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heneka, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thal, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giedraitis, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lannfelt, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Livesey, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meissner, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herms, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konnerth, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marie, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haass, C.</span></span> <span> </span><span class="NLM_article-title">η-Secretase processing of APP inhibits neuronal activity in the hippocampus</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>526</i></span>,  <span class="NLM_fpage">443</span>– <span class="NLM_lpage">447</span>, <span class="refDoi"> DOI: 10.1038/nature14864</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=10.1038%2Fnature14864" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=26322584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVCis7%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=526&publication_year=2015&pages=443-447&author=M.+Willemauthor=S.+Tahirovicauthor=M.+A.+Buscheauthor=S.+V.+Ovsepianauthor=M.+Chafaiauthor=S.+Kootarauthor=D.+Hornburgauthor=L.+D.+B.+Evansauthor=S.+Mooreauthor=A.+Dariaauthor=H.+Hampelauthor=V.+M%C3%BCllerauthor=C.+Giudiciauthor=B.+Nuscherauthor=A.+Wenninger-Weinzierlauthor=E.+Kremmerauthor=M.+T.+Henekaauthor=D.+R.+Thalauthor=V.+Giedraitisauthor=L.+Lannfeltauthor=U.+M%C3%BCllerauthor=F.+J.+Liveseyauthor=F.+Meissnerauthor=J.+Hermsauthor=A.+Konnerthauthor=H.+Marieauthor=C.+Haass&title=%CE%B7-Secretase+processing+of+APP+inhibits+neuronal+activity+in+the+hippocampus&doi=10.1038%2Fnature14864"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">η-Secretase processing of APP inhibits neuronal activity in the hippocampus</span></div><div class="casAuthors">Willem, Michael; Tahirovic, Sabina; Busche, Marc Aurel; Ovsepian, Saak V.; Chafai, Magda; Kootar, Scherazad; Hornburg, Daniel; Evans, Lewis D. B.; Moore, Steven; Daria, Anna; Hampel, Heike; Mueller, Veronika; Giudici, Camilla; Nuscher, Brigitte; Wenninger-Weinzierl, Andrea; Kremmer, Elisabeth; Heneka, Michael T.; Thal, Dietmar R.; Giedraitis, Vilmantas; Lannfelt, Lars; Mueller, Ulrike; Livesey, Frederick J.; Meissner, Felix; Herms, Jochen; Konnerth, Arthur; Marie, Helene; Haass, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">526</span>
        (<span class="NLM_cas:issue">7573</span>),
    <span class="NLM_cas:pages">443-447</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Alzheimer disease (AD) is characterized by the accumulation of amyloid plaques, which are predominantly composed of amyloid-β peptide.  Two principal physiol. pathways either prevent or promote amyloid-β generation from its precursor, β-amyloid precursor protein (APP), in a competitive manner.  Although APP processing has been studied in great detail, unknown proteolytic events seem to hinder stoichiometric analyses of APP metab. in vivo.  Here we describe a new physiol. APP processing pathway, which generates proteolytic fragments capable of inhibiting neuronal activity within the hippocampus.  We identify higher mol. mass carboxy-terminal fragments (CTFs) of APP, termed CTF-η, in addn. to the long-known CTF-α and CTF-β fragments generated by the α- and β-secretases ADAM10 (a disintegrin and metalloproteinase 10) and BACE1 (β-site APP cleaving enzyme 1), resp.  CTF-η generation is mediated in part by membrane-bound matrix metalloproteinases such as MT5-MMP, referred to as η-secretase activity.  η-Secretase cleavage occurs primarily at amino acids 504-505 of APP695, releasing a truncated ectodomain.  After shedding of this ectodomain, CTF-η is further processed by ADAM10 and BACE1 to release long and short Aη peptides (termed Aη-α and Aη-β).  CTFs produced by η-secretase are enriched in dystrophic neurites in an AD mouse model and in human AD brains.  Genetic and pharmacol. inhibition of BACE1 activity results in robust accumulation of CTF-η and Aη-α.  In mice treated with a potent BACE1 inhibitor, hippocampal long-term potentiation was reduced.  Notably, when recombinant or synthetic Aη-α was applied on hippocampal slices ex vivo, long-term potentiation was lowered.  Furthermore, in vivo single-cell two-photon calcium imaging showed that hippocampal neuronal activity was attenuated by Aη-α.  These findings not only demonstrate a major functionally relevant APP processing pathway, but may also indicate potential translational relevance for therapeutic strategies targeting APP processing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_5ub5j4eaRbVg90H21EOLACvtfcHk0li3H1wa2ZJFNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVCis7%252FN&md5=e56ae17f893de088e80fe973d4885930</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnature14864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature14864%26sid%3Dliteratum%253Aachs%26aulast%3DWillem%26aufirst%3DM.%26aulast%3DTahirovic%26aufirst%3DS.%26aulast%3DBusche%26aufirst%3DM.%2BA.%26aulast%3DOvsepian%26aufirst%3DS.%2BV.%26aulast%3DChafai%26aufirst%3DM.%26aulast%3DKootar%26aufirst%3DS.%26aulast%3DHornburg%26aufirst%3DD.%26aulast%3DEvans%26aufirst%3DL.%2BD.%2BB.%26aulast%3DMoore%26aufirst%3DS.%26aulast%3DDaria%26aufirst%3DA.%26aulast%3DHampel%26aufirst%3DH.%26aulast%3DM%25C3%25BCller%26aufirst%3DV.%26aulast%3DGiudici%26aufirst%3DC.%26aulast%3DNuscher%26aufirst%3DB.%26aulast%3DWenninger-Weinzierl%26aufirst%3DA.%26aulast%3DKremmer%26aufirst%3DE.%26aulast%3DHeneka%26aufirst%3DM.%2BT.%26aulast%3DThal%26aufirst%3DD.%2BR.%26aulast%3DGiedraitis%26aufirst%3DV.%26aulast%3DLannfelt%26aufirst%3DL.%26aulast%3DM%25C3%25BCller%26aufirst%3DU.%26aulast%3DLivesey%26aufirst%3DF.%2BJ.%26aulast%3DMeissner%26aufirst%3DF.%26aulast%3DHerms%26aufirst%3DJ.%26aulast%3DKonnerth%26aufirst%3DA.%26aulast%3DMarie%26aufirst%3DH.%26aulast%3DHaass%26aufirst%3DC.%26atitle%3D%25CE%25B7-Secretase%2520processing%2520of%2520APP%2520inhibits%2520neuronal%2520activity%2520in%2520the%2520hippocampus%26jtitle%3DNature%26date%3D2015%26volume%3D526%26spage%3D443%26epage%3D447%26doi%3D10.1038%2Fnature14864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duong, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seyfried, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levey, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, K.</span></span> <span> </span><span class="NLM_article-title">δ-Secretase cleaves amyloid precursor protein and regulates the pathogenesis in Alzheimer’s disease</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">8762</span>– <span class="NLM_lpage">8778</span>, <span class="refDoi"> DOI: 10.1038/ncomms9762</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=10.1038%2Fncomms9762" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=26549211" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsl2gs73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=8762-8778&author=Z.+Zhangauthor=M.+Songauthor=X.+Liuauthor=S.+S.+Kangauthor=D.+M.+Duongauthor=N.+T.+Seyfriedauthor=X.+Caoauthor=L.+Chengauthor=Y.+E.+Sunauthor=S.+P.+Yuauthor=J.+Jiaauthor=A.+I.+Leveyauthor=K.+Ye&title=%CE%B4-Secretase+cleaves+amyloid+precursor+protein+and+regulates+the+pathogenesis+in+Alzheimer%E2%80%99s+disease&doi=10.1038%2Fncomms9762"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Delta-secretase cleaves amyloid precursor protein and regulates the pathogenesis in Alzheimer's disease</span></div><div class="casAuthors">Zhang, Zhentao; Song, Mingke; Liu, Xia; Su Kang, Seong; Duong, Duc M.; Seyfried, Nicholas T.; Cao, Xuebing; Cheng, Liming; Sun, Yi E.; Ping Yu, Shan; Jia, Jianping; Levey, Allan I.; Ye, Keqiang</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">8762</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The age-dependent deposition of amyloid-β peptides, derived from amyloid precursor protein (APP), is a neuropathol. hallmark of Alzheimer's disease (AD).  Despite age being the greatest risk factor for AD, the mol. mechanisms linking ageing to APP processing are unknown.  Here we show that asparagine endopeptidase (AEP), a pH-controlled cysteine proteinase, is activated during ageing and mediates APP proteolytic processing.  AEP cleaves APP at N373 and N585 residues, selectively influencing the amyloidogenic fragmentation of APP.  AEP is activated in normal mice in an age-dependent manner, and is strongly activated in 5XFAD transgenic mouse model and human AD brains.  Deletion of AEP from 5XFAD or APP/PS1 mice decreases senile plaque formation, ameliorates synapse loss, elevates long-term potentiation and protects memory.  Blockade of APP cleavage by AEP in mice alleviates pathol. and behavioral deficits.  Thus, AEP acts as a δ-secretase, contributing to the age-dependent pathogenic mechanisms in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7XX7eyTKfE7Vg90H21EOLACvtfcHk0lijoh4d3czEOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsl2gs73L&md5=a107a6df97c929208a490ac590f7c0c8</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fncomms9762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms9762%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DSong%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DKang%26aufirst%3DS.%2BS.%26aulast%3DDuong%26aufirst%3DD.%2BM.%26aulast%3DSeyfried%26aufirst%3DN.%2BT.%26aulast%3DCao%26aufirst%3DX.%26aulast%3DCheng%26aufirst%3DL.%26aulast%3DSun%26aufirst%3DY.%2BE.%26aulast%3DYu%26aufirst%3DS.%2BP.%26aulast%3DJia%26aufirst%3DJ.%26aulast%3DLevey%26aufirst%3DA.%2BI.%26aulast%3DYe%26aufirst%3DK.%26atitle%3D%25CE%25B4-Secretase%2520cleaves%2520amyloid%2520precursor%2520protein%2520and%2520regulates%2520the%2520pathogenesis%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNat.%2520Commun.%26date%3D2015%26volume%3D6%26spage%3D8762%26epage%3D8778%26doi%3D10.1038%2Fncomms9762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mullan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawford, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houlden, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Axelman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lilius, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winblad, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lannfelt, L.</span></span> <span> </span><span class="NLM_article-title">A pathogenic mutation for probable Alzheimer’s disease in the APP gene at the N-terminus of β-amyloid</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">345</span>– <span class="NLM_lpage">347</span>, <span class="refDoi"> DOI: 10.1038/ng0892-345</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=10.1038%2Fng0892-345" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=1302033" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=1%3ACAS%3A528%3ADyaK38XlsVyms7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1992&pages=345-347&author=M.+Mullanauthor=F.+Crawfordauthor=H.+Houldenauthor=K.+Axelmanauthor=L.+Liliusauthor=B.+Winbladauthor=L.+Lannfelt&title=A+pathogenic+mutation+for+probable+Alzheimer%E2%80%99s+disease+in+the+APP+gene+at+the+N-terminus+of+%CE%B2-amyloid&doi=10.1038%2Fng0892-345"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of β-amyloid</span></div><div class="casAuthors">Mullan, Mike; Crawford, Fiona; Axelman, Karin; Houlden, Henry; Lilius, Lena; Winblad, Bengt; Lannfelt, Lars</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">345-7</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    </div><div class="casAbstract">Mutations at codon 717 in exon 17 of the β-amyloid precursor protein (APP) gene have previously been shown to segregate with early onset Alzheimer's disease in some families.  The authors have identified a double mutation at codons 670 and 671 (APP 70 transcript) in exon 16 which co-segregates with the disease in two large (probably related) early-onset Alzheimer's disease families from Sweden.  Two base pair transversions (G to T, A to C) from the normal sequence predict Lys to Asn and Met to Leu amino acid substitutions at codons 670 and 671 of the APP transcript.  This mutation occurs at the amino terminal of β-amyloid and may be pathogenic because it occurs at or close to the endosomal/lysosomal cleavage site of the mol.  Thus, pathogenic mutations in APP frame the β-amyloid sequence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgOJnPYRyWy7Vg90H21EOLACvtfcHk0lijoh4d3czEOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XlsVyms7o%253D&md5=bb47f91ebc60786b1ef9b9c2461c71e5</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fng0892-345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng0892-345%26sid%3Dliteratum%253Aachs%26aulast%3DMullan%26aufirst%3DM.%26aulast%3DCrawford%26aufirst%3DF.%26aulast%3DHoulden%26aufirst%3DH.%26aulast%3DAxelman%26aufirst%3DK.%26aulast%3DLilius%26aufirst%3DL.%26aulast%3DWinblad%26aufirst%3DB.%26aulast%3DLannfelt%26aufirst%3DL.%26atitle%3DA%2520pathogenic%2520mutation%2520for%2520probable%2520Alzheimer%25E2%2580%2599s%2520disease%2520in%2520the%2520APP%2520gene%2520at%2520the%2520N-terminus%2520of%2520%25CE%25B2-amyloid%26jtitle%3DNat.%2520Genet.%26date%3D1992%26volume%3D1%26spage%3D345%26epage%3D347%26doi%3D10.1038%2Fng0892-345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di
Fede, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catania, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morbin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suardi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzoleni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merlin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giovagnoli, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prioni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erbetta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falcone, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobbi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colombo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bastone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beeg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manzoni, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francescucci, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spagnoli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Favero, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levy, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salmona, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tagliavini, F.</span></span> <span> </span><span class="NLM_article-title">A recessive mutation in the APP gene with dominant-negative effect on amyloidogenesis</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>323</i></span>,  <span class="NLM_fpage">1473</span>– <span class="NLM_lpage">1477</span>, <span class="refDoi"> DOI: 10.1126/science.1168979</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=10.1126%2Fscience.1168979" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=19286555" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=1%3ACAS%3A528%3ADC%252BD1MXivFSmu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=323&publication_year=2009&pages=1473-1477&author=G.+Di%0AFedeauthor=M.+Cataniaauthor=M.+Morbinauthor=G.+Rossiauthor=S.+Suardiauthor=G.+Mazzoleniauthor=M.+Merlinauthor=A.+R.+Giovagnoliauthor=S.+Prioniauthor=A.+Erbettaauthor=C.+Falconeauthor=M.+Gobbiauthor=L.+Colomboauthor=A.+Bastoneauthor=M.+Beegauthor=C.+Manzoniauthor=B.+Francescucciauthor=A.+Spagnoliauthor=L.+Cantuauthor=E.+Del+Faveroauthor=E.+Levyauthor=M.+Salmonaauthor=F.+Tagliavini&title=A+recessive+mutation+in+the+APP+gene+with+dominant-negative+effect+on+amyloidogenesis&doi=10.1126%2Fscience.1168979"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">A Recessive mutation in the APP gene with dominant-negative effect on amyloidogenesis</span></div><div class="casAuthors">Di Fede, Giuseppe; Catania, Marcella; Morbin, Michela; Rossi, Giacomina; Suardi, Silvia; Mazzoleni, Giulia; Merlin, Marco; Giovagnoli, Anna Rita; Prioni, Sara; Erbetta, Alessandra; Falcone, Chiara; Gobbi, Marco; Colombo, Laura; Bastone, Antonio; Beeg, Marten; Manzoni, Claudia; Francescucci, Bruna; Spagnoli, Alberto; Cantu, Laura; Del Favero, Elena; Levy, Efrat; Salmona, Mario; Tagliavini, Fabrizio</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">323</span>
        (<span class="NLM_cas:issue">5920</span>),
    <span class="NLM_cas:pages">1473-1477</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">β-Amyloid precursor protein (APP) mutations cause familial Alzheimer's disease with nearly complete penetrance.  We found an APP mutation [alanine-673→valine-673 (A673V)] that causes disease only in the homozygous state, whereas heterozygous carriers were unaffected, consistent with a recessive Mendelian trait of inheritance.  The A673V mutation affected APP processing, resulting in enhanced β-amyloid (Aβ) prodn. and formation of amyloid fibrils in vitro.  Co-incubation of mutated and wild-type peptides conferred instability on Aβ aggregates and inhibited amyloidogenesis and neurotoxicity.  The highly amyloidogenic effect of the A673V mutation in the homozygous state and its anti-amyloidogenic effect in the heterozygous state account for the autosomal recessive pattern of inheritance and have implications for genetic screening and the potential treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqL79MU6KuccrVg90H21EOLACvtfcHk0ljPOfv7SlSPqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXivFSmu7k%253D&md5=c89b5231df3078387c1c0356210ac2fa</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1126%2Fscience.1168979&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1168979%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BFede%26aufirst%3DG.%26aulast%3DCatania%26aufirst%3DM.%26aulast%3DMorbin%26aufirst%3DM.%26aulast%3DRossi%26aufirst%3DG.%26aulast%3DSuardi%26aufirst%3DS.%26aulast%3DMazzoleni%26aufirst%3DG.%26aulast%3DMerlin%26aufirst%3DM.%26aulast%3DGiovagnoli%26aufirst%3DA.%2BR.%26aulast%3DPrioni%26aufirst%3DS.%26aulast%3DErbetta%26aufirst%3DA.%26aulast%3DFalcone%26aufirst%3DC.%26aulast%3DGobbi%26aufirst%3DM.%26aulast%3DColombo%26aufirst%3DL.%26aulast%3DBastone%26aufirst%3DA.%26aulast%3DBeeg%26aufirst%3DM.%26aulast%3DManzoni%26aufirst%3DC.%26aulast%3DFrancescucci%26aufirst%3DB.%26aulast%3DSpagnoli%26aufirst%3DA.%26aulast%3DCantu%26aufirst%3DL.%26aulast%3DDel%2BFavero%26aufirst%3DE.%26aulast%3DLevy%26aufirst%3DE.%26aulast%3DSalmona%26aufirst%3DM.%26aulast%3DTagliavini%26aufirst%3DF.%26atitle%3DA%2520recessive%2520mutation%2520in%2520the%2520APP%2520gene%2520with%2520dominant-negative%2520effect%2520on%2520amyloidogenesis%26jtitle%3DScience%26date%3D2009%26volume%3D323%26spage%3D1473%26epage%3D1477%26doi%3D10.1126%2Fscience.1168979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jonsson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atwal, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinberg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snaedal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonsson, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjornsson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefansson, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sulem, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gudbjartsson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maloney, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoyte, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhangale, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huttenlocher, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjornsdottir, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreassen, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonsson, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palotie, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behrens, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnusson, O. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorsteinsdottir, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watts, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefansson, K.</span></span> <span> </span><span class="NLM_article-title">A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>488</i></span>,  <span class="NLM_fpage">96</span>– <span class="NLM_lpage">99</span>, <span class="refDoi"> DOI: 10.1038/nature11283</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=10.1038%2Fnature11283" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=22801501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFWmt73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=488&publication_year=2012&pages=96-99&author=T.+Jonssonauthor=J.+K.+Atwalauthor=S.+Steinbergauthor=J.+Snaedalauthor=P.+V.+Jonssonauthor=S.+Bjornssonauthor=H.+Stefanssonauthor=P.+Sulemauthor=D.+Gudbjartssonauthor=J.+Maloneyauthor=K.+Hoyteauthor=A.+Gustafsonauthor=Y.+Liuauthor=Y.+Luauthor=T.+Bhangaleauthor=R.+R.+Grahamauthor=J.+Huttenlocherauthor=G.+Bjornsdottirauthor=O.+A.+Andreassenauthor=E.+G.+Jonssonauthor=A.+Palotieauthor=T.+W.+Behrensauthor=O.+T.+Magnussonauthor=A.+Kongauthor=U.+Thorsteinsdottirauthor=R.+J.+Wattsauthor=K.+Stefansson&title=A+mutation+in+APP+protects+against+Alzheimer%E2%80%99s+disease+and+age-related+cognitive+decline&doi=10.1038%2Fnature11283"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">A mutation in APP protects against Alzheimer's disease and age-related cognitive decline</span></div><div class="casAuthors">Jonsson, Thorlakur; Atwal, Jasvinder K.; Steinberg, Stacy; Snaedal, Jon; Jonsson, Palmi V.; Bjornsson, Sigurbjorn; Stefansson, Hreinn; Sulem, Patrick; Gudbjartsson, Daniel; Maloney, Janice; Hoyte, Kwame; Gustafson, Amy; Liu, Yichin; Lu, Yanmei; Bhangale, Tushar; Graham, Robert R.; Huttenlocher, Johanna; Bjornsdottir, Gyda; Andreassen, Ole A.; Joensson, Erik G.; Palotie, Aarno; Behrens, Timothy W.; Magnusson, Olafur T.; Kong, Augustine; Thorsteinsdottir, Unnur; Watts, Ryan J.; Stefansson, Kari</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">488</span>
        (<span class="NLM_cas:issue">7409</span>),
    <span class="NLM_cas:pages">96-99</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The prevalence of dementia in the Western world in people over the age of 60 has been estd. to be greater than 5%, about two-thirds of which are due to Alzheimer's disease.  The age-specific prevalence of Alzheimer's disease nearly doubles every 5 years after age 65, leading to a prevalence of greater than 25% in those over the age of 90 (ref. 3).  Here, to search for low-frequency variants in the amyloid-β precursor protein (APP) gene with a significant effect on the risk of Alzheimer's disease, we studied coding variants in APP in a set of whole-genome sequence data from 1795 Icelanders.  We found a coding mutation (A673T) in the APP gene that protects against Alzheimer's disease and cognitive decline in the elderly without Alzheimer's disease.  This substitution is adjacent to the aspartyl protease β-site in APP, and results in an approx. 40% redn. in the formation of amyloidogenic peptides in vitro.  The strong protective effect of the A673T substitution against Alzheimer's disease provides proof of principle for the hypothesis that reducing the β-cleavage of APP may protect against the disease.  Furthermore, as the A673T allele also protects against cognitive decline in the elderly without Alzheimer's disease, the two may be mediated through the same or similar mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4AFwQCLRQOLVg90H21EOLACvtfcHk0ljPOfv7SlSPqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFWmt73M&md5=4db9cb2e3842d5a9d4af4ce102249b70</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnature11283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11283%26sid%3Dliteratum%253Aachs%26aulast%3DJonsson%26aufirst%3DT.%26aulast%3DAtwal%26aufirst%3DJ.%2BK.%26aulast%3DSteinberg%26aufirst%3DS.%26aulast%3DSnaedal%26aufirst%3DJ.%26aulast%3DJonsson%26aufirst%3DP.%2BV.%26aulast%3DBjornsson%26aufirst%3DS.%26aulast%3DStefansson%26aufirst%3DH.%26aulast%3DSulem%26aufirst%3DP.%26aulast%3DGudbjartsson%26aufirst%3DD.%26aulast%3DMaloney%26aufirst%3DJ.%26aulast%3DHoyte%26aufirst%3DK.%26aulast%3DGustafson%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DBhangale%26aufirst%3DT.%26aulast%3DGraham%26aufirst%3DR.%2BR.%26aulast%3DHuttenlocher%26aufirst%3DJ.%26aulast%3DBjornsdottir%26aufirst%3DG.%26aulast%3DAndreassen%26aufirst%3DO.%2BA.%26aulast%3DJonsson%26aufirst%3DE.%2BG.%26aulast%3DPalotie%26aufirst%3DA.%26aulast%3DBehrens%26aufirst%3DT.%2BW.%26aulast%3DMagnusson%26aufirst%3DO.%2BT.%26aulast%3DKong%26aufirst%3DA.%26aulast%3DThorsteinsdottir%26aufirst%3DU.%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26aulast%3DStefansson%26aufirst%3DK.%26atitle%3DA%2520mutation%2520in%2520APP%2520protects%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520age-related%2520cognitive%2520decline%26jtitle%3DNature%26date%3D2012%26volume%3D488%26spage%3D96%26epage%3D99%26doi%3D10.1038%2Fnature11283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Öhlrich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prokopcova, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H. J. M.</span></span> <span> </span><span class="NLM_article-title">The evolution of amidine-based brain penetrant BACE1 inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">2033</span>– <span class="NLM_lpage">2045</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.03.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=10.1016%2Fj.bmcl.2014.03.025" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=2033-2045&author=D.+%C3%96hlrichauthor=H.+Prokopcovaauthor=H.+J.+M.+Gijsen&title=The+evolution+of+amidine-based+brain+penetrant+BACE1+inhibitors&doi=10.1016%2Fj.bmcl.2014.03.025"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.03.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.03.025%26sid%3Dliteratum%253Aachs%26aulast%3D%25C3%2596hlrich%26aufirst%3DD.%26aulast%3DProkopcova%26aufirst%3DH.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26atitle%3DThe%2520evolution%2520of%2520amidine-based%2520brain%2520penetrant%2520BACE1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D2033%26epage%3D2045%26doi%3D10.1016%2Fj.bmcl.2014.03.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cebers, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Budd Haeberlein, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldwater, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ereshefsky, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maltby, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eketjäll, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kugler, A. R.</span></span> <span> </span><span class="NLM_article-title">AZD3293: pharmacokinetic and pharmacodynamic effects in healthy subjects and patients with Alzheimer’s disease</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">1039</span>– <span class="NLM_lpage">1053</span>, <span class="refDoi"> DOI: 10.3233/JAD-160701</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=10.3233%2FJAD-160701" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=27767991" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVyrt7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2017&pages=1039-1053&author=G.+Cebersauthor=R.+C.+Alexanderauthor=S.+Budd+Haeberleinauthor=D.+Hanauthor=R.+Goldwaterauthor=L.+Ereshefskyauthor=T.+Olssonauthor=N.+Yeauthor=L.+Rosenauthor=M.+Russellauthor=J.+Maltbyauthor=S.+Eketj%C3%A4llauthor=A.+R.+Kugler&title=AZD3293%3A+pharmacokinetic+and+pharmacodynamic+effects+in+healthy+subjects+and+patients+with+Alzheimer%E2%80%99s+disease&doi=10.3233%2FJAD-160701"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">AZD3293: Pharmacokinetic and Pharmacodynamic Effects in Healthy Subjects and Patients with Alzheimer's Disease</span></div><div class="casAuthors">Cebers, Gvido; Alexander, Robert C.; Haeberlein, Samantha Budd; Han, David; Goldwater, Ronald; Ereshefsky, Larry; Olsson, Tina; Ye, Naidong; Rosen, Laura; Russell, Muir; Maltby, Justine; Eketjaell, Susanna; Kugler, Alan R.; Murphy, M. Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1039-1053</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">AZD3293 (LY3314814) is a promising new potentially disease-modifying BACE1 (β-secretase) inhibitor in Phase III clin. development for the treatment of Alzheimer's disease.  Reported here are the first two Phase I studies: (1) a single ascending dose study evaluating doses of 1-750mg with a food-effect component (n=72), and (2) a 2-wk multiple ascending dose study evaluating doses of 15 or 50mg once daily (QD) or 70mg once weekly (QW) in elderly subjects (Part 1, n=31), and 15, 50, or 150mg QD in patients with mild to moderate Alzheimer's disease (Part 2, n=16).  AZD3293 was generally well tolerated up to the highest doses given.  No notable food effects were obsd.  PK following multiple doses (Part 2) were tmax of 1 to 3h and mean t1/2 of 16 to 21h across the 15 to 150mg dose range.  For single doses of ≥5mg, a ≥70% redn. was obsd. in mean plasma Aβ40 and Aβ42 concns., with prolonged suppression for up to 3 wk at the highest dose level studied.  Following multiple doses, robust redns. in plasma (≥64% at 15mg and ≥78% at ≥50mg) and cerebrospinal fluid (≥51% at 15mg and ≥76% at ≥50mg) Aβ peptides were seen, including prolonged suppression even with a QW dosing regimen.  AZD3293 is the only BACE1 inhibitor for which prolonged suppression of plasma Aβ with a QW dosing schedule has been reported.  Two Phase III studies of AZD3293 (AMARANTH, NCT02245737; and DAYBREAK-ALZ, NCT02783573) are now ongoing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHGDodXrxjXLVg90H21EOLACvtfcHk0ljPOfv7SlSPqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVyrt7%252FK&md5=2b190c11cc8d905c734982ecec4a1e10</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.3233%2FJAD-160701&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-160701%26sid%3Dliteratum%253Aachs%26aulast%3DCebers%26aufirst%3DG.%26aulast%3DAlexander%26aufirst%3DR.%2BC.%26aulast%3DBudd%2BHaeberlein%26aufirst%3DS.%26aulast%3DHan%26aufirst%3DD.%26aulast%3DGoldwater%26aufirst%3DR.%26aulast%3DEreshefsky%26aufirst%3DL.%26aulast%3DOlsson%26aufirst%3DT.%26aulast%3DYe%26aufirst%3DN.%26aulast%3DRosen%26aufirst%3DL.%26aulast%3DRussell%26aufirst%3DM.%26aulast%3DMaltby%26aufirst%3DJ.%26aulast%3DEketj%25C3%25A4ll%26aufirst%3DS.%26aulast%3DKugler%26aufirst%3DA.%2BR.%26atitle%3DAZD3293%253A%2520pharmacokinetic%2520and%2520pharmacodynamic%2520effects%2520in%2520healthy%2520subjects%2520and%2520patients%2520with%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2017%26volume%3D55%26spage%3D1039%26epage%3D1053%26doi%3D10.3233%2FJAD-160701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, R.</span></span> <span> </span><span class="NLM_article-title">Physiological functions of the β-Site amyloid precursor protein cleaving enzyme 1 and 2</span>.  <i>Front. Mol. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume">10</span>. DOI: <span class="refDoi"> DOI: 10.3389/fnmol.2017.00097</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=10.3389%2Ffnmol.2017.00097" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2017&author=R.+Yan&title=Physiological+functions+of+the+%CE%B2-Site+amyloid+precursor+protein+cleaving+enzyme+1+and+2&doi=10.3389%2Ffnmol.2017.00097"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.3389%2Ffnmol.2017.00097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnmol.2017.00097%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DR.%26atitle%3DPhysiological%2520functions%2520of%2520the%2520%25CE%25B2-Site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520and%25202%26jtitle%3DFront.%2520Mol.%2520Neurosci.%26date%3D2017%26volume%3D10%26doi%3D10.3389%2Ffnmol.2017.00097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rochin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurbain, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serneels, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fort, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watt, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leblanc, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marks, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeStrooper, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raposo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Niel, G.</span></span> <span> </span><span class="NLM_article-title">BACE2 processes PMEL to form the melanosome amyloid matrix in pigment cells</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">10658</span>– <span class="NLM_lpage">10663</span>, <span class="refDoi"> DOI: 10.1073/pnas.1220748110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=10.1073%2Fpnas.1220748110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=23754390" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFejs7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=10658-10663&author=L.+Rochinauthor=I.+Hurbainauthor=L.+Serneelsauthor=C.+Fortauthor=B.+Wattauthor=P.+Leblancauthor=M.+S.+Marksauthor=B.+DeStrooperauthor=G.+Raposoauthor=G.+van+Niel&title=BACE2+processes+PMEL+to+form+the+melanosome+amyloid+matrix+in+pigment+cells&doi=10.1073%2Fpnas.1220748110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">BACE2 processes PMEL to form the melanosome amyloid matrix in pigment cells</span></div><div class="casAuthors">Rochin, Leila; Hurbain, Ilse; Serneels, Lutgarde; Fort, Cecile; Watt, Brenda; Leblanc, Pascal; Marks, Michael S.; De Strooper, Bart; Raposo, Graca; van Niel, Guillaume</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">10658-10663,S10658/1-S10658/7</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Amyloids are often assocd. with pathol. processes such as in Alzheimer's disease (AD), but can also underlie physiol. processes such as pigmentation.  Formation of pathol. and functional amyloidogenic substrates can require precursor processing by proteases, as exemplified by the generation of Aβ peptide from amyloid precursor protein (APP) by beta-site APP cleaving enzyme (BACE)1 and γ-secretase.  Proteolytic processing of the pigment cell-specific Melanocyte Protein (PMEL) is also required to form functional amyloid fibrils during melanogenesis, but the enzymes involved are incompletely characterized.  Here we show that the BACE1 homolog BACE2 processes PMEL to generate functional amyloids.  BACE2 is highly expressed in pigment cells and Bace2-/- but not Bace1-/- mice display coat color defects, implying a specific role for BACE2 during melanogenesis.  By using biochem. and morphol. analyses, combined with RNA silencing, pharmacol. inhibition, and BACE2 overexpression in a human melanocytic cell line, we show that BACE2 cleaves the integral membrane form of PMEL within the juxtamembrane domain, releasing the PMEL luminal domain into endosomal precursors for the formation of amyloid fibrils and downstream melanosome morphogenesis.  These studies identify an amyloidogenic substrate of BACE2, reveal an important physiol. role for BACE2 in pigmentation, and highlight analogies in the generation of PMEL-derived functional amyloids and APP-derived pathol. amyloids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLBEney5KFyLVg90H21EOLACvtfcHk0liFvCntgslSWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFejs7rK&md5=3deb3f80dca6a32748aa6fe2e50c2df1</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1220748110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1220748110%26sid%3Dliteratum%253Aachs%26aulast%3DRochin%26aufirst%3DL.%26aulast%3DHurbain%26aufirst%3DI.%26aulast%3DSerneels%26aufirst%3DL.%26aulast%3DFort%26aufirst%3DC.%26aulast%3DWatt%26aufirst%3DB.%26aulast%3DLeblanc%26aufirst%3DP.%26aulast%3DMarks%26aufirst%3DM.%2BS.%26aulast%3DDeStrooper%26aufirst%3DB.%26aulast%3DRaposo%26aufirst%3DG.%26aulast%3Dvan%2BNiel%26aufirst%3DG.%26atitle%3DBACE2%2520processes%2520PMEL%2520to%2520form%2520the%2520melanosome%2520amyloid%2520matrix%2520in%2520pigment%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D10658%26epage%3D10663%26doi%3D10.1073%2Fpnas.1220748110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cebers, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lejeune, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attalla, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soderberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Budd Haeberlein, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kugler, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingersoll, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Platz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, C. W.</span></span> <span> </span><span class="NLM_article-title">Reversible and species-specific depigmentation effects of AZD3293, a BACE inhibitor for the treatment of Alzheimer’s disease, are related to BACE2 inhibition and confined to epidermis and hair</span>. <i>J. Prev. Alzheimer’s Dis.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">202</span>– <span class="NLM_lpage">218</span>, <span class="refDoi"> DOI: 10.14283/jpad.2016.119</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=10.14283%2Fjpad.2016.119" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=29199322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=1%3ACAS%3A280%3ADC%252BC1M3ntlKisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2016&pages=202-218&author=G.+Cebersauthor=T.+Lejeuneauthor=B.+Attallaauthor=M.+Soderbergauthor=R.+C.+Alexanderauthor=S.+Budd+Haeberleinauthor=A.+R.+Kuglerauthor=E.+W.+Ingersollauthor=S.+Platzauthor=C.+W.+Scott&title=Reversible+and+species-specific+depigmentation+effects+of+AZD3293%2C+a+BACE+inhibitor+for+the+treatment+of+Alzheimer%E2%80%99s+disease%2C+are+related+to+BACE2+inhibition+and+confined+to+epidermis+and+hair&doi=10.14283%2Fjpad.2016.119"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Reversible and Species-Specific Depigmentation Effects of AZD3293, a BACE Inhibitor for the Treatment of Alzheimer's Disease, Are Related to BACE2 Inhibition and Confined to Epidermis and Hair</span></div><div class="casAuthors">Cebers G; Lejeune T; Attalla B; Soderberg M; Alexander R C; Budd Haeberlein S; Kugler A R; Ingersoll E W; Platz S; Scott C W</div><div class="citationInfo"><span class="NLM_cas:title">The journal of prevention of Alzheimer's disease</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">202-218</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  AZD3293 (also known as LY3314814) is a novel, potent, non-selective BACE1/BACE2 inhibitor currently in Phase 3 clinical development for the treatment of Alzheimer's disease.  OBJECTIVES:  The purpose of these studies was to characterize the effects, putative mechanism, and reversibility of hypopigmentation following treatment with AZD3293 in pigmented Long-Evans rats, Beagle dogs, human cell cultures, and humans.  DESIGN:  Nonclinical studies were conducted in Long-Evans pigmented rats, and both young and older Beagle dogs using a variety of oral dose levels of AZD3293 or AZD3839 (BACE inhibition reference compound; used in older dogs only) for dosing durations of 13 to 26 weeks.  In vitro studies of normal human epidermal melanocytes and reconstituted human epidermis were also conducted.  Skin biopsy data from a multiple-dose Phase 1 clinical study of AZD3293 (NCT01795339) are also reported.  SETTING:  Nonclinical in vivo and in vitro studies were conducted in laboratory settings in the US, Canada, and France; the multiple dose clinical study was conducted in a specialized inpatient setting in the US.  PARTICIPANTS:  Beagle dogs: 13-week study N=36 young (8-10 mo) animals; 39-week study N=64 young animals; and a second 13-week study N=32 older (30-32 mo) animals.  Long-Evans rats: N=68 animals.  Multiple-dose clinical study: only data for subjects enrolled in Part 2 of this study are included in this report (N=16).  INTERVENTIONS:  AZD3293 was the primary intervention used in these studies.  AZD3839, a relatively BACE1-selective reference inhibitor compound was used in one group in the 13 week study in older Beagle dogs and one in vitro assessment.  Finally, AZ1340, another relatively BACE1-selective reference inhibitor compound was used only in one in vitro assessment.  MEASUREMENTS:  Measurements for the nonclinical studies in dogs and rats included macroscopic observation and assessment of skin biopsies via histopathology, immunochemistry, and electron microscopy.  Measurements for the in vitro studies included melanocyte premelanosome protein (PMEL) processing, cytotoxicity, melanin synthesis, Pmel17 labeling, and melanocyte dendricity.  Measurements in the clinical study included scoring of melanin content in skin biopsies taken before and after dosing with AZD3293 over 14 days at dose levels up to 150 mg.  RESULTS:  Depigmentation in rats and dogs was limited to skin, hair, and mucosa with no effects on other pigmented tissues.  At a cellular level depigmentation was observed within a week of treatment, whereas the appearance of depigmentation in skin and hair did not become apparent until, at earliest, 4 weeks of treatment.  The depigmentation effects were reversible, not associated with degenerative or inflammatory changes, and were dose- and species-dependent in severity.  Full recovery of melanization was observed at the microscopic (cellular) level and at least partial recovery was seen in the macroscopic appearance of animals by the end of the 12-week recovery period in both rats and dogs.  Interestingly, no changes in melanin production or melanocyte morphology were seen in human primary melanocytes or reconstituted human epidermis in vitro.  Finally, there were no changes in melanization level in skin biopsies following 12 days of daily AZD3293 treatment at doses of AZD3293 up to 150 mg/day in human subjects.  CONCLUSIONS:  AZD3293, a novel, potent, non-selective BACE1/BACE2 inhibitor is in development as a potentially disease-modifying treatment for Alzheimer's disease.  Chronic nonclinical studies in Beagle dogs and pigmented rats showed macroscopic and microscopic hypopigmentation effects of AZD3293 that were limited to skin, hair, and mucosa.  These effects were shown to be reversible in both species.  Analysis of data from nonclinical and in vitro studies suggests that hypopigmentation is caused by BACE2 inhibition resulting in accumulation of a premelanosome protein fragment, which interrupts the normal production of melanin.  No macroscopic or microscopic reports of hypopigmentation were observed in a Phase 1 clinical study following 13 doses of AZD3293 over 14 days at dose levels up to 150 mg/day.  These data suggest that hypopigmentation is species-specific and humans appear to be least sensitive to the depigmentation effect caused by BACE2 inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSnMZvqjWSFT7t7lRqEFUJVfW6udTcc2eYS6-dT05GxUbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M3ntlKisw%253D%253D&md5=8eaa57d7d8e3bb8bfad9244ffb5ae16a</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.14283%2Fjpad.2016.119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.14283%252Fjpad.2016.119%26sid%3Dliteratum%253Aachs%26aulast%3DCebers%26aufirst%3DG.%26aulast%3DLejeune%26aufirst%3DT.%26aulast%3DAttalla%26aufirst%3DB.%26aulast%3DSoderberg%26aufirst%3DM.%26aulast%3DAlexander%26aufirst%3DR.%2BC.%26aulast%3DBudd%2BHaeberlein%26aufirst%3DS.%26aulast%3DKugler%26aufirst%3DA.%2BR.%26aulast%3DIngersoll%26aufirst%3DE.%2BW.%26aulast%3DPlatz%26aufirst%3DS.%26aulast%3DScott%26aufirst%3DC.%2BW.%26atitle%3DReversible%2520and%2520species-specific%2520depigmentation%2520effects%2520of%2520AZD3293%252C%2520a%2520BACE%2520inhibitor%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%252C%2520are%2520related%2520to%2520BACE2%2520inhibition%2520and%2520confined%2520to%2520epidermis%2520and%2520hair%26jtitle%3DJ.%2520Prev.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2016%26volume%3D3%26spage%3D202%26epage%3D218%26doi%3D10.14283%2Fjpad.2016.119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shimshek, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolly, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamurovic, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balavenkatraman, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morawiec, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreutzer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schelle, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jucker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertschi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Theil, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bigot, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beltz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machauer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brzak, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrot, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, U.</span></span> <span> </span><span class="NLM_article-title">Pharmacological BACE1 and BACE2 inhibition induces hair depigmentation by inhibiting PMEL17 processing in mice</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">21917</span>, <span class="refDoi"> DOI: 10.1038/srep21917</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=10.1038%2Fsrep21917" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=26912421" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjt1eku7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=21917&author=D.+R.+Shimshekauthor=L.+H.+Jacobsonauthor=C.+Kollyauthor=N.+Zamurovicauthor=K.+K.+Balavenkatramanauthor=L.+Morawiecauthor=R.+Kreutzerauthor=J.+Schelleauthor=M.+Juckerauthor=B.+Bertschiauthor=D.+Theilauthor=A.+Heierauthor=K.+Bigotauthor=K.+Beltzauthor=R.+Machauerauthor=I.+Brzakauthor=L.+Perrotauthor=U.+Neumann&title=Pharmacological+BACE1+and+BACE2+inhibition+induces+hair+depigmentation+by+inhibiting+PMEL17+processing+in+mice&doi=10.1038%2Fsrep21917"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological BACE1 and BACE2 inhibition induces hair depigmentation by inhibiting PMEL17 processing in mice</span></div><div class="casAuthors">Shimshek, Derya R.; Jacobson, Laura H.; Kolly, Carine; Zamurovic, Natasa; Balavenkatraman, Kamal Kumar; Morawiec, Laurent; Kreutzer, Robert; Schelle, Juliane; Jucker, Mathias; Bertschi, Barbara; Theil, Diethilde; Heier, Annabelle; Bigot, Karine; Beltz, Karen; Machauer, Rainer; Brzak, Irena; Perrot, Ludovic; Neumann, Ulf</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">21917</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Melanocytes of the hair follicle produce melanin and are essential in detg. the differences in hair color.  Pigment cell-specific MELanocyte Protein (PMEL17) plays a crucial role in melanogenesis.  One of the crit. steps is the amyloid-like functional oligomerization of PMEL17.  Beta Site APP Cleaving Enzyme-2 (BACE2) and γ-secretase have been shown to be key players in generating the proteolytic fragments of PMEL17.  The β-secretase (BACE1) is responsible for the generation of amyloid-β (Aβ) fragments in the brain and is therefore proposed as a therapeutic target for Alzheimer's disease (AD).  Currently BACE1 inhibitors, most of which lack selectivity over BACE2, have demonstrated efficacious redn. of amyloid-β peptides in animals and the CSF of humans.  BACE2 knock-out mice have a deficiency in PMEL17 proteolytic processing leading to impaired melanin storage and hair depigmentation.  Here, we confirm BACE2-mediated inhibition of PMEL17 proteolytic processing in vitro in mouse and human melanocytes.  Furthermore, we show that wildtype as well as bace2+/- and bace2-/- mice treated with a potent dual BACE1/BACE2 inhibitor NB-360 display dose-dependent appearance of irreversibly depigmented hair.  Retinal pigmented epithelium showed no morphol. changes.  Our data demonstrates that BACE2 as well as addnl. BACE1 inhibition affects melanosome maturation and induces hair depigmentation in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtlQ-3Lxc4CLVg90H21EOLACvtfcHk0lgOHJUYAHsHHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjt1eku7Y%253D&md5=e3641d48cc7fcf08c4502b5899a49066</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fsrep21917&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep21917%26sid%3Dliteratum%253Aachs%26aulast%3DShimshek%26aufirst%3DD.%2BR.%26aulast%3DJacobson%26aufirst%3DL.%2BH.%26aulast%3DKolly%26aufirst%3DC.%26aulast%3DZamurovic%26aufirst%3DN.%26aulast%3DBalavenkatraman%26aufirst%3DK.%2BK.%26aulast%3DMorawiec%26aufirst%3DL.%26aulast%3DKreutzer%26aufirst%3DR.%26aulast%3DSchelle%26aufirst%3DJ.%26aulast%3DJucker%26aufirst%3DM.%26aulast%3DBertschi%26aufirst%3DB.%26aulast%3DTheil%26aufirst%3DD.%26aulast%3DHeier%26aufirst%3DA.%26aulast%3DBigot%26aufirst%3DK.%26aulast%3DBeltz%26aufirst%3DK.%26aulast%3DMachauer%26aufirst%3DR.%26aulast%3DBrzak%26aufirst%3DI.%26aulast%3DPerrot%26aufirst%3DL.%26aulast%3DNeumann%26aufirst%3DU.%26atitle%3DPharmacological%2520BACE1%2520and%2520BACE2%2520inhibition%2520induces%2520hair%2520depigmentation%2520by%2520inhibiting%2520PMEL17%2520processing%2520in%2520mice%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D21917%26doi%3D10.1038%2Fsrep21917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Van
Bebber, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hruscha, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willem, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haass, C.</span></span> <span> </span><span class="NLM_article-title">Loss of BACE2 in zebrafish affects melanocyte migration and is distinct from BACE1 knock out phenotypes</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">471</span>– <span class="NLM_lpage">481</span>, <span class="refDoi"> DOI: 10.1111/jnc.12198</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=10.1111%2Fjnc.12198" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=23406323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslWqs7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2013&pages=471-481&author=F.+Van%0ABebberauthor=A.+Hruschaauthor=M.+Willemauthor=B.+Schmidauthor=C.+Haass&title=Loss+of+BACE2+in+zebrafish+affects+melanocyte+migration+and+is+distinct+from+BACE1+knock+out+phenotypes&doi=10.1111%2Fjnc.12198"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Loss of Bace2 in zebrafish affects melanocyte migration and is distinct from Bace1 knock out phenotypes</span></div><div class="casAuthors">van Bebber, Frauke; Hruscha, Alexander; Willem, Michael; Schmid, Bettina; Haass, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">3&4</span>),
    <span class="NLM_cas:pages">471-481</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Alzheimer's disease is the most frequent dementia.  Pathol., Alzheimer's disease is characterized by the accumulation of senile plaques composed of amyloid β-peptide (Aβ).  Two proteases, β- and γ-secretase proteolytically generate Aβ from its precursor, the β-amyloid precursor protein (APP).  Inhibition of β-secretase, also referred to as beta-site APP cleaving enzyme (BACE1) or γ-secretase is therefore of prime interest for the development of amyloid-lowering drugs.  To assess the in vivo function of zebrafish Bace1 (zBace1), we generated zBace1 knock out fish by zinc finger nuclease-mediated genome editing.  Bace1 mutants (bace1-/-) are hypomyelinated in the PNS while the CNS is not affected.  Moreover, the no. of mechanosensory neuromasts is elevated in bace1-/-.  Mutations in zebrafish Bace2 (zBace2) revealed a distinct melanocyte migration phenotype, which is not obsd. in bace1-/-.  Double homozygous bace1-/-;bace2-/- fish do not enhance the single mutant phenotypes indicating non-redundant distinct physiol. functions.  Single homozygous bace1 mutants as well as double homozygous bace1 and bace2 mutants are viable and fertile suggesting that Bace1 is a promising drug target without major side effects.  The identification of a specific bace2 -/- assocd. phenotype further allows improving selective Bace1 inhibitors and to distinguish between Bace 1 and Bace 2 inhibition in vivo.  Inhibition of BACE1 protease activity has therapeutic importance for Alzheimer's disease.  Anal. of BACE1 and BACE2 knock-out zebrafish revealed that they exhibit distinct phenotypes.  Bace1 mutants display hypomyelination in the PNS and supernumerary neuromasts while in bace2 mutants the shape and migration of melanocytes is affected.  These phenotypes are not further enhanced in the viable double mutants.  Our data suggest that blocking BACE1 activity is a safe therapeutic approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6hPBx6BmbmLVg90H21EOLACvtfcHk0lgOHJUYAHsHHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslWqs7bL&md5=9a8f81383e56f96dfa821c98182a739f</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1111%2Fjnc.12198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjnc.12198%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BBebber%26aufirst%3DF.%26aulast%3DHruscha%26aufirst%3DA.%26aulast%3DWillem%26aufirst%3DM.%26aulast%3DSchmid%26aufirst%3DB.%26aulast%3DHaass%26aufirst%3DC.%26atitle%3DLoss%2520of%2520BACE2%2520in%2520zebrafish%2520affects%2520melanocyte%2520migration%2520and%2520is%2520distinct%2520from%2520BACE1%2520knock%2520out%2520phenotypes%26jtitle%3DJ.%2520Neurochem.%26date%3D2013%26volume%3D127%26spage%3D471%26epage%3D481%26doi%3D10.1111%2Fjnc.12198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rulifson, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopecky, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samayoa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuruda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Homann, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baribault, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamane, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiltzius, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span> <span> </span><span class="NLM_article-title">Identification of human islet amyloid polypeptide as a BACE2 substrate</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">e0147254</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0147254</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=10.1371%2Fjournal.pone.0147254" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=26840340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=1%3ACAS%3A528%3ADC%252BC28XnslOqtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=e0147254&author=I.+C.+Rulifsonauthor=P.+Caoauthor=L.+Miaoauthor=D.+Kopeckyauthor=L.+Huangauthor=R.+D.+Whiteauthor=K.+Samayoaauthor=J.+Gardnerauthor=X.+Wuauthor=K.+Chenauthor=T.+Tsurudaauthor=O.+Homannauthor=H.+Baribaultauthor=H.+Yamaneauthor=T.+Carlsonauthor=J.+Wiltziusauthor=Y.+Li&title=Identification+of+human+islet+amyloid+polypeptide+as+a+BACE2+substrate&doi=10.1371%2Fjournal.pone.0147254"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of human islet amyloid polypeptide as a BACE2 substrate</span></div><div class="casAuthors">Rulifson, Ingrid C.; Cao, Ping; Miao, Li; Kopecky, David; Huang, Linda; White, Ryan D.; Samayoa, Kim; Gardner, Jonitha; Wu, Xiaosu; Chen, Kui; Tsuruda, Trace; Homann, Oliver; Baribault, Helene; Yamane, Harvey; Carlson, Tim; Wiltzius, Jed; Li, Yang</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e0147254/1-e0147254/23</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Pancreatic amyloid formation by islet amyloid polypeptide (IAPP) is a hallmark pathol. feature of type 2 diabetes.  IAPP is stored in the secretory granules of pancreatic beta-cells and co-secreted with insulin to maintain glucose homeostasis.  IAPP is innocuous under homeostatic conditions but imbalances in prodn. or processing of IAPP may result in homodimer formation leading to the rapid prodn. of cytotoxic oligomers and amyloid fibrils.  The consequence is beta-cell dysfunction and the accumulation of proteinaceous plaques in and around pancreatic islets.  Beta-site APP-cleaving enzyme 2, BACE2, is an aspartyl protease commonly assocd. with BACE1, a related homolog responsible for amyloid processing in the brain and strongly implicated in Alzheimer's disease.  Herein, we identify two distinct sites of the mature human IAPP sequence that are susceptible to BACE2-mediated proteolytic activity.  The result of proteolysis is modulation of human IAPP fibrillation and human IAPP protein degrdn.  These results suggest a potential therapeutic role for BACE2 in type 2 diabetes-assocd. hyperamylinemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXxpM4hmm1pLVg90H21EOLACvtfcHk0lgOHJUYAHsHHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnslOqtL4%253D&md5=ab081153a95c7462bd208bac8779bd1d</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0147254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0147254%26sid%3Dliteratum%253Aachs%26aulast%3DRulifson%26aufirst%3DI.%2BC.%26aulast%3DCao%26aufirst%3DP.%26aulast%3DMiao%26aufirst%3DL.%26aulast%3DKopecky%26aufirst%3DD.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DWhite%26aufirst%3DR.%2BD.%26aulast%3DSamayoa%26aufirst%3DK.%26aulast%3DGardner%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DTsuruda%26aufirst%3DT.%26aulast%3DHomann%26aufirst%3DO.%26aulast%3DBaribault%26aufirst%3DH.%26aulast%3DYamane%26aufirst%3DH.%26aulast%3DCarlson%26aufirst%3DT.%26aulast%3DWiltzius%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DY.%26atitle%3DIdentification%2520of%2520human%2520islet%2520amyloid%2520polypeptide%2520as%2520a%2520BACE2%2520substrate%26jtitle%3DPLoS%2520One%26date%3D2016%26volume%3D11%26spage%3De0147254%26doi%3D10.1371%2Fjournal.pone.0147254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jeppsson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eketjäll, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlström, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustavsson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsson, L.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radesäter, A.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ploeger, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cebers, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolmodin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swahn, B.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Berg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bueters, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fälting, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of AZD3839, a potent and selective BACE1 inhibitor clinical candidate for the treatment of Alzheimer’s Disease</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>287</i></span>,  <span class="NLM_fpage">41245</span>– <span class="NLM_lpage">41257</span>, <span class="refDoi"> DOI: 10.1074/jbc.M112.409110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=10.1074%2Fjbc.M112.409110" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=41245-41257&author=F.+Jeppssonauthor=S.+Eketj%C3%A4llauthor=J.+Jansonauthor=S.+Karlstr%C3%B6mauthor=S.+Gustavssonauthor=L.-L.+Olssonauthor=A.-C.+Rades%C3%A4terauthor=B.+Ploegerauthor=G.+Cebersauthor=K.+Kolmodinauthor=B.-M.+Swahnauthor=S.+von+Bergauthor=T.+Buetersauthor=J.+F%C3%A4lting&title=Discovery+of+AZD3839%2C+a+potent+and+selective+BACE1+inhibitor+clinical+candidate+for+the+treatment+of+Alzheimer%E2%80%99s+Disease&doi=10.1074%2Fjbc.M112.409110"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.409110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.409110%26sid%3Dliteratum%253Aachs%26aulast%3DJeppsson%26aufirst%3DF.%26aulast%3DEketj%25C3%25A4ll%26aufirst%3DS.%26aulast%3DJanson%26aufirst%3DJ.%26aulast%3DKarlstr%25C3%25B6m%26aufirst%3DS.%26aulast%3DGustavsson%26aufirst%3DS.%26aulast%3DOlsson%26aufirst%3DL.-L.%26aulast%3DRades%25C3%25A4ter%26aufirst%3DA.-C.%26aulast%3DPloeger%26aufirst%3DB.%26aulast%3DCebers%26aufirst%3DG.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DSwahn%26aufirst%3DB.-M.%26aulast%3Dvon%2BBerg%26aufirst%3DS.%26aulast%3DBueters%26aufirst%3DT.%26aulast%3DF%25C3%25A4lting%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520AZD3839%252C%2520a%2520potent%2520and%2520selective%2520BACE1%2520inhibitor%2520clinical%2520candidate%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D41245%26epage%3D41257%26doi%3D10.1074%2Fjbc.M112.409110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vuillard, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cleasby, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yon, J.</span></span> <span> </span><span class="NLM_article-title">Apo and inhibitor complex structures of BACE (β-secretase)</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>343</i></span>,  <span class="NLM_fpage">407</span>– <span class="NLM_lpage">416</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2004.08.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=10.1016%2Fj.jmb.2004.08.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=15451669" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnvVyqt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=343&publication_year=2004&pages=407-416&author=S.+Patelauthor=L.+Vuillardauthor=A.+Cleasbyauthor=C.+W.+Murrayauthor=J.+Yon&title=Apo+and+inhibitor+complex+structures+of+BACE+%28%CE%B2-secretase%29&doi=10.1016%2Fj.jmb.2004.08.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Apo and Inhibitor Complex Structures of BACE (β-secretase)</span></div><div class="casAuthors">Patel, Sahil; Vuillard, Laurent; Cleasby, Anne; Murray, Christopher W.; Yon, Jeff</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">343</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">407-416</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Human BACE, also known as β-secretase, shows promise as a potential therapeutic target for Alzheimer's disease.  The authors detd. the apo structure of BACE to 1.75 Å, and a structure of a hydroxyethylamine inhibitor complex derived by soaking.  These show significant active-site movements compared to previously described BACE structures.  Addnl., the structures reveal two pockets that could be targeted by structure-based drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpH0afg2-ZxjLVg90H21EOLACvtfcHk0lhj92w-urmA7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnvVyqt7w%253D&md5=b14e17f86a4729fb8ee66d84ee6c1fab</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2004.08.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2004.08.018%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DVuillard%26aufirst%3DL.%26aulast%3DCleasby%26aufirst%3DA.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DYon%26aufirst%3DJ.%26atitle%3DApo%2520and%2520inhibitor%2520complex%2520structures%2520of%2520BACE%2520%2528%25CE%25B2-secretase%2529%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2004%26volume%3D343%26spage%3D407%26epage%3D416%26doi%3D10.1016%2Fj.jmb.2004.08.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tosaki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaneko, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hisano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakurai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nukina, N.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of an active form of BACE1, an enzyme responsible for amyloid beta protein production</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">3663</span>– <span class="NLM_lpage">3671</span>, <span class="refDoi"> DOI: 10.1128/MCB.02185-07</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=10.1128%2FMCB.02185-07" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=18378702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=1%3ACAS%3A528%3ADC%252BD1cXms1elsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=3663-3671&author=H.+Shimizuauthor=A.+Tosakiauthor=K.+Kanekoauthor=T.+Hisanoauthor=T.+Sakuraiauthor=N.+Nukina&title=Crystal+structure+of+an+active+form+of+BACE1%2C+an+enzyme+responsible+for+amyloid+beta+protein+production&doi=10.1128%2FMCB.02185-07"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of an active form of BACE1, an enzyme responsible for amyloid β protein production</span></div><div class="casAuthors">Shimizu, Hideaki; Tosaki, Asako; Kaneko, Kumi; Hisano, Tamao; Sakurai, Takashi; Nukina, Nobuyuki</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3663-3671</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">β-Secretase (BACE1) is a transmembrane aspartic protease that cleaves the β-amyloid precursor protein and generates the amyloid β peptide (Aβ).  BACE1 cycles between the cell surface and the endosomal system many times and becomes activated interconvertibly during its cellular trafficking, leading to the prodn. of Aβ.  Here, the authors report the crystal structure of the catalytically active form of human BACE1.  The active form had novel structural features involving the conformation of the flap and subsites that promote substrate binding.  The functionally essential residues and water mols. were well-defined and play a key role in the iterative activation of BACE1.  The authors further describe the crystal structure of the dehydrated form of BACE1, showing that BACE1 activity is dependent on the dynamics of a catalytically required Asp-bound water mol., which directly affects its catalytic properties.  These findings provide insight into a novel regulation of BACE1 activity and elucidate how BACE1 modulates its activity during cellular trafficking.  The crystal structure of BACE1 complexed with its inhibitor, OM 99-2, was also described and discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr44oqN8OB8JLVg90H21EOLACvtfcHk0lhj92w-urmA7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXms1elsro%253D&md5=6cc9634690fa04789c18358432937c74</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1128%2FMCB.02185-07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.02185-07%26sid%3Dliteratum%253Aachs%26aulast%3DShimizu%26aufirst%3DH.%26aulast%3DTosaki%26aufirst%3DA.%26aulast%3DKaneko%26aufirst%3DK.%26aulast%3DHisano%26aufirst%3DT.%26aulast%3DSakurai%26aufirst%3DT.%26aulast%3DNukina%26aufirst%3DN.%26atitle%3DCrystal%2520structure%2520of%2520an%2520active%2520form%2520of%2520BACE1%252C%2520an%2520enzyme%2520responsible%2520for%2520amyloid%2520beta%2520protein%2520production%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2008%26volume%3D28%26spage%3D3663%26epage%3D3671%26doi%3D10.1128%2FMCB.02185-07" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gravenfors, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viklund, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blid, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ginman, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlström, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kihlström, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolmodin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindström, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Berg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Kieseritzky, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slivo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swahn, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsson, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eketjäll, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fälting, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeppsson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strömberg, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahm, F.</span></span> <span> </span><span class="NLM_article-title">New aminoimidazoles as β-secretase (BACE-1) inhibitors showing amyloid-β (Aβ) lowering in brain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">9297</span>– <span class="NLM_lpage">9311</span>, <span class="refDoi"> DOI: 10.1021/jm300991n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300991n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVagtLfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9297-9311&author=Y.+Gravenforsauthor=J.+Viklundauthor=J.+Blidauthor=T.+Ginmanauthor=S.+Karlstr%C3%B6mauthor=J.+Kihlstr%C3%B6mauthor=K.+Kolmodinauthor=J.+Lindstr%C3%B6mauthor=S.+von+Bergauthor=F.+von+Kieseritzkyauthor=K.+Bogarauthor=C.+Slivoauthor=B.+M.+Swahnauthor=L.+L.+Olssonauthor=P.+Johanssonauthor=S.+Eketj%C3%A4llauthor=J.+F%C3%A4ltingauthor=F.+Jeppssonauthor=K.+Str%C3%B6mbergauthor=J.+Jansonauthor=F.+Rahm&title=New+aminoimidazoles+as+%CE%B2-secretase+%28BACE-1%29+inhibitors+showing+amyloid-%CE%B2+%28A%CE%B2%29+lowering+in+brain&doi=10.1021%2Fjm300991n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">New Aminoimidazoles as β-Secretase (BACE-1) Inhibitors Showing Amyloid-β (Aβ) Lowering in Brain</span></div><div class="casAuthors">Gravenfors, Ylva; Viklund, Jenny; Blid, Jan; Ginman, Tobias; Karlstroem, Sofia; Kihlstroem, Jacob; Kolmodin, Karin; Lindstroem, Johan; von Berg, Stefan; von Kieseritzky, Fredrik; Bogar, Krisztian; Slivo, Can; Swahn, Britt-Marie; Olsson, Lise-Lotte; Johansson, Patrik; Eketjaell, Susanna; Faelting, Johanna; Jeppsson, Fredrik; Stroemberg, Kia; Janson, Juliette; Rahm, Fredrik</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9297-9311</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Amino-2H-imidazoles are described as a new class of BACE-1 inhibitors for the treatment of Alzheimer's disease.  Synthetic methods, crystal structures, and structure-activity relationships for target activity, permeability, and hERG activity are reported and discussed.  Compd. (S)-1m (I) was one of the most promising compds. in this report, with high potency in the cellular assay and a good overall profile.  When guinea pigs were treated with compd. (S)-1m, a concn. and time dependent decrease in Aβ40 and Aβ42 levels in plasma, brain, and CSF was obsd.  The max. redn. of brain Aβ was 40-50%, 1.5 h after oral dosing (100 μmol/kg).  The results presented highlight the potential of this new class of BACE-1 inhibitors with good target potency and with low effect on hERG, in combination with a fair CNS exposure in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdDDOKlDOgVbVg90H21EOLACvtfcHk0lhj92w-urmA7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVagtLfI&md5=65b5aae9d7b5aa83df67a7e4a1f03da0</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm300991n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300991n%26sid%3Dliteratum%253Aachs%26aulast%3DGravenfors%26aufirst%3DY.%26aulast%3DViklund%26aufirst%3DJ.%26aulast%3DBlid%26aufirst%3DJ.%26aulast%3DGinman%26aufirst%3DT.%26aulast%3DKarlstr%25C3%25B6m%26aufirst%3DS.%26aulast%3DKihlstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DLindstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3Dvon%2BBerg%26aufirst%3DS.%26aulast%3Dvon%2BKieseritzky%26aufirst%3DF.%26aulast%3DBogar%26aufirst%3DK.%26aulast%3DSlivo%26aufirst%3DC.%26aulast%3DSwahn%26aufirst%3DB.%2BM.%26aulast%3DOlsson%26aufirst%3DL.%2BL.%26aulast%3DJohansson%26aufirst%3DP.%26aulast%3DEketj%25C3%25A4ll%26aufirst%3DS.%26aulast%3DF%25C3%25A4lting%26aufirst%3DJ.%26aulast%3DJeppsson%26aufirst%3DF.%26aulast%3DStr%25C3%25B6mberg%26aufirst%3DK.%26aulast%3DJanson%26aufirst%3DJ.%26aulast%3DRahm%26aufirst%3DF.%26atitle%3DNew%2520aminoimidazoles%2520as%2520%25CE%25B2-secretase%2520%2528BACE-1%2529%2520inhibitors%2520showing%2520amyloid-%25CE%25B2%2520%2528A%25CE%25B2%2529%2520lowering%2520in%2520brain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9297%26epage%3D9311%26doi%3D10.1021%2Fjm300991n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Geschwindner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulander, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansson, P.</span></span> <span> </span><span class="NLM_article-title">Ligand binding thermodynamics in drug discovery: still a hot tip?</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">6321</span>– <span class="NLM_lpage">6335</span>, <span class="refDoi"> DOI: 10.1021/jm501511f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501511f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=1%3ACAS%3A528%3ADC%252BC2MXntFGitbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6321-6335&author=S.+Geschwindnerauthor=J.+Ulanderauthor=P.+Johansson&title=Ligand+binding+thermodynamics+in+drug+discovery%3A+still+a+hot+tip%3F&doi=10.1021%2Fjm501511f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand Binding Thermodynamics in Drug Discovery: Still a Hot Tip?</span></div><div class="casAuthors">Geschwindner, Stefan; Ulander, Johan; Johansson, Patrik</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6321-6335</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The use of ligand binding thermodn. has been proposed as a potential success factor to accelerate drug discovery.  However, despite the intuitive appeal of optimizing binding enthalpy, a no. of factors complicate routine use of thermodn. data.  On a macroscopic level, a range of exptl. parameters including temp. and buffer choice significantly influence the obsd. thermodn. signatures.  On a microscopic level, solute effects, structural flexibility, and cooperativity lead to nonlinear changes in enthalpy.  This multifactorial character hides essential enthalpy contributions of intermol. contacts, making them exptl. nonobservable.  In this perspective, we present three case studies, reflect on some key factors affecting thermodn. signatures, and investigate their relation to the hydrophobic effect, enthalpy-entropy compensation, lipophilic ligand efficiency, and promiscuity.  The studies highlight that enthalpy and entropy cannot be used as direct end points but can together with calcns. increase our understanding of ligand binding and identify interesting outliers that do not behave as expected.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr47fgLvr2PP7Vg90H21EOLACvtfcHk0lgP_99n5YYa3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXntFGitbs%253D&md5=686b213b9488bc51d2d6a07e391c6644</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm501511f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501511f%26sid%3Dliteratum%253Aachs%26aulast%3DGeschwindner%26aufirst%3DS.%26aulast%3DUlander%26aufirst%3DJ.%26aulast%3DJohansson%26aufirst%3DP.%26atitle%3DLigand%2520binding%2520thermodynamics%2520in%2520drug%2520discovery%253A%2520still%2520a%2520hot%2520tip%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D6321%26epage%3D6335%26doi%3D10.1021%2Fjm501511f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ostermann, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eder, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eidhoff, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zink, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassiepen, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Worpenberg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maibaum, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simic, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hommel, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerhartz, B.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of human BACE2 in complex with a hydroxyethylamine transition state inhibitor</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>355</i></span>,  <span class="NLM_fpage">249</span>– <span class="NLM_lpage">261</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2005.10.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=10.1016%2Fj.jmb.2005.10.027" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=2006&pages=249-261&author=N.+Ostermannauthor=J.+Ederauthor=U.+Eidhoffauthor=F.+Zinkauthor=U.+Hassiepenauthor=S.+Worpenbergauthor=J.+Maibaumauthor=O.+Simicauthor=U.+Hommelauthor=B.+Gerhartz&title=Crystal+structure+of+human+BACE2+in+complex+with+a+hydroxyethylamine+transition+state+inhibitor&doi=10.1016%2Fj.jmb.2005.10.027"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2005.10.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2005.10.027%26sid%3Dliteratum%253Aachs%26aulast%3DOstermann%26aufirst%3DN.%26aulast%3DEder%26aufirst%3DJ.%26aulast%3DEidhoff%26aufirst%3DU.%26aulast%3DZink%26aufirst%3DF.%26aulast%3DHassiepen%26aufirst%3DU.%26aulast%3DWorpenberg%26aufirst%3DS.%26aulast%3DMaibaum%26aufirst%3DJ.%26aulast%3DSimic%26aufirst%3DO.%26aulast%3DHommel%26aufirst%3DU.%26aulast%3DGerhartz%26aufirst%3DB.%26atitle%3DCrystal%2520structure%2520of%2520human%2520BACE2%2520in%2520complex%2520with%2520a%2520hydroxyethylamine%2520transition%2520state%2520inhibitor%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2006%26volume%3D355%26spage%3D249%26epage%3D261%26doi%3D10.1016%2Fj.jmb.2005.10.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumalo, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soliman, M. E.</span></span> <span> </span><span class="NLM_article-title">A comparative molecular dynamics study on BACE1 and BACE2 flap flexibility</span>. <i>J. Recept. Signal Transduction Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">505</span>– <span class="NLM_lpage">514</span>, <span class="refDoi"> DOI: 10.3109/10799893.2015.1130058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=10.3109%2F10799893.2015.1130058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=26804314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=1%3ACAS%3A280%3ADC%252BC28njs12nsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2016&pages=505-514&author=H.+M.+Kumaloauthor=M.+E.+Soliman&title=A+comparative+molecular+dynamics+study+on+BACE1+and+BACE2+flap+flexibility&doi=10.3109%2F10799893.2015.1130058"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">A comparative molecular dynamics study on BACE1 and BACE2 flap flexibility</span></div><div class="casAuthors">Kumalo H M; Soliman Mahmoud E</div><div class="citationInfo"><span class="NLM_cas:title">Journal of receptor and signal transduction research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">505-14</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Beta-amyloid precursor protein cleavage enzyme1 (BACE1) and beta-amyloid precursor protein cleavage enzyme2 (BACE2), members of aspartyl protease family, are close homologs and have high similarity in their protein crystal structures.  However, their enzymatic properties are different, which leads to different clinical outcomes.  In this study, we performed sequence analysis and all-atom molecular dynamic (MD) simulations for both enzymes in their ligand-free states in order to compare their dynamical flap behaviors.  This is to enhance our understanding of the relationship between sequence, structure and the dynamics of this protein family.  Sequence analysis shows that in BACE1 and BACE2, most of the ligand-binding sites are conserved, indicative of their enzymatic property as aspartyl protease members.  The other conserved residues are more or less unsystematically localized throughout the structure.  Herein, we proposed and applied different combined parameters to define the asymmetric flap motion; the distance, d1, between the flap tip and the flexible region; the dihedral angle, φ, to account for the twisting motion and the TriCα angle, θ2 and θ1.  All four combined parameters were found to appropriately define the observed "twisting" motion during the flaps different conformational states.  Additional analysis of the parameters indicated that the flaps can exist in an ensemble of conformations, i.e. closed, semi-open and open conformations for both systems.  However, the behavior of the flap tips during simulations is different between BACE1 and BACE2.  The BACE1 active site cavity is more spacious as compared to that of BACE2.  The analysis of 10S loop and 113S loop showed a similar trend to that of flaps, with the BACE1 loops being more flexible and less stable than those of BACE2.  We believe that the results, methods and perspectives highlighted in this report would assist researchers in the discovery of BACE inhibitors as potential Alzheimer's disease therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQHqCw7fPU_ktLIORRPd5lbfW6udTcc2eYq26LR2cgzPLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28njs12nsw%253D%253D&md5=e2c5e147e4c1dd1ca4a960399ff1b703</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.3109%2F10799893.2015.1130058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10799893.2015.1130058%26sid%3Dliteratum%253Aachs%26aulast%3DKumalo%26aufirst%3DH.%2BM.%26aulast%3DSoliman%26aufirst%3DM.%2BE.%26atitle%3DA%2520comparative%2520molecular%2520dynamics%2520study%2520on%2520BACE1%2520and%2520BACE2%2520flap%2520flexibility%26jtitle%3DJ.%2520Recept.%2520Signal%2520Transduction%2520Res.%26date%3D2016%26volume%3D36%26spage%3D505%26epage%3D514%26doi%3D10.3109%2F10799893.2015.1130058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hitchcock, A. S.</span></span> <span> </span><span class="NLM_article-title">Structural modifications that alter the P-glycoprotein efflux properties of compounds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">4877</span>– <span class="NLM_lpage">4895</span>, <span class="refDoi"> DOI: 10.1021/jm201136z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201136z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=1%3ACAS%3A528%3ADC%252BC38XlsFKlt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4877-4895&author=A.+S.+Hitchcock&title=Structural+modifications+that+alter+the+P-glycoprotein+efflux+properties+of+compounds&doi=10.1021%2Fjm201136z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Modifications that Alter the P-Glycoprotein Efflux Properties of Compounds</span></div><div class="casAuthors">Hitchcock, Stephen A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4877-4895</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This perspective is focused on structural modifications and strategies that can be applied during compd. optimization in order to modulate the P-glycoprotein efflux properties of small mols. with a particular emphasis on implications for CNS penetration. The precise mol. interactions that confer P-glycoprotein efflux remain relatively poorly defined. The promiscuous nature of P-glycoprotein efflux renders the rational circumvention of efflux, while simultaneously optimizing compds. for eficacy, safety, and pharmacokinetic properties, an extremely challenging undertaking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3_5RBtwgb-rVg90H21EOLACvtfcHk0lgP_99n5YYa3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlsFKlt7s%253D&md5=6c5dffbb11db6fa893ff3c50fe7778cc</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm201136z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201136z%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DA.%2BS.%26atitle%3DStructural%2520modifications%2520that%2520alter%2520the%2520P-glycoprotein%2520efflux%2520properties%2520of%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4877%26epage%3D4895%26doi%3D10.1021%2Fjm201136z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wager, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoest, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villalobos, A.</span></span> <span> </span><span class="NLM_article-title">Central nervous system multiparameter optimization desirability: application in drug discovery</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">767</span>– <span class="NLM_lpage">775</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.6b00029</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.6b00029" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=1%3ACAS%3A528%3ADC%252BC28XksVSktbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=767-775&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Central+nervous+system+multiparameter+optimization+desirability%3A+application+in+drug+discovery&doi=10.1021%2Facschemneuro.6b00029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Central Nervous System Multiparameter Optimization Desirability: Application in Drug Discovery</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">767-775</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Significant progress has been made in prospectively designing mols. using the central nervous system multiparameter optimization (CNS MPO) desirability tool, as evidenced by the anal. reported herein of a second wave of drug candidates that originated after the development and implementation of this tool.  This simple-to-use design algorithm has expanded design space for CNS candidates and has further demonstrated the advantages of utilizing a flexible, multiparameter approach in drug discovery rather than individual parameters and hard cutoffs of physicochem. properties.  The CNS MPO tool has helped to increase the percentage of compds. nominated for clin. development that exhibit alignment of ADME attributes, cross the blood-brain barrier, and reside in lower-risk safety space (low ClogP and high TPSA).  The use of this tool has played a role in reducing the no. of compds. submitted to exploratory toxicity studies and increasing the survival of our drug candidates through regulatory toxicol. into First in Human studies.  Overall, the CNS MPO algorithm has helped to improve the prioritization of design ideas and the quality of the compds. nominated for clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp46WD7qMaX6bVg90H21EOLACvtfcHk0li19VIc3yyyCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XksVSktbw%253D&md5=061c3aef6c88758cbaee1a2abb34796a</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.6b00029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.6b00029%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DCentral%2520nervous%2520system%2520multiparameter%2520optimization%2520desirability%253A%2520application%2520in%2520drug%2520discovery%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2016%26volume%3D7%26spage%3D767%26epage%3D775%26doi%3D10.1021%2Facschemneuro.6b00029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittington, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, V. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dineen, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epstein, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graceffa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiang, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Louie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahl, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fremeau, R. T.</span></span> <span> </span><span class="NLM_article-title">Structure- and property-based design of aminooxazoline xanthenes as selective, orally efficacious, and CNS penetrable BACE inhibitors for the treatment of Alzheimer’s Disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">9156</span>– <span class="NLM_lpage">9169</span>, <span class="refDoi"> DOI: 10.1021/jm300598e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300598e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1yhsLjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9156-9169&author=H.+Huangauthor=D.+S.+Laauthor=A.+C.+Chengauthor=D.+A.+Whittingtonauthor=V.+F.+Patelauthor=K.+Chenauthor=T.+A.+Dineenauthor=O.+Epsteinauthor=R.+Graceffaauthor=D.+Hickmanauthor=Y.-H.+Kiangauthor=S.+Louieauthor=Y.+Luoauthor=R.+C.+Wahlauthor=P.+H.+Wenauthor=S.+Woodauthor=R.+T.+Fremeau&title=Structure-+and+property-based+design+of+aminooxazoline+xanthenes+as+selective%2C+orally+efficacious%2C+and+CNS+penetrable+BACE+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+Disease&doi=10.1021%2Fjm300598e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Structure- and property-based design of aminooxazoline xanthenes as selective, orally efficacious, and CNS penetrable BACE inhibitors for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Huang, Hongbing; La, Daniel S.; Cheng, Alan C.; Whittington, Douglas A.; Patel, Vinod F.; Chen, Kui; Dineen, Thomas A.; Epstein, Oleg; Graceffa, Russell; Hickman, Dean; Kiang, Y.-H.; Louie, Steven; Luo, Yi; Wahl, Robert C.; Wen, Paul H.; Wood, Stephen; Fremeau, Robert T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9156-9169</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A structure- and property-based drug design approach was employed to identify aminooxazoline xanthenes as potent and selective human β-secretase inhibitors.  These compds. exhibited good isolated enzyme, cell potency, and selectivity against the structurally related aspartyl protease cathepsin D.  Our efforts resulted in the identification of a potent, orally bioavailable CNS penetrant compd. that exhibited in vivo efficacy.  A single oral dose of compd. (I) resulted in a significant redn. of CNS Aβ40 in naive rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDEYfU4moxMbVg90H21EOLACvtfcHk0li19VIc3yyyCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1yhsLjJ&md5=0ecd50ec1ea82a058e499bb712c45272</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm300598e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300598e%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DCheng%26aufirst%3DA.%2BC.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DEpstein%26aufirst%3DO.%26aulast%3DGraceffa%26aufirst%3DR.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DKiang%26aufirst%3DY.-H.%26aulast%3DLouie%26aufirst%3DS.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWood%26aufirst%3DS.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26atitle%3DStructure-%2520and%2520property-based%2520design%2520of%2520aminooxazoline%2520xanthenes%2520as%2520selective%252C%2520orally%2520efficacious%252C%2520and%2520CNS%2520penetrable%2520BACE%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9156%26epage%3D9169%26doi%3D10.1021%2Fjm300598e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Judd, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartberger, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunn, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epstein, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fremeau, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harried, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hitchcock, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minatti, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, V. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vargas, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahl, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittington, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, S.</span></span> <span> </span><span class="NLM_article-title">An orally available BACE1 inhibitor that affords robust CNS Aβ reduction without cardiovascular liabilities</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">210</span>– <span class="NLM_lpage">215</span>, <span class="refDoi"> DOI: 10.1021/ml500458t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500458t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFyhtLzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=210-215&author=Y.+Chengauthor=J.+Brownauthor=T.+C.+Juddauthor=P.+Lopezauthor=W.+Qianauthor=T.+S.+Powersauthor=J.+J.+Chenauthor=M.+D.+Bartbergerauthor=K.+Chenauthor=R.+T.+Dunnauthor=O.+Epsteinauthor=R.+T.+Fremeauauthor=S.+Harriedauthor=D.+Hickmanauthor=S.+A.+Hitchcockauthor=Y.+Luoauthor=A.+E.+Minattiauthor=V.+F.+Patelauthor=H.+M.+Vargasauthor=R.+C.+Wahlauthor=M.+M.+Weissauthor=P.+H.+Wenauthor=R.+D.+Whiteauthor=D.+A.+Whittingtonauthor=X.+M.+Zhengauthor=S.+Wood&title=An+orally+available+BACE1+inhibitor+that+affords+robust+CNS+A%CE%B2+reduction+without+cardiovascular+liabilities&doi=10.1021%2Fml500458t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">An Orally Available BACE1 Inhibitor That Affords Robust CNS Aβ Reduction without Cardiovascular Liabilities</span></div><div class="casAuthors">Cheng, Yuan; Brown, James; Judd, Ted C.; Lopez, Patricia; Qian, Wenyuan; Powers, Timothy S.; Chen, Jian Jeffrey; Bartberger, Michael D.; Chen, Kui; Dunn, Robert T.; Epstein, Oleg; Fremeau, Robert T.; Harried, Scott; Hickman, Dean; Hitchcock, Stephen A.; Luo, Yi; Minatti, Ana Elena; Patel, Vinod F.; Vargas, Hugo M.; Wahl, Robert C.; Weiss, Matthew M.; Wen, Paul H.; White, Ryan D.; Whittington, Douglas A.; Zheng, Xiao Mei; Wood, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">210-215</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">BACE1 inhibition to prevent Aβ peptide formation is considered to be a potential route to a disease-modifying treatment for Alzheimer's disease.  Previous efforts in our lab. using a combined structure- and property-based approach have resulted in the identification of aminooxazoline xanthenes as potent BACE1 inhibitors.  Herein, we report further optimization leading to the discovery of inhibitor 15 as an orally available and highly efficacious BACE1 inhibitor that robustly reduces CSF and brain Aβ levels in both rats and nonhuman primates.  In addn., compd. 15 exhibited low activity on the hERG ion channel and was well tolerated in an integrated cardiovascular safety model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbH-0fLNUlbrVg90H21EOLACvtfcHk0ljEMxpfPbTvkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFyhtLzI&md5=bd8e5a33d06a51646873c4c43d01b003</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fml500458t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500458t%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DJudd%26aufirst%3DT.%2BC.%26aulast%3DLopez%26aufirst%3DP.%26aulast%3DQian%26aufirst%3DW.%26aulast%3DPowers%26aufirst%3DT.%2BS.%26aulast%3DChen%26aufirst%3DJ.%2BJ.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DDunn%26aufirst%3DR.%2BT.%26aulast%3DEpstein%26aufirst%3DO.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26aulast%3DHarried%26aufirst%3DS.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DMinatti%26aufirst%3DA.%2BE.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26aulast%3DVargas%26aufirst%3DH.%2BM.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWhite%26aufirst%3DR.%2BD.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DZheng%26aufirst%3DX.%2BM.%26aulast%3DWood%26aufirst%3DS.%26atitle%3DAn%2520orally%2520available%2520BACE1%2520inhibitor%2520that%2520affords%2520robust%2520CNS%2520A%25CE%25B2%2520reduction%2520without%2520cardiovascular%2520liabilities%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D210%26epage%3D215%26doi%3D10.1021%2Fml500458t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eketjäll, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaspersson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogstedt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeppsson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fälting, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Budd Haeberlein, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kugler, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cebers, G.</span></span> <span> </span><span class="NLM_article-title">AZD3293: a novel, orally active BACE1 Inhibitor with high potency and permeability and markedly slow off-rate kinetics</span>. <i>J. Alzheimer’s Dis.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">1109</span>– <span class="NLM_lpage">1123</span>, <span class="refDoi"> DOI: 10.3233/JAD-150834</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=10.3233%2FJAD-150834" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=26890753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=1%3ACAS%3A280%3ADC%252BC28jhvFWqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2016&pages=1109-1123&author=S.+Eketj%C3%A4llauthor=J.+Jansonauthor=K.+Kasperssonauthor=A.+Bogstedtauthor=F.+Jeppssonauthor=J.+F%C3%A4ltingauthor=S.+Budd+Haeberleinauthor=A.+R.+Kuglerauthor=R.+C.+Alexanderauthor=G.+Cebers&title=AZD3293%3A+a+novel%2C+orally+active+BACE1+Inhibitor+with+high+potency+and+permeability+and+markedly+slow+off-rate+kinetics&doi=10.3233%2FJAD-150834"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">AZD3293: A Novel, Orally Active BACE1 Inhibitor with High Potency and Permeability and Markedly Slow Off-Rate Kinetics</span></div><div class="casAuthors">Eketjall Susanna; Janson Juliette; Bogstedt Anna; Eketjall Susanna; Janson Juliette; Bogstedt Anna; Kaspersson Karin; Jeppsson Fredrik; Falting Johanna; Jeppsson Fredrik; Haeberlein Samantha Budd; Kugler Alan R; Alexander Robert C; Cebers Gvido</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's disease : JAD</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1109-23</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">A growing body of pathological, biomarker, genetic, and mechanistic data suggests that amyloid accumulation, as a result of changes in production, processing, and/or clearance of brain amyloid-β peptide (Aβ) concentrations, plays a key role in the pathogenesis of Alzheimer's disease (AD).  Beta-secretase 1 (BACE1) mediates the first step in the processing of amyloid-β protein precursor (AβPP) to Aβ peptides, with the soluble N terminal fragment of AβPP (sAβPPβ) as a direct product, and BACE1 inhibition is an attractive target for therapeutic intervention to reduce the production of Aβ.  Here, we report the in vitro and in vivo pharmacological profile of AZD3293, a potent, highly permeable, orally active, blood-brain barrier (BBB) penetrating, BACE1 inhibitor with unique slow off-rate kinetics.  The in vitro potency of AZD3293 was demonstrated in several cellular models, including primary cortical neurons.  In vivo in mice, guinea pigs, and dogs, AZD3293 displayed significant dose- and time-dependent reductions in plasma, cerebrospinal fluid, and brain concentrations of Aβ40, Aβ42, and sAβPPβ.  The in vitro potency of AZD3293 in mouse and guinea pig primary cortical neuronal cells was correlated to the in vivo potency expressed as free AZD3293 concentrations in mouse and guinea pig brains.  In mice and dogs, the slow off-rate from BACE1 may have translated into a prolongation of the observed effect beyond the turnover rate of Aβ.  The preclinical data strongly support the clinical development of AZD3293, and patients with AD are currently being recruited into a combined Phase 2/3 study to test the disease-modifying properties of AZD3293.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT8YDBirvcLa6qcneEtCi92fW6udTcc2eZhAILxLIlxo7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28jhvFWqtA%253D%253D&md5=afb144f0247c7dd1ecf2ccd8bebcafa4</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.3233%2FJAD-150834&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-150834%26sid%3Dliteratum%253Aachs%26aulast%3DEketj%25C3%25A4ll%26aufirst%3DS.%26aulast%3DJanson%26aufirst%3DJ.%26aulast%3DKaspersson%26aufirst%3DK.%26aulast%3DBogstedt%26aufirst%3DA.%26aulast%3DJeppsson%26aufirst%3DF.%26aulast%3DF%25C3%25A4lting%26aufirst%3DJ.%26aulast%3DBudd%2BHaeberlein%26aufirst%3DS.%26aulast%3DKugler%26aufirst%3DA.%2BR.%26aulast%3DAlexander%26aufirst%3DR.%2BC.%26aulast%3DCebers%26aufirst%3DG.%26atitle%3DAZD3293%253A%2520a%2520novel%252C%2520orally%2520active%2520BACE1%2520Inhibitor%2520with%2520high%2520potency%2520and%2520permeability%2520and%2520markedly%2520slow%2520off-rate%2520kinetics%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2016%26volume%3D50%26spage%3D1109%26epage%3D1123%26doi%3D10.3233%2FJAD-150834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mullard, A.</span></span> <span> </span><span class="NLM_article-title">Deuterated drugs draw heavier backing</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">219</span>– <span class="NLM_lpage">221</span>, <span class="refDoi"> DOI: 10.1038/nrd.2016.63</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=10.1038%2Fnrd.2016.63" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=27032821" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=1%3ACAS%3A528%3ADC%252BC28XltlWjtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=219-221&author=A.+Mullard&title=Deuterated+drugs+draw+heavier+backing&doi=10.1038%2Fnrd.2016.63"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Deuterated drugs draw heavier backing</span></div><div class="casAuthors">Mullard, Asher</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">219-221</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The FDA is considering a first approval of a deuterated drug, and large pharmaceutical companies have started to incorporate 'heavy hydrogen' into novel candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvu-ucz_PqFbVg90H21EOLACvtfcHk0ljEMxpfPbTvkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XltlWjtLk%253D&md5=8c61bbc57d480f91b59d197894a771d5</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.63&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.63%26sid%3Dliteratum%253Aachs%26aulast%3DMullard%26aufirst%3DA.%26atitle%3DDeuterated%2520drugs%2520draw%2520heavier%2520backing%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2016%26volume%3D15%26spage%3D219%26epage%3D221%26doi%3D10.1038%2Fnrd.2016.63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tebbe, F. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parshall, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, G. S.</span></span> <span> </span><span class="NLM_article-title">Olefin homologation with titanium methylene compounds</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1978</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">3611</span>– <span class="NLM_lpage">3613</span>, <span class="refDoi"> DOI: 10.1021/ja00479a061</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00479a061" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=1%3ACAS%3A528%3ADyaE1cXlt12lsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=1978&pages=3611-3613&author=F.+N.+Tebbeauthor=G.+W.+Parshallauthor=G.+S.+Reddy&title=Olefin+homologation+with+titanium+methylene+compounds&doi=10.1021%2Fja00479a061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Olefin homologation with titanium methylene compounds</span></div><div class="casAuthors">Tebbe, F. N.; Parshall, G. W.; Reddy, G. S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1978</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3611-13</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">The synthesis and chem. of Cp2TiCH2AlClMe2 (I, Cp = η5-cyclopentadienyl) and Cp2TiCH2AlMe3 is described.  Thus, treating Cp2TiCl2 with AlMe3 at room temp. 60 h gave I.  I transfers the methylene group to olefins to produce new olefins or, in small yields, cyclopropanes.  It reacts with ketones, esters, and aldehydes to produce terminal olefins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvl65Ec5YKErVg90H21EOLACvtfcHk0lj_bIIJEqdrEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXlt12lsbg%253D&md5=a99e760e1a5992dfbfb7d5aa0cd60f40</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fja00479a061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00479a061%26sid%3Dliteratum%253Aachs%26aulast%3DTebbe%26aufirst%3DF.%2BN.%26aulast%3DParshall%26aufirst%3DG.%2BW.%26aulast%3DReddy%26aufirst%3DG.%2BS.%26atitle%3DOlefin%2520homologation%2520with%2520titanium%2520methylene%2520compounds%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1978%26volume%3D100%26spage%3D3611%26epage%3D3613%26doi%3D10.1021%2Fja00479a061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="note"><p class="first last">The crystal structures of compounds <b>23</b> and <b>28</b> were deposited at the Protein Data Bank with the PDB codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EJ3">6EJ3</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EJ2">6EJ2</a>, respectively.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ginman, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viklund, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malmström, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blid, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emond, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forsblom, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kers, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lake, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sehgelmeble, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sterky, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindgren, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeppsson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fälting, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gravenfors, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahm, F.</span></span> <span> </span><span class="NLM_article-title">Core refinement toward permeable β-secretase (BACE-1) inhibitors with low hERG activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">4181</span>– <span class="NLM_lpage">4205</span>, <span class="refDoi"> DOI: 10.1021/jm3011349</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3011349" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Wgsb3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4181-4205&author=T.+Ginmanauthor=J.+Viklundauthor=J.+Malmstr%C3%B6mauthor=J.+Blidauthor=R.+Emondauthor=R.+Forsblomauthor=A.+Johanssonauthor=A.+Kersauthor=F.+Lakeauthor=F.+Sehgelmebleauthor=K.+J.+Sterkyauthor=M.+Berghauthor=A.+Lindgrenauthor=P.+Johanssonauthor=F.+Jeppssonauthor=J.+F%C3%A4ltingauthor=Y.+Gravenforsauthor=F.+Rahm&title=Core+refinement+toward+permeable+%CE%B2-secretase+%28BACE-1%29+inhibitors+with+low+hERG+activity&doi=10.1021%2Fjm3011349"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Core Refinement toward Permeable β-Secretase (BACE-1) Inhibitors with Low hERG Activity</span></div><div class="casAuthors">Ginman, Tobias; Viklund, Jenny; Malmstroem, Jonas; Blid, Jan; Emond, Rikard; Forsblom, Rickard; Johansson, Anh; Kers, Annika; Lake, Fredrik; Sehgelmeble, Fernando; Sterky, Karin J.; Bergh, Margareta; Lindgren, Anders; Johansson, Patrik; Jeppsson, Fredrik; Faelting, Johanna; Gravenfors, Ylva; Rahm, Fredrik</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4181-4205</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">By use of iterative design aided by predictive models for target affinity, brain permeability, and hERG activity, novel and diverse compds. based on cyclic amidine and guanidine cores were synthesized with the goal of finding BACE-1 inhibitors as a treatment for Alzheimer's disease (e.g., I and II).  Since synthesis feasibility had low priority in the design of the cores, an extensive synthesis effort was needed to make the relevant compds.  Syntheses of these compds. are reported, together with physicochem. properties and structure-activity relationships based on in vitro data.  Four crystal structures of diverse amidines binding in the active site are deposited and discussed.  Inhibitors of BACE-1 with 3 μM to 32 nM potencies in cells are shown, together with data on in vivo brain exposure levels for four compds.  The results presented show the importance of the core structure for the profile of the final compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3tOcYPI6wPrVg90H21EOLACvtfcHk0lj_bIIJEqdrEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Wgsb3F&md5=71c61b60748ed41a5b177f68ffa157d4</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm3011349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3011349%26sid%3Dliteratum%253Aachs%26aulast%3DGinman%26aufirst%3DT.%26aulast%3DViklund%26aufirst%3DJ.%26aulast%3DMalmstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DBlid%26aufirst%3DJ.%26aulast%3DEmond%26aufirst%3DR.%26aulast%3DForsblom%26aufirst%3DR.%26aulast%3DJohansson%26aufirst%3DA.%26aulast%3DKers%26aufirst%3DA.%26aulast%3DLake%26aufirst%3DF.%26aulast%3DSehgelmeble%26aufirst%3DF.%26aulast%3DSterky%26aufirst%3DK.%2BJ.%26aulast%3DBergh%26aufirst%3DM.%26aulast%3DLindgren%26aufirst%3DA.%26aulast%3DJohansson%26aufirst%3DP.%26aulast%3DJeppsson%26aufirst%3DF.%26aulast%3DF%25C3%25A4lting%26aufirst%3DJ.%26aulast%3DGravenfors%26aufirst%3DY.%26aulast%3DRahm%26aufirst%3DF.%26atitle%3DCore%2520refinement%2520toward%2520permeable%2520%25CE%25B2-secretase%2520%2528BACE-1%2529%2520inhibitors%2520with%2520low%2520hERG%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4181%26epage%3D4205%26doi%3D10.1021%2Fjm3011349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bridgland-Taylor, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hargreaves, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Easter, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orme, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henthorn, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Small, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heapy, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abi-Gerges, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Persson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albertson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valentin, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollard, C. E.</span></span> <span> </span><span class="NLM_article-title">Optimisation and validation of a medium-throughput electrophysiology-based hERG assay using IonWorks HT</span>. <i>J. Pharmacol. Toxicol. Methods</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">189</span>– <span class="NLM_lpage">199</span>, <span class="refDoi"> DOI: 10.1016/j.vascn.2006.02.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=10.1016%2Fj.vascn.2006.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=16563806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=1%3ACAS%3A528%3ADC%252BD28XptFChtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2006&pages=189-199&author=M.+H.+Bridgland-Taylorauthor=A.+C.+Hargreavesauthor=A.+Easterauthor=A.+Ormeauthor=D.+C.+Henthornauthor=M.+Dingauthor=A.+M.+Davisauthor=B.+G.+Smallauthor=C.+G.+Heapyauthor=N.+Abi-Gergesauthor=F.+Perssonauthor=I.+Jacobsonauthor=M.+Sullivanauthor=N.+Albertsonauthor=T.+G.+Hammondauthor=E.+Sullivanauthor=J.-P.+Valentinauthor=C.+E.+Pollard&title=Optimisation+and+validation+of+a+medium-throughput+electrophysiology-based+hERG+assay+using+IonWorks+HT&doi=10.1016%2Fj.vascn.2006.02.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization and validation of a medium-throughput electrophysiology-based hERG assay using IonWorks HT</span></div><div class="casAuthors">Bridgland-Taylor, M. H.; Hargreaves, A. C.; Easter, A.; Orme, A.; Henthorn, D. C.; Ding, M.; Davis, A. M.; Small, B. G.; Heapy, C. G.; Abi-Gerges, N.; Persson, F.; Jacobson, I.; Sullivan, M.; Albertson, N.; Hammond, T. G.; Sullivan, E.; Valentin, J.-P.; Pollard, C. E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological and Toxicological Methods</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">189-199</span>CODEN:
                <span class="NLM_cas:coden">JPTMEZ</span>;
        ISSN:<span class="NLM_cas:issn">1056-8719</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Introduction: Regulatory and competitive pressure to reduce the QT interval prolongation risk of potential new drugs has led to focus on methods to test for inhibition of the human ether-a-go-go-related gene (hERG)-encoded K+ channel, the primary mol. target underlying this safety issue.  Here we describe the validation of a method that combines medium-throughput with direct assessment of channel function.  Methods: The electrophysiol. and pharmacol. properties of hERG were compared using two methods: conventional, low-throughput electrophysiol. and planar-array-based, medium-throughput electrophysiol. (IonWorks HT).  A pharmacol. comparison was also made between IonWorks HT and an indirect assay (Rb+ efflux).  Results: Basic electrophysiol. properties of hERG were similar whether recorded conventionally (HEK cells) or using IonWorks HT (CHO cells): for example, tail current V1/2 - 12.1 ± 5.0 mV (32) for conventional and - 9.5 ± 6.0 mV (46) for IonWorks HT (mean ± S.D. (n)).  A key finding was that as the no. of cells per well was increased in IonWorks HT, the potency reported for a given compd. decreased.  Using the lowest possible cell concn. (250,000 cells/mL) and 89 compds. spanning a broad potency range, the pIC50 values from IonWorks HT (CHO-hERG) were found to correlate well with those obtained using conventional methodol. (HEK-hERG)(r = 0.90; p < 0.001).  Further validation using CHO-hERG cells with both methods confirmed the correlation (r = 0.94; p < 0.001).  In contrast, a comparison of IonWorks HT and Rb+ efflux data with 649 compds. using CHO-hERG cells showed that the indirect assay consistently reported compds. as being, on av., 6-fold less potent, though the differences varied depending on chem. series.  Discussion: The main finding of this work is that providing a relatively low cell concn. is used in IonWorks HT, the potency information generated correlates well with that detd. using conventional electrophysiol.  The effect on potency of increasing cell concn. may relate to a reduced free concn. of test compd. owing to partitioning into cell membranes.  In summary, the IonWorks HT hERG assay can generate pIC50 values based on a direct assessment of channel function in a timeframe short enough to influence chem. design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTcBXhwRw0nLVg90H21EOLACvtfcHk0lj_bIIJEqdrEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XptFChtbw%253D&md5=730258a42517947c0b972ca87cef46b6</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.vascn.2006.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vascn.2006.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DBridgland-Taylor%26aufirst%3DM.%2BH.%26aulast%3DHargreaves%26aufirst%3DA.%2BC.%26aulast%3DEaster%26aufirst%3DA.%26aulast%3DOrme%26aufirst%3DA.%26aulast%3DHenthorn%26aufirst%3DD.%2BC.%26aulast%3DDing%26aufirst%3DM.%26aulast%3DDavis%26aufirst%3DA.%2BM.%26aulast%3DSmall%26aufirst%3DB.%2BG.%26aulast%3DHeapy%26aufirst%3DC.%2BG.%26aulast%3DAbi-Gerges%26aufirst%3DN.%26aulast%3DPersson%26aufirst%3DF.%26aulast%3DJacobson%26aufirst%3DI.%26aulast%3DSullivan%26aufirst%3DM.%26aulast%3DAlbertson%26aufirst%3DN.%26aulast%3DHammond%26aufirst%3DT.%2BG.%26aulast%3DSullivan%26aufirst%3DE.%26aulast%3DValentin%26aufirst%3DJ.-P.%26aulast%3DPollard%26aufirst%3DC.%2BE.%26atitle%3DOptimisation%2520and%2520validation%2520of%2520a%2520medium-throughput%2520electrophysiology-based%2520hERG%2520assay%2520using%2520IonWorks%2520HT%26jtitle%3DJ.%2520Pharmacol.%2520Toxicol.%2520Methods%26date%3D2006%26volume%3D54%26spage%3D189%26epage%3D199%26doi%3D10.1016%2Fj.vascn.2006.02.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hunt, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watts, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vigers, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metcalf, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunawardana, I. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burkard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geck
Do, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutcher, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rana, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kallan, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeLisle, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzi, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regal, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sammond, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groneberg, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Purkey, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyssikatos, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marlow, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, T. P.</span></span> <span> </span><span class="NLM_article-title">Spirocyclic β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors: from hit to lowering of cerebrospinal fluid (CSF) amyloid β in a higher species</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">3379</span>– <span class="NLM_lpage">3403</span>, <span class="refDoi"> DOI: 10.1021/jm4002154</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4002154" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;key=1%3ACAS%3A528%3ADC%252BC3sXkslagsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3379-3403&author=K.+W.+Huntauthor=A.+W.+Cookauthor=R.+J.+Wattsauthor=C.+T.+Clarkauthor=G.+Vigersauthor=D.+Smithauthor=A.+T.+Metcalfauthor=I.+W.+Gunawardanaauthor=M.+Burkardauthor=A.+A.+Coxauthor=M.+K.+Geck%0ADoauthor=D.+Dutcherauthor=A.+A.+Thomasauthor=S.+Ranaauthor=N.+C.+Kallanauthor=R.+K.+DeLisleauthor=J.+P.+Rizziauthor=K.+Regalauthor=D.+Sammondauthor=R.+Gronebergauthor=M.+Siuauthor=H.+Purkeyauthor=J.+P.+Lyssikatosauthor=A.+Marlowauthor=X.+Liuauthor=T.+P.+Tang&title=Spirocyclic+%CE%B2-site+amyloid+precursor+protein+cleaving+enzyme+1+%28BACE1%29+inhibitors%3A+from+hit+to+lowering+of+cerebrospinal+fluid+%28CSF%29+amyloid+%CE%B2+in+a+higher+species&doi=10.1021%2Fjm4002154"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Spirocyclic β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors: From Hit to Lowering of Cerebrospinal Fluid (CSF) Amyloid β in a Higher Species</span></div><div class="casAuthors">Hunt, Kevin W.; Cook, Adam W.; Watts, Ryan J.; Clark, Christopher T.; Vigers, Guy; Smith, Darin; Metcalf, Andrew T.; Gunawardana, Indrani W.; Burkard, Michael; Cox, April A.; Geck Do, Mary K.; Dutcher, Darrin; Thomas, Allen A.; Rana, Sumeet; Kallan, Nicholas C.; DeLisle, Robert K.; Rizzi, James P.; Regal, Kelly; Sammond, Douglas; Groneberg, Robert; Siu, Michael; Purkey, Hans; Lyssikatos, Joseph P.; Marlow, Allison; Liu, Xingrong; Tang, Tony P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3379-3403</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A hallmark of Alzheimer's disease is the brain deposition of amyloid beta (Aβ), a peptide of 36-43 amino acids that is likely a primary driver of neurodegeneration.  Aβ is produced by the sequential cleavage of APP by BACE1 and γ-secretase; therefore, inhibition of BACE1 represents an attractive therapeutic target to slow or prevent Alzheimer's disease.  Herein are described BACE1 inhibitors with limited mol. flexibility and mol. wt. that decrease CSF Aβ in vivo, despite efflux.  Starting with spirocycle I, the authors explore structure-activity relationships of core changes, P3 moieties, and Asp binding functional groups in order to optimize BACE1 affinity, cathepsin D selectivity, and blood-brain barrier (BBB) penetration.  Using wild type guinea pig and rat, they demonstrate a PK/PD relationship between free drug concns. in the brain and CSF Aβ lowering.  Optimization of brain exposure led to the discovery of (R)-II which reduced CSF Aβ in rodents and in monkey.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYTaFN1ZrY-bVg90H21EOLACvtfcHk0lhzRQbndWnPXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXkslagsLg%253D&md5=b0f610967870013abee4a4bf4ce28b7f</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm4002154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4002154%26sid%3Dliteratum%253Aachs%26aulast%3DHunt%26aufirst%3DK.%2BW.%26aulast%3DCook%26aufirst%3DA.%2BW.%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26aulast%3DClark%26aufirst%3DC.%2BT.%26aulast%3DVigers%26aufirst%3DG.%26aulast%3DSmith%26aufirst%3DD.%26aulast%3DMetcalf%26aufirst%3DA.%2BT.%26aulast%3DGunawardana%26aufirst%3DI.%2BW.%26aulast%3DBurkard%26aufirst%3DM.%26aulast%3DCox%26aufirst%3DA.%2BA.%26aulast%3DGeck%2BDo%26aufirst%3DM.%2BK.%26aulast%3DDutcher%26aufirst%3DD.%26aulast%3DThomas%26aufirst%3DA.%2BA.%26aulast%3DRana%26aufirst%3DS.%26aulast%3DKallan%26aufirst%3DN.%2BC.%26aulast%3DDeLisle%26aufirst%3DR.%2BK.%26aulast%3DRizzi%26aufirst%3DJ.%2BP.%26aulast%3DRegal%26aufirst%3DK.%26aulast%3DSammond%26aufirst%3DD.%26aulast%3DGroneberg%26aufirst%3DR.%26aulast%3DSiu%26aufirst%3DM.%26aulast%3DPurkey%26aufirst%3DH.%26aulast%3DLyssikatos%26aufirst%3DJ.%2BP.%26aulast%3DMarlow%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DTang%26aufirst%3DT.%2BP.%26atitle%3DSpirocyclic%2520%25CE%25B2-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520%2528BACE1%2529%2520inhibitors%253A%2520from%2520hit%2520to%2520lowering%2520of%2520cerebrospinal%2520fluid%2520%2528CSF%2529%2520amyloid%2520%25CE%25B2%2520in%2520a%2520higher%2520species%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3379%26epage%3D3403%26doi%3D10.1021%2Fjm4002154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunt, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newhouse, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watts, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vigers, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rhodes, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otten, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burkard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geck
Do, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutcher, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rana, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeLisle, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regal, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groneberg, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scearce-Levie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Purkey, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyssikatos, J. P.</span></span> <span> </span><span class="NLM_article-title">8-Tetrahydropyran-2-yl chromans: highly selective β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">10112</span>– <span class="NLM_lpage">10129</span>, <span class="refDoi"> DOI: 10.1021/jm5015132</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5015132" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=10112-10129&author=A.+A.+Thomasauthor=K.+W.+Huntauthor=B.+Newhouseauthor=R.+J.+Wattsauthor=X.+Liuauthor=G.+Vigersauthor=D.+Smithauthor=S.+P.+Rhodesauthor=K.+D.+Brownauthor=J.+N.+Ottenauthor=M.+Burkardauthor=A.+A.+Coxauthor=M.+K.+Geck%0ADoauthor=D.+Dutcherauthor=S.+Ranaauthor=R.+K.+DeLisleauthor=K.+Regalauthor=A.+D.+Wrightauthor=R.+Gronebergauthor=J.+Liaoauthor=K.+Scearce-Levieauthor=M.+Siuauthor=H.+E.+Purkeyauthor=J.+P.+Lyssikatos&title=8-Tetrahydropyran-2-yl+chromans%3A+highly+selective+%CE%B2-site+amyloid+precursor+protein+cleaving+enzyme+1+%28BACE1%29+inhibitors&doi=10.1021%2Fjm5015132"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm5015132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5015132%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DA.%2BA.%26aulast%3DHunt%26aufirst%3DK.%2BW.%26aulast%3DNewhouse%26aufirst%3DB.%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DVigers%26aufirst%3DG.%26aulast%3DSmith%26aufirst%3DD.%26aulast%3DRhodes%26aufirst%3DS.%2BP.%26aulast%3DBrown%26aufirst%3DK.%2BD.%26aulast%3DOtten%26aufirst%3DJ.%2BN.%26aulast%3DBurkard%26aufirst%3DM.%26aulast%3DCox%26aufirst%3DA.%2BA.%26aulast%3DGeck%2BDo%26aufirst%3DM.%2BK.%26aulast%3DDutcher%26aufirst%3DD.%26aulast%3DRana%26aufirst%3DS.%26aulast%3DDeLisle%26aufirst%3DR.%2BK.%26aulast%3DRegal%26aufirst%3DK.%26aulast%3DWright%26aufirst%3DA.%2BD.%26aulast%3DGroneberg%26aufirst%3DR.%26aulast%3DLiao%26aufirst%3DJ.%26aulast%3DScearce-Levie%26aufirst%3DK.%26aulast%3DSiu%26aufirst%3DM.%26aulast%3DPurkey%26aufirst%3DH.%2BE.%26aulast%3DLyssikatos%26aufirst%3DJ.%2BP.%26atitle%3D8-Tetrahydropyran-2-yl%2520chromans%253A%2520highly%2520selective%2520%25CE%25B2-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520%2528BACE1%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D10112%26epage%3D10129%26doi%3D10.1021%2Fjm5015132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1W50" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1W50','PDB','1W50'); return false;">PDB: 1W50</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EJ3" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EJ3','PDB','6EJ3'); return false;">PDB: 6EJ3</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EJ2" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EJ2','PDB','6EJ2'); return false;">PDB: 6EJ2</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i35"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01716">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_61885"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b01716">10.1021/acs.jmedchem.7b01716</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">General methods (experimental details for analytical methods); protocols describing the preparation of intermediates for the synthesis of compounds <b>25</b>, <b>27</b>, <b>29</b>; experimental details for the determination of the crystal structures of compounds <b>23</b> and <b>28</b>; protocols for all biological, in vitro metabolic and in vivo pharmacokinetic assays; molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01716/suppl_file/jm7b01716_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01716/suppl_file/jm7b01716_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01716/suppl_file/jm7b01716_si_001.pdf">jm7b01716_si_001.pdf (288.33 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01716/suppl_file/jm7b01716_si_002.csv">jm7b01716_si_002.csv (3.03 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The coordinates and structure factors of compounds <b>23</b> and <b>28</b> have been deposited to the Protein Data Bank with PDB codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EJ3">6EJ3</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EJ2">6EJ2</a>, respectively. Authors will release the atomic coordinates and experimental data upon article publication.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b01716%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-8%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b01716" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67990a54da1a3cc4","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
